Freedom Holding (FRHC) 10-Q 14 Feb 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Dec. 31, 2022	Feb. 14, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	001-33034
Entity Registrant Name	FREEDOM HOLDING CORP.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	30-0233726
Entity Address, Address Line One	“Esentai Tower” BC, Floor 7
Entity Address, Address Line Two	77/7 Al Farabi Ave
Entity Address, City or Town	Almaty
Entity Address, Country	KZ
Entity Address, Postal Zip Code	50040
City Area Code	+7 727
Local Phone Number	311 10 64
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	FRHC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		59,542,212
Entity Central Index Key	0000924805
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
ASSETS
Cash and cash equivalents	$ 664,095	$ 225,464	[1]
Restricted cash	449,979	547,950	[1]
Trading securities	1,929,840	1,158,377	[1]
Available-for-sale securities, at fair value	174,326	161,364	[1]
Margin lending, brokerage and other receivables, net	403,568	147,659	[1]
Loans issued	639,377	92,446	[1]
Fixed assets, net	43,862	17,823	[1]
Intangible assets, net	9,010	5,163	[1]
Goodwill	9,460	5,898	[1]
Right-of-use asset	24,054	7,431	[1]
Insurance contract assets	11,243	5,712	[1]
Other assets	47,754	27,044	[1]
Assets held for sale	961,566	825,419	[1]
TOTAL ASSETS	5,368,134	3,227,750	[1]
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations	1,233,928	840,224	[1]
Customer liabilities	1,786,452	765,628	[1]
Margin lending and trade payables	142,341	45,083	[1]
Liabilities from insurance activity	156,542	119,490	[1]
Current income tax liability	0	14,556	[1]
Securities sold, not yet purchased – at fair value	0	13,865	[1]
Debt securities issued	37,192	34,390	[1]
Lease liability	24,175	7,504	[1]
Payable for acquisition	16,055	0	[1]
Liability arising from continuing involvement	319,694	6,447
Other liabilities	37,940	21,477	[1]
Liabilities held for sale	931,484	812,478	[1]
TOTAL LIABILITIES	4,685,803	2,681,142	[1]
Commitments and Contingent Liabilities (Note 26)	0	0	[1]
SHAREHOLDERS’ EQUITY
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding	0	0	[1]
Common stock - $0.001 par value; 500,000,000 shares authorized; 59,542,212 shares issued and outstanding as of December 31, 2022, and March 31, 2022, respectively	59	59	[1]
Additional paid in capital	159,580	174,745	[1]
Retained earnings	592,115	441,924	[1]
Accumulated other comprehensive loss	(60,920)	(63,125)	[1]
TOTAL FRHC SHAREHOLDERS’ EQUITY	690,834	553,603	[1]
Non-controlling interest	(8,503)	(6,995)	[1]
TOTAL SHAREHOLDERS’ EQUITY	682,331	546,608	[1]
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 5,368,134	$ 3,227,750	[1]
Common stock, issued (in shares)	59,542,212	59,542,212
Common stock, outstanding (in shares)	59,542,212	59,542,212
[1]* Please see Note 3

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2022	Mar. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	20,000,000	20,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	500,000,000	500,000,000
Common stock, issued (in shares)	59,542,212	59,542,212
Common stock, outstanding (in shares)	59,542,212	59,542,212

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND STATEMENTS OF OTHER COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Revenue:
Fee and commission income	$ 80,883	$ 91,408	$ 253,486	$ 262,549
Net gain on trading securities	25,456	7,663	38,894	197,947
Interest income	80,255	33,657	187,817	82,514
Insurance underwriting income	28,557	21,394	78,998	51,491
Net gain on foreign exchange operations	20,866	1,361	30,014	4,076
Net loss on derivative	(21,469)	(314)	(22,523)	(1,028)
Total revenue, net	214,548	155,169	566,686	597,549
Expense:
Fee and commission expense	18,314	24,782	60,068	68,626
Interest expense	52,037	21,890	132,971	52,852
Insurance claims incurred, net of reinsurance	17,419	16,286	51,586	41,096
Operating expense	50,608	31,581	126,367	72,772
Provision for impairment losses/(recovery)	24,140	(333)	30,294	911
Other expense	570	979	79	2,426
TOTAL EXPENSE	163,088	95,185	401,365	238,683
INCOME BEFORE INCOME TAX	51,460	59,984	165,321	358,866
Income tax expense	(5,069)	(1,806)	(26,567)	(39,026)
INCOME FROM CONTINUING OPERATIONS	46,391	58,178	138,754	319,840
Income/(loss) before income tax (expense)/benefit of discontinued operations (including loss on disposal of $2,509 and $0 for the three months ended December 31, 2022 and 2021, respectively, and loss on disposal of $43,973 and $0 for nine months ended December 31, 2022 and 2021, respectively, see Note 25)	13,667	(5,067)	14,467	(4,609)
Income tax (expense)/benefit of discontinued operations	2,342	962	(4,538)	953
Income/(loss) from discontinued operations	16,009	(4,105)	9,929	(3,656)
NET INCOME	62,400	54,073	148,683	316,184
Less: Net loss attributable to non-controlling interest in subsidiary	(464)	(343)	(1,508)	(415)
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS	62,864	54,416	150,191	316,599
OTHER COMPREHENSIVE INCOME
Change in unrealized gain on investments available-for-sale, net of tax effect	(54)	(1,063)	2,309	(1,789)
Reclassification adjustment for net realized loss on available-for-sale investments disposed of in the period, net of tax effect	320	953	197	1,606
Foreign currency translation adjustments	(5,611)	(8,650)	(301)	(4,447)
OTHER COMPREHENSIVE (LOSS)/ INCOME	(5,345)	(8,760)	2,205	(4,630)
COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS	57,055	45,313	150,888	311,554
Less: Comprehensive loss attributable to non-controlling interest in subsidiary	(464)	(343)	(1,508)	(415)
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ 57,519	$ 45,656	$ 152,396	$ 311,969
EARNINGS PER COMMON SHARE (In U.S. dollars):
Earnings from continuing operations per common share - basic (in USD per share)	$ 0.79	$ 0.98	$ 2.37	$ 5.40
Earnings from continuing operations per common share - diluted (in USD per share)	0.78	0.98	2.33	5.40
Earnings/(loss) from discontinued operations per common share - basic (in USD per share)	0.59	(0.07)	0.49	(0.06)
Earnings/(loss) from discontinued operations per common share - diluted (in USD per share)	0.58	(0.07)	0.48	(0.06)
Earnings per common share-basic (in USD per share)	1.38	0.91	2.86	5.34
Earnings per common share- diluted (in USD per share)	$ 1.36	$ 0.91	$ 2.81	$ 5.34
Weighted average number of shares, basic (in shares)	58,678,730,000	59,534,712,000	58,642,637,000	59,326,201,000
Weighted average number of shares, diluted (in shares)	59,522,701,000	59,534,712,000	59,527,743,000	59,326,201,000

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows From Operating Activities
NET INCOME	$ 148,683,000	$ 316,184,000
Net income/(loss) from discontinued operations	9,929,000	(3,656,000)
Net income from continued operations	138,754,000	319,840,000
Adjustments to reconcile net income used in operating activities:
Depreciation and amortization	3,502,000	2,854,000
Noncash lease expense	3,453,000	2,587,000
Change in deferred taxes	(3,392,000)	(2,508,000)
Stock compensation expense	6,520,000	5,636,000
Unrealized gain on trading securities	(65,684,000)	(7,903,000)
Net change in accrued interest	(35,984,000)	(27,858,000)
Change in insurance reserves	42,236,000	35,381,000
Allowances for receivables	30,294,000	907,000
Changes in operating assets and liabilities:
Trading securities	(630,879,000)	(364,995,000)
Margin lending, brokerage and other receivables	(270,725,000)	(141,678,000)
Insurance contract assets	6,460,000	(106,000)
Other assets	(11,058,000)	(12,028,000)
Securities sold, not yet purchased – at fair value	(13,865,000)	5,979,000
Brokerage customer liabilities	240,362,000	(230,143,000)
Current income tax liability	(14,556,000)	6,404,000
Margin lending and trade payables	92,225,000	28,720,000
Lease liabilities	(3,470,000)	(2,839,000)
Liabilities from insurance activity	(22,581,000)	(7,937,000)
Other liabilities	10,432,000	735,000
Net cash flows used in operating activities from continuing operations	(497,956,000)	(388,952,000)
Net cash flows from/(used in) operating activities from discontinued operations	32,165,000	(222,901,000)
Net cash flows used in operating activities	(465,791,000)	(611,853,000)
Cash Flows Used In Investing Activities
Purchase of fixed assets	(27,345,000)	(4,078,000)
Proceeds from sale of fixed assets	0	172,000
Purchase from microfinance organizations loans, net	(57,031,000)	(22,192,000)
Net change in loans issued to customers	(507,728,000)	(11,946,000)
Purchase of available-for-sale securities, at fair value	(205,781,000)	(223,482,000)
Proceeds from sale of available-for-sale securities, at fair value	196,799,000	171,221,000
Consideration paid for acquisition of London Almaty	(16,343,000)	0
Consideration paid for acquisition of Freedom Life	(13,630,000)	0
Cash, cash equivalents and restricted cash received from acquisitions	11,385,000	0
Net cash flows used in investing activities from continuing operations	(619,674,000)	(90,305,000)
Net cash flows used in investing activities from discontinued operations	(21,647,000)	(2,790,000)
Net cash flows used in investing activities	(641,321,000)	(93,095,000)
Cash Flows From Financing Activities
Proceeds from securities repurchase agreement obligations	388,675,000	315,383,000
Proceeds from issuance of debt securities	23,861,000	13,000,000
Repurchase of debt securities	(23,387,000)	(10,104,000)
Repurchase of mortgage loans under the State Program	(7,117,000)	0
Funds received under state program for financing of mortgage loans	318,330,000	0
Net change in bank customer deposits	779,044,000	83,448,000
Capital contributions	677,000	1,966,000
Exercise of options	0	119,000
Net cash flows from financing activities from continuing operations	1,480,083,000	403,812,000
Net cash flows from financing activities from discontinued operations	26,105,000	37,982,000
Net cash flows from financing activities	1,506,188,000	441,794,000
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations	23,591,000	(7,321,000)
Effect of changes in foreign exchange rates on cash and cash equivalents from discontinued operations	61,473,000	13,695,000
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	484,140,000	(256,780,000)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD FROM CONTINUED OPERATIONS	773,414,000	659,495,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD FROM DISCONTINUED OPERATIONS	456,886,000	559,385,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD	1,230,300,000	1,218,880,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD FROM CONTINUED OPERATIONS	1,114,074,000	582,376,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD FROM DISCONTINUED OPERATIONS	600,366,000	379,724,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD	1,714,440,000	962,100,000
Supplemental disclosure of cash flow information:
Cash paid for interest	133,286,000	29,190,000
Income tax paid	47,262,000	42,237,000
Supplemental non-cash disclosures:
Operating lease right-of-use assets obtained/disposed of in exchange for operating lease obligations during the period, net	19,089,000	4,684,000
Cash and cash equivalents	664,095,000	165,633,000
Restricted cash	449,979,000	416,743,000
Total cash, cash equivalents and restricted cash shown as in the statement of cash flows	$ 1,114,074,000	$ 582,376,000

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited) - USD ($) $ in Thousands	Total		Parent	Common Stock	Additional paid in capital	Retained earnings	Accumulated other comprehensive (loss)/income	Non- controlling interest
Beginning balance (in shares) at Mar. 31, 2021				58,443,212,000
Equity, beginning of period at Mar. 31, 2021	$ 307,671		$ 309,312	$ 58	$ 135,260	$ 214,427	$ (40,433)	$ (1,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation	11,281		11,281	$ 1	11,280
Stock based compensation (in shares)				1,031,500,000
Sale of Freedom Ukraine shares	416		(796)		(796)			1,212
Contribution of shareholder	1,966		1,966		1,966
Exercise of options (in shares)				60,000,000
Exercise of options	119		119		119
Other comprehensive loss	(183)		(183)				(183)
Translation difference	(4,447)		(4,447)				(4,447)
Net income/(loss)	316,184		316,599			316,599		(415)
Ending balance (in shares) at Dec. 31, 2021				59,534,712,000
Equity, end of period at Dec. 31, 2021	633,007		633,851	$ 59	147,829	531,026	(45,063)	(844)
Beginning balance (in shares) at Sep. 30, 2021				59,534,712,000
Equity, beginning of period at Sep. 30, 2021	583,132		583,633	$ 59	143,268	476,610	(36,304)	(501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation	4,561		4,561		4,561
Other comprehensive loss	(109)		(109)				(109)
Translation difference	(8,650)		(8,650)				(8,650)
Net income/(loss)	54,073		54,416			54,416		(343)
Ending balance (in shares) at Dec. 31, 2021				59,534,712,000
Equity, end of period at Dec. 31, 2021	$ 633,007		633,851	$ 59	147,829	531,026	(45,063)	(844)
Beginning balance (in shares) at Mar. 31, 2022	59,542,212			59,542,212
Equity, beginning of period at Mar. 31, 2022	$ 546,608	[1]	553,603	$ 59	174,745	441,924	(63,125)	(6,995)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation	10,746		10,746		10,746
Contribution of shareholder	677		677		677
Other comprehensive loss	2,506		2,506				2,506
Acquisition of insurance companies	(26,588)		(26,588)		(26,588)
Translation difference	(301)		(301)				(301)
Net income/(loss)	$ 148,683		150,191			150,191		(1,508)
Ending balance (in shares) at Dec. 31, 2022	59,542,212			59,542,212
Equity, end of period at Dec. 31, 2022	$ 682,331		690,834	$ 59	159,580	592,115	(60,920)	(8,503)
Beginning balance (in shares) at Sep. 30, 2022				59,542,212
Equity, beginning of period at Sep. 30, 2022	621,331		629,370	$ 59	155,635	529,251	(55,575)	(8,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation	3,945		3,945		3,945
Other comprehensive loss	266		266				266
Translation difference	(5,611)		(5,611)				(5,611)
Net income/(loss)	$ 62,400		62,864			62,864		(464)
Ending balance (in shares) at Dec. 31, 2022	59,542,212			59,542,212
Equity, end of period at Dec. 31, 2022	$ 682,331		$ 690,834	$ 59	$ 159,580	$ 592,115	$ (60,920)	$ (8,503)
[1]* Please see Note 3

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND STATEMENTS OF OTHER COMPREHENSIVE INCOME (Unaudited) (Parenthetical)) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Provision for impairment of discontinued operations	$ 0	$ (43,973)	$ 0

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	9 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS	DESCRIPTION OF BUSINESS Overview Freedom Holding Corp. (the "Company" or "FRHC") is a corporation organized in the United States under the laws of the State of Nevada that through its operating subsidiaries provides financial services including retail securities brokerage, research, investment counseling, securities trading, market making, retail banking, corporate investment banking and underwriting services, commercial banking and insurance products. The Company is headquartered in Almaty, Kazakhstan, with supporting administrative office locations in Cyprus, the United States and Russia (with the Russian business classified as discontinued operations pending sale). The Company has retail locations in Kazakhstan, Russia (with the Russian business classified as discontinued operations pending sale), Ukraine, Uzbekistan, Kyrgyzstan, Azerbaijan, Armenia, Cyprus, the United Kingdom, Greece, Spain, France, Germany, the United Arab Emirates and Turkey. The Company also has a subsidiary in the United States which is a U.S. Securities and Exchange Commission ("SEC") registered broker dealer. The Company's common stock trades on the Nasdaq Capital Market, KASE, AIX and SPBX. As of December 31, 2022, the Company owned directly, or through subsidiaries, the following companies: • Freedom Finance JSC, an Almaty, Kazakhstan-based securities broker-dealer ("Freedom KZ"); • Freedom Finance Global PLC, an Astana International Financial Centre-based securities broker-dealer ("Freedom Global"); • Bank Freedom Finance Kazakhstan JSC, an Almaty, Kazakhstan-based bank ("Freedom Bank KZ"); • Freedom Finance Life JSC, an Almaty, Kazakhstan-based life/health insurance company ("Freedom Life"); • Freedom Finance Insurance JSC, an Almaty, Kazakhstan-based general insurance company ("Freedom Insurance"); • Freedom Finance Special Purpose Company LTD, an Astana International Financial Centre-based special purpose company ("Freedom SPC"); • Freedom Finance Commercial LLP, a Kazakhstan-based sales consulting company ("Freedom Commercial"); • Freedom Finance Europe Limited, a Limassol, Cyprus-based broker-dealer ("Freedom EU"); • Freedom Finance Technologies Ltd, a Limassol, Cyprus-based IT development company ("Freedom Technologies"); • Freedom Finance Germany GmbH, a Berlin, Germany-based tied agent of Freedom EU ("Freedom GE"); • Freedom UK Prime Limited, a London, United Kingdom-based financial intermediary company ("Prime UK"); • Freedom Finance Uzbekistan LLC, a Tashkent, Uzbekistan-based broker-dealer ("Freedom UZ"); • Freedom Finance Azerbaijan LLC, an Azerbaijan-based financial educational center ("Freedom AZ"); • Freedom Finance Armenia LLC, an Armenia-based broker-dealer ("Freedom AR"); • Prime Executions, Inc., a New York City, New York-based NYSE institutional brokerage, that is also authorized to engage in certain capital markets and investment banking activities ("PrimeEx"); • FFIN Securities, Inc., a currently-dormant Nevada corporation ("FFIN"); • Freedom Finance Ltd., a Dubai, United Arab Emirates-based financial intermediary company ("Freedom UAE"); • ITS Tech Limited, an Astana International Financial Centre-based, IT-support company ("ITS Tech"); • Freedom Kazakhstan PC Ltd. ("Freedom Kazakhstan PC Ltd.") • Ticketon Events LLP, an Almaty, Kazakhstan-based online ticket sales company ("Ticketon"); • Freedom Finance Turkey LLC, an Istanbul, Turkiye-based financial consulting company ("Freedom TR"); • Investment Company Freedom Finance LLC, a Moscow, Russia-based securities broker-dealer ("Freedom RU"); • FFIN Bank LLC, a Moscow, Russia-based bank ("Freedom Bank RU"); and • Freedom Finance Auto LLC, a Russia-based car loans company ("Freedom Auto"). The Company also owns a 9% interest in Freedom Finance Ukraine LLC, a Kiev, Ukraine-based broker-dealer ("Freedom UA"). The remaining 91% interest in Freedom UA is controlled by Askar Tashtitov, the Company's president. The Company has entered into a series of contractual arrangements with Freedom UA and Mr. Tashtitov, including a consulting services agreement, an operating agreement and an option agreement. Because such agreements obligate the Company to guarantee the performance of all Freedom UA obligations and provide Freedom UA sufficient funding to cover all Freedom UA operating losses and net capital requirements, enable the Company to receive 90% of the net profits of Freedom UA after tax, and require the Company to provide Freedom UA the management competence, operational support, and ongoing access to the Company's significant assets, necessary technology resources and expertise to conduct the business of Freedom UA, the Company determined that Freedom UA is a variable interest entity ("VIE"). Accordingly, the Company consolidated Freedom UA into the financial statements of the Company. Prior to July 2021, the Company controlled approximately 32.9% of Freedom UA, but due to changes to Ukrainian regulations to restrict foreign ownership of registered Ukrainian broker-dealers, in July 2021, the Company was required to sell approximately 23.9% of its equity interest in Freedom UA to Mr. Tashtitov, reducing the Company's direct ownership interest in Freedom UA to approximately 9%. The Company has entered into an agreement to sell its Russian subsidiaries, Freedom RU and Freedom Bank RU. For financial information regarding the Company's Russian subsidiaries see Note 25 - Assets and Liabilities held for sale and Divestiture of our Russian Subsidiaries in the Overview section of Management's Discussion and Analysis of Financial Condition and Results of Operations in this quarterly report on Form 10-Q. The sale of the Company's Russian subsidiaries was approved by the Central Bank of the Russian Federation on February 10, 2023, and the sale is expected to be completed before the end of February 2023. In July 2022, Freedom RU established a Russian subsidiary Freedom Finance Auto LLC. In January 2023, Freedom RU concluded an agreement with Maxim Povalishin to sell Freedom Finance Auto LLC for RUB 50 million (approximately $695 based on the applicable currency exchange rate on the reporting date). On February 7, 2023, the sale of Freedom Finance Auto LLC was completed. Through its subsidiaries, the Company is a professional participant, with a license to provide one or more types of services, on a number of stock exchanges, including the Kazakhstan Stock Exchange (KASE), the Astana International Stock Exchange (AIX), the Moscow Exchange (MOEX), the Saint-Petersburg Exchange (SPBX), the Ukrainian Exchange (UX), the Republican Stock Exchange of Tashkent (UZSE) and the Uzbek Republican Currency Exchange (UZCE) and is a member of the New York Stock Exchange (NYSE) and the Nasdaq Stock Exchange (Nasdaq). The Company also owns a 24.3% interest in the UX. Freedom EU provides the Company's clients with operational support and access to investment opportunities in the U.S. and European securities markets. On October 19, 2022, Freedom UA's brokerage license was suspended for a period of five years and its assets were frozen by the Ukrainian authorities following its inclusion on a sanctions list of the Ukrainian government. As of December 31, 2022, Freedom UA's total assets and total liabilities of $7,835 and $7,284, respectively, were reclassified to restricted assets and liabilities as part of other assets and other liabilities, respectively. The Company believes that the decision to include Freedom UA on such list was erroneous and it is in the process of appealing such decision. Unless otherwise specifically or contextually indicated, the “Company” refers to FRHC, together with its consolidated subsidiaries.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting principles The Company's accounting policies and accompanying condensed consolidated financial statements conform to accounting principles generally accepted in the United States of America (U.S. GAAP). Basis of presentation and principles of consolidation The condensed consolidated financial statements present the condensed consolidated accounts of FRHC and its consolidated subsidiaries. In the opinion of management, all normal, recurring adjustments necessary for fair presentation of the condensed consolidated financial statements have been included. Consolidation of variable interest entities In accordance with accounting standards regarding consolidation of variable interest entities ("VIEs"), VIEs are generally entities that lack sufficient equity to finance their activities without additional subordinated financial support from other parties or whose equity holders at risk lack adequate decision making ability. VIEs must be evaluated to determine the primary beneficiary of the risks and rewards of the VIE. The primary beneficiary is required to consolidate the VIE for financial reporting purposes. As of and for the three and nine months ended December 31, 2022, the only VIE of the Company was Freedom UA. The carrying amounts of the VIE’s consolidated assets and liabilities are as follows: December 31, 2022 March 31, 2022 Cash and cash equivalents 1 134 Restricted cash 1,942 2,843 Trading securities 3,477 2,942 Margin lending, brokerage and other receivables, net 967 435 Fixed assets, net 800 1,043 Intangible assets, net 140 205 Right-of-use asset 424 905 Other assets 84 127 Total assets 7,835 8,634 Customer liabilities 6,441 8,439 Securities repurchase agreement obligations 12 3,267 Trade payables 81 35 Lease liability 454 914 Other liabilities 296 434 Total liabilities 7,284 13,089 Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that the estimates utilized in preparing the Company's financial statements are reasonable and prudent. Actual results could differ from those estimates. Revenue and expense recognition Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers ("ASC Topic 606"), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity's contracts to provide goods or services to customers. The core principle requires an entity to recognize revenue to depict the transfer of goods or services promised to customers in an amount that reflects the consideration that it expects to be entitled to receive in exchange for those goods or services recognized as performance obligations are satisfied. A significant portion of the Company's revenue-generating transactions are not subject to ASC Topic 606, including revenue generated from financial instruments, such as loans and investment securities, as these activities are subject to other U.S. GAAP guidance discussed elsewhere within these disclosures. Descriptions of the Company's revenue-generating activities that are within the scope of ASC Topic 606, which are presented in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income as components of total revenue, net are as follows: • Commissions on brokerage services; • Commissions on banking services (money transfers, foreign exchange operations and other); and • Commissions on investment banking services (underwriting, market making, and bondholders' representation services). Gross Versus Net Revenue ASC 606 provides guidance on proper recognition of principal versus agent considerations which is used to determine gross versus net revenue recognition. Under ASC 606, the core objective of the guidance on gross versus net revenue recognition is to help determine whether the Company is a principal or an agent in a transaction. In general, the primary difference between these two is the performance obligation being satisfied. The principal has a performance obligation to provide the desired goods or services to the end customer, whereas the agent arranges for the principal to provide the desired goods or services. Additionally, a fundamental characteristic of a principal in a transaction is control. A principal substantively controls the goods and services before they are transferred to the customer as well as controls the price of the good or service being provided. An agent normally receives a commission or fee for these activities. In addition to control, the level at which the Com controls the price of the good or service being transferred determines principal versus agent status. The more discretion over setting price a company has in providing the good or service, the more likely they are considered a principal rather than an agent. In certain cases, other parties are involved with providing products and services to our customers. If the Company is principal in the transaction (providing goods or services itself), revenues are reported based on the gross consideration received from the customer and any related expenses are reported gross in noninterest expense. If the Company is an agent in the transaction (arranging for another party to provide goods or services), the Company reports its net fee or commission retained as revenue. Interest income Interest income on margin loans, loans issued, trading securities, available-for-sale securities and reverse repurchase agreement obligations is recognized based on the contractual provisions of the underlying arrangements. Loan premiums and discounts are deferred and generally amortized into interest income as yield adjustments over the contractual life and/or commitment period using the effective interest method. Unamortized premiums, discounts and other basis adjustments on trading securities are generally recognized in interest income over the contractual lives of the securities using the effective interest method. Loans The Company's loan portfolio is divided into: mortgages, uncollateralized bank customer loans, collateralized bank customer loans, car loans and subordinated loans. Mortgage loans consist of loans provided to individuals to purchase real estate, which is used as collateral for the loan. Uncollateralized bank customer loans consist of loans provided through credit cards to individuals and retail unsecured banking loans provided to individuals. Collateralized bank customer loans consist of retail collateralized loans provided to individuals. Subordinated loans consist of uncollateralized loans provided to the legal entities to support their businesses, that ranks below other, more senior loans or securities with respect to claims on assets or earnings. Margin loans are not classified as part of the Company's loan portfolio and are instead recorded on the Condensed Consolidated Balance Sheets under Margin lending, brokerage and other receivables, net. Loans Acquired All purchased loans are initially recorded at fair value, which includes consideration of expected future losses, at the date of the loan acquisition. To determine the fair value of loans at the date of acquisition, the Company estimates the discounted contractual cash flows due using an observable market rate of interest, adjusted for factors such as probable default rates of the borrowers, and the loan terms that a market participant would consider in determining fair value. In determining fair value, contractual cash flows are adjusted to include prepayment estimates based upon historical payment trends, forecasted default rates and loss severities and other relevant factors. The difference between the fair value and the contractual cash flows is recorded as a loan premium or discount, which may relate to either credit or non-credit factors, at acquisition. The Company accounts for purchased loans under the accounting guidance for purchased financial assets with credit deterioration when, at the time of purchase, the loans have experienced a more-than-insignificant deterioration in credit quality since origination. The Company recognizes an allowance for credit losses on purchased loans that have not experienced a more-than-insignificant deterioration in credit quality since origination at the time of purchase through earnings in a manner that is consistent with originated loans. The policies relating to the allowance for credit losses on loans is described below in the "Estimate of Incurred Loan Losses" section of this Note. Estimate of Incurred Loan Losses The allowance represents management's current estimate of incurred loan losses inherent in the Company's loan portfolio as of each balance sheet date. The provision for credit losses reflects credit losses the Company believes have been incurred and will eventually be recognized over time through charge-offs. Management performed a quarterly analysis of the Company's loan portfolio to determine if impairment had occurred and to assess the adequacy of the allowance based on historical and current trends as well as other factors affecting credit losses. The Company applied separate calculations of the allowances for its credit cards, mortgages and retail loan portfolios. Based on the adopted methodology, the Company estimated the probability of default based on historical default rates, adjusted for certain macro indicators, such as GDP, average exchange rates, unemployment rate, real wage index, inflation rate and retail trade index. Loss given default is calculated based on the collateral coverage of the loans. The Company's allowance for loan losses consists of two components that are allocated to cover the estimated probable losses in each loan portfolio based on the results of the Company's detailed review and loan impairment assessment process a component for loans collectively evaluated for impairment. Derivative financial instruments In the normal course of business, the Company invests in various derivative financial contracts including futures. Derivatives are initially recognized at fair value at the date a derivative contract is entered into and are subsequently re-measured to their fair value at each reporting date. The fair values are estimated based on quoted market prices or pricing models that take into account the current market and contractual prices of the underlying instruments and other factors. Derivatives are carried as assets when their fair value is positive and as liabilities when it is negative. Functional currency Management has adopted ASC 830, Foreign Currency Translation Matters as it pertains to its foreign currency translation. The Company's functional currencies are the Kazakhstan tenge, the Russian ruble, the euro, the U.S. dollar, the Ukrainian hryvnia, the Uzbekistani som, the Kyrgyzstani som, the Azerbaijani manat, the British pound sterling, the Armenian dram, the United Arab Emirates dirham and the Turkish lira, and its reporting currency is the U.S. dollar. For financial reporting purposes, foreign currencies are translated into U.S. dollars as the reporting currency. Monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average quarterly rates are used to translate revenues and expenses. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of shareholders' equity as "Accumulated other comprehensive loss". The Company uses exchange rates from the National Bank of the Republic of Kazakhstan for foreign currency translation purposes. Cash and cash equivalents Cash and cash equivalents are generally comprised of certain highly liquid investments with original maturities of three months or less at the date of purchase. Cash and cash equivalents include those reverse repurchase agreements, where maturity is less than 90 days, and the credit risk of the counterparty is low, which are recorded at the amounts at which the securities were acquired plus accrued interest. Securities reverse repurchase and repurchase agreements A reverse repurchase agreement is a transaction in which the Company purchases financial instruments from a seller, typically in exchange for cash, and simultaneously enters into an agreement to resell the same or substantially the same financial instruments to the seller for an amount equal to the cash or other consideration exchanged plus interest at a future date. Securities purchased under reverse repurchase agreements are accounted for as collateralized financing transactions and are recorded at the contractual amount for which the securities will be resold, including accrued interest. Financial instruments purchased under reverse repurchase agreements are recorded in the financial statements as cash placed on deposit collateralized by securities and classified as cash and cash equivalents in the Condensed Consolidated Balance Sheets. A repurchase agreement is a transaction in which the Company sells financial instruments to another party, typically in exchange for cash, and simultaneously enters into an agreement to reacquire the same or substantially the same financial instruments from the buyer for an amount equal to the cash or other consideration exchanged plus interest at a future date. These agreements are accounted for as collateralized financing transactions. The Company retains the financial instruments sold under repurchase agreements and classifies them as trading securities in the Condensed Consolidated Balance Sheets. The cash consideration received under repurchase agreements is classified as securities repurchase agreement obligations in the Condensed Consolidated Balance Sheets. The Company enters into reverse repurchase agreements, repurchase agreements, securities borrowed and securities loaned transactions to, among other things, acquire securities to leverage and grow its proprietary trading portfolio, cover short positions and settle other securities obligations, to accommodate customers' needs and to finance its inventory positions. The Company enters into these transactions in accordance with normal market practice. Under standard terms for repurchase transactions, the recipient of collateral has the right to sell or repledge the collateral, subject to returning equivalent securities on settlement of the transaction. Available-for-sale securities Financial assets categorized as available-for-sale ("AFS") are non-derivatives that are either designated as available-for-sale or not classified as (a) loans and receivables, (b) held to maturity investments or (c) trading securities. Gains and losses arising from changes in fair value are recognized in other comprehensive income and accumulated in the Accumulated other comprehensive loss, with the exception of other-than-temporary impairment losses, interest calculated using the effective interest method, and foreign exchange gains and losses are recognized in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income. When the investment is disposed of or is determined to be impaired, the cumulative gain or loss previously accumulated in the accumulated other comprehensive (loss)/income is then reclassified to net realized gain/(loss) on investments available-for-sale in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income. Trading securities Financial assets are classified as trading securities if the financial asset has been acquired principally for the purpose of selling it in the near term. Trading securities are stated at fair value, with any gains or losses arising on remeasurement recognized in revenue. Changes in fair value are recognized in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income and included in net gain on trading securities. Interest earned and dividend income are recognized in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income and included in interest income, according to the terms of the contract and when the right to receive the payment has been established. Investments in nonconsolidated managed funds are accounted for at fair value based on the net asset value of the funds provided by the fund managers with gains or losses included in net gain on trading securities in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income. Debt securities issued Debt securities issued are initially recognized at the fair value of the consideration received, less directly attributable transaction costs. Subsequently, amounts due are stated at amortized cost and any difference between net proceeds and the redemption value is recognized over the period of the borrowings using the effective interest method. If the Company purchases its own debt it is removed from the Condensed Consolidated Balance Sheets and the difference between the carrying amount of the liability and the consideration paid is recognized in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income. Margin lending, brokerage and other receivables The Company engages in securities financing transactions with and for clients through margin lending. In margin lending, the Company's customers borrow funds from the Company against the value of their qualifying securities, primarily for the purpose of purchasing additional securities. Under these agreements, the Company is permitted to sell or repledge securities received as collateral. Furthermore, the Company can use the collateral for repurchase agreement operations, securities lending transactions or delivery to counterparties to cover short positions. Margin lending, brokerage and other receivables comprise margin lending receivables, brokerage commissions and other receivables related to the securities brokerage and banking activity of the Company. At initial recognition, margin lending, brokerage and other receivables are recognized at fair value. Subsequently, margin lending, brokerage and other receivables are carried at cost net of any allowance for impairment losses. Derecognition of financial assets A financial asset (or, where applicable a part of a financial asset or a part of a group of similar financial assets) is derecognized where all of the following conditions are met: • The transferred financial assets have been isolated from the Company - put presumptively beyond the reach of the Company and its creditors, even in bankruptcy or other receivership. • The transferee has rights to pledge or exchange financial assets. • The Company or its agents do not maintain effective control over the transferred financial assets or third-party beneficial interests related to those transferred assets. Where the Company has not met the asset derecognition conditions above, it continues to recognize the asset to the extent of its continuing involvement. Impairment of long-lived assets In accordance with the accounting guidance for the impairment or disposal of long-lived assets, the Company periodically evaluates the carrying value of long-lived assets to be held and used when events and circumstances warrant such a review. The carrying value of a long-lived asset is considered impaired when the fair value from such asset is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Losses on long-lived assets to be disposed of are determined in a similar manner, except that fair values are reduced for the cost of disposal. During the fiscal year ended March 31, 2022, the Company write-off the client base that was recognized with the Company's acquisition of Zerich in the amount of $3,125 due to economic uncertainty during the Company's fourth fiscal quarter stemming from the Russia/Ukraine Conflict. During the nine months ended December 31, 2022, there were no write-offs. Impairment of goodwill As of December 31, 2022, and March 31, 2022, goodwill recorded in the Company’s Condensed Consolidated Balance Sheets totaled $9,460 and $5,898, respectively. The Company performs an impairment review at least annually unless indicators of impairment exist in interim periods. The entity compares the fair value of a reporting unit with its carrying amount. The goodwill impairment charge recognized for the amount by which the reporting unit’s carrying amount exceeds its fair value. If fair value exceeds the carrying amount, no impairment is recorded. In its annual goodwill impairment test, the Company estimated the fair value of the reporting unit based on the income approach (also known as the discounted cash flow method) and determined the fair value of the Company’s goodwill previously recognized for Freedom Bank RU, Freedom UA and Zerich is below of the carrying amount of the Company’s goodwill. The Company recognized impairment loss for the goodwill in the amount of $2,300 as of March 31, 2022, and presented goodwill, net of impairment loss in the Company's Condensed Consolidated Balance Sheets. During the nine months ended December 31, 2022, the Company did not recognize additional impairment loss for the goodwill. The carrying amount of goodwill on the Company's Condensed Consolidated Balance Sheet as of December 31, 2022, increased compared to March 31, 2022, due to the Company's acquisition of London Almaty and Ticketon. The changes in the carrying amount of goodwill as of March 31, 2022, and as of December 31, 2022, were as follows: Amount Balance as of March 31, 2022 (Recasted) $ 5,898 Acquisition of London Almaty 485 Acquisition of Ticketon 3,172 Foreign currency translation (95) Balance as of December 31, 2022 $ 9,460 Asset and Liabilities Held for Sale The Company classifies assets and liabilities (the "disposal group") as held for sale in the period when all of the relevant criteria to be classified as held for sale are met. Criteria include management commitment to sell the disposal group in its present condition and the sale being deemed probable of being completed within one year. Assets held for sale are reported at the lower of their carrying value or fair value less cost to sell. Any loss resulting from the measurement is recognized in the period the held for sale criteria are met. The Company assesses the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and reports any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the initial carrying value of the disposal group. Assets held for sale are not amortized or depreciated. During the three months ended December 31, 2022, the Company accrued provision for impairment of discontinued operations by an amount of $2,509. As a result, the provision for impairment of discontinued operations, within the line item Net income from discontinued operation on the Condensed Consolidated Statements of Operations, amounted to $43,973 as of December 31, 2022. A disposal group that represents a strategic shift to the Company or is acquired with the intention to sell is reflected as a discontinued operation on the Condensed Consolidated Statements of Operation and Statement of Other Comprehensive Income and prior periods are recast to reflect the earnings or losses as income from discontinued operations. The Condensed Consolidated Financial Statements and related Notes reflect the securities brokerage and complementary banking operations in Russia as discontinued operations as the Company has entered into an agreement to divest these operations. The sale of these operations was approved by the Central Bank of the Russian Federation on February 10, 2023, and the sale is expected to be completed before the end of February 2023. See Note 25 Assets and Liabilities held for sale , for more information on assets held for sale and discontinued operations. Income taxes The Company recognizes deferred tax liabilities and assets based on the difference between the financial statements and tax basis of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to reverse. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. Current income tax expenses are provided for in accordance with the laws of the relevant taxing authorities. As part of the process of preparing financial statements, the Company is required to estimate its income taxes in each of the jurisdictions in which it operates. The Company accounts for income taxes using the asset and liability approach. Under this method, deferred income taxes are recognized for tax consequences in future years based on differences between the tax bases of assets and liabilities and their reported amounts in the financial statements at each year-end and tax loss carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates applicable for the differences that are expected to affect taxable income. The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority. The Company will include interest and penalties arising from the underpayment of income taxes in the provision for income taxes (if anticipated). As of December 31, 2022, and March 31, 2022, the Company had no accrued interest or penalties related to uncertain tax positions. The Global Intangible Low-Taxed Income (“GILTI”) provisions of the Tax Cuts and Jobs Act require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. The Company has presented the deferred tax impacts of GILTI tax in its Condensed Consolidated Balance Sheets as of December 31, 2022, and March 31, 2022, and in its Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2022, and 2021. Financial instruments Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most advantageous market for the asset or liability. Fair value is the current bid price for financial assets, current ask price for financial liabilities and the average of current bid and ask prices when the Company is both in short and long positions for the financial instrument. A financial instrument is regarded as quoted in an active market if quoted prices are readily and regularly available from an exchange or other institution and those prices represent actual and regularly occurring market transactions on an arm’s length basis. Leases The Company follows ASU No. 2016-02, “Leases (Topic 842)”, which requires leases with durations greater than twelve months to be recognized on the balance sheet. Operating lease assets and corresponding lease liabilities were recognized on the Company's Condensed Consolidated Balance Sheets. Refer to Note 23 Leases , to the condensed consolidated financial statements for additional disclosure and significant accounting policies affecting leases. Fixed assets Fixed assets are carried at cost, net of accumulated depreciation. Maintenance, repairs, and minor renewals are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range between three Insurance contract assets and liabilities Insurance and reinsurance receivable Insurance and reinsurance receivable is recognized when related income is earned and measured on initial recognition at the fair value of the consideration receivable. Subsequent to initial recognition, any insurance and reinsurance receivable is measured at cost net of any allowance for impairment losses. Insurance and reinsurance payable Payables on insurance business comprise advances received, amounts payable to insured (claims and premium refund payable) and amounts payable to agents and brokers, and advances received from insurers and reinsurers. Payables on reinsurance business comprise net amounts payable to reinsurers. Amounts payable to reinsurers include ceded reinsurance premiums, assumed premium refunds and claims on assumed reinsurance. Insurance and reinsurance payable are accounted for at amortized cost. Unearned premium reserve and claims Unearned premium is determined by the method of proportion for each contract, as the product of the insurance premium under the contract for the ratio of the expiration of the insurance cover (in days) to the balance sheet date (in days) from the date of recognition of the insurance premium in accounting as income until the end of the insurance coverage. The reinsurer's share in the unearned premium reserve is calculated separately for each insurance (reinsurance) contract and is determined as the ratio of the insurance premium under the reinsurance contract to the insurance premium under the insurance contract multiplied by the unearned premium reserve. Results of insurance activity includes net written insurance premiums reduced by the net change in the unearned premium reserve, commissions recognized from assumed insurance and reinsurance contracts, claims paid net and net change in the loss reserves. Net written insurance premiums represent gross written premiums less premiums ceded to reinsurers. Upon inception of a contract (except for classes of life and annuity insurance), premiums are recorded as written and are earned on a pro rata basis over the term of the related contract coverage. The unearned premium reserve represents the portion of the premiums written relating to the unexpired terms of coverage and is included in the accompanying statement of Condensed Consolidated Balance Sheets. Unearned premium reserve relates to non-life insurance products and non-annuity insurance products. Claims are expensed to th e Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income as incurred. Loss reserves Non-life and general insurance Loss reserves are a summary of estimates of ultimate losses, and include both claims reported but not settled (RBNS) and claims incurred but not reported (IBNR). RBNS is created for existing reported claims not settled at the reporting date. Estimates are made on the basis of information received by the Company during its investigation of insured events. IBNR is estimated by the Company based on its previous history of reported/settled claims using actuarial methods of calculation, which include claim development triangles. Reinsurance assets in IBNR are estimated applying the same actuarial method used in IBNR estimation. Life insurance Not incurred claims reserves (NIC) on life insurance contracts equal the NIC amount for all life insurance contracts valid as at the reporting date. NIC reserve on a separate contract of life insurance is equal to the maximum value of the net level premium reserve and gross-premium reserve. Net level premium reserve is the present value of future benefits (excluding survival benefits) less present value of future net premiums. Gross-p

RECAST

RECAST	9 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
RECAST	RECAST When preparing the condensed consolidated financial statements as of and for the three and nine months ended December 31, 2022, management determined that certain amounts included in the Company’s condensed consolidated financial statements as of March 31, 2022, required revision due to the closing on May 17, 2022, of the Company's acquisition of two insurance companies in Kazakhstan, a life insurance company, Freedom Life, and a direct insurance carrier, excluding life, health and medical, Freedom Insurance, which were deemed to be entities under common control with the Company since 2018. Prior to the Company's acquisition of these companies, each was wholly owned by the Company's controlling shareholder, chairman and chief executive officer, Timur Turlov, who had previously acquired Freedom Life and Freedom Insurance from a non-related party on February 28, 2018, and August 22, 2018, respectively. The two companies were deemed to be under common control with the Company since the dates when they were acquired by Timur Turlov. The Company acquired these companies from Mr. Turlov at the historical cost paid by him plus amounts he had contributed as additional paid in capital since his purchase. The Company acquired the two companies to expand its presence in the insurance segment. The purchase price for 100% of the outstanding shares of Freedom Insurance was $13,977 and the purchase price for 100% of the outstanding shares of Freedom Life was $12,611. As at December 31, 2022 Freedom KZ had repaid the payable for acquisition of Freedom Life for $13,630. The payment of the consideration for the acquisition of Freedom Insurance is planned to be made in February 2023. As required by ASC 805 Business Combinations, acquisitions with parties under common control are required to have all previously presented periods recast to the date of the initial acquisition by the seller. Accordingly, the financial results of Freedom Life and Freedom Insurance have been consolidated in the condensed consolidated financial statements as of and for the three and nine months ended December 31, 2022, and in the corresponding periods of 2021 for comparative purposes, as if they had been acquired prior to such periods. In addition, because the assets and liabilities to be disposed of in connection with the planned sale of Freedom RU and Freedom Bank RU met the held for sale criteria as of December 31, 2022, such subsidiaries are presented as discontinued operations in accordance with ASC 205 and 360 in the condensed consolidated financial statements as of and for the three and nine months ended December 31, 2022 and in the corresponding periods of 2021 for comparative purposes. For additional information see Note 25 Assets and Liabilities held for sale to the condensed consolidated financial statements. The previously issued Condensed Consolidated Balance Sheet as of March 31, 2022, and Condensed Consolidated Statement of Operations and Statements of Other Comprehensive Income for the three and nine months ended December 31, 2021, have been revised as follows: As of March 31, 2022 As previously reported FF Life acquisition Elimi-nations FF Insurance acquisition Elimi-nations Recast discontinued operations As recasted ASSETS Cash and cash equivalents $ 625,547 $ 1,427 $ (901) $ 371 $ (82) $ (400,898) $ 225,464 Trading securities 1,203,479 8,875 — 68,520 — (122,497) 1,158,377 Restricted cash 553,680 — — — — (5,730) 547,950 Margin lending, brokerage and other receivables, net 357,567 173 (34) 60 (20) (210,087) 147,659 Loans issued 94,797 44 — — — (2,395) 92,446 Other assets 37,725 7,267 — 427 — (18,375) 27,044 Fixed assets, net 21,365 182 — 254 — (3,978) 17,823 Right-of-use asset 15,669 532 — 152 — (8,922) 7,431 Intangible assets, net 5,791 1,489 — 161 — (2,278) 5,163 Goodwill 5,388 359 — 151 — — 5,898 Available-for-sale securities, at fair value 1 161,363 — — — — 161,364 Insurance contract assets — 3,555 — 2,157 — — 5,712 Assets held for sale — — — — — 825,419 825,419 TOTAL ASSETS $ 2,921,009 $ 185,266 $ (935) $ 72,253 $ (102) $ 50,259 $ 3,227,750 LIABILITIES AND SHAREHOLDERS’ EQUITY Securities repurchase agreement obligations $ 775,178 $ 47,691 $ — $ 49,824 $ — $ (32,469) $ 840,224 Customer liabilities 1,417,937 — (901) — (82) (651,326) 765,628 Margin lending and trade payables 45,229 — — 21 (20) (147) 45,083 Liabilities from insurance activity — 106,329 — 13,161 — — 119,490 Current income tax liability 14,556 — — — — — 14,556 Securities sold, not yet purchased – at fair value 14,103 — — — — (238) 13,865 Debt securities issued 99,027 — — — — (64,637) 34,390 Lease liability 15,315 543 — 176 — (8,530) 7,504 Liability arising from continuing involvement 6,447 — — — — — 6,447 Other liabilities 25,542 550 (35) 292 — (4,872) 21,477 Liabilities held for sale — — — — — 812,478 812,478 TOTAL LIABILITIES $ 2,413,334 $ 155,113 $ (936) $ 63,474 $ (102) $ 50,259 $ 2,681,142 Commitments and Contingent Liabilities (Note 26) — — — — — — — SHAREHOLDERS’ EQUITY Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding — — — — — — — Common stock - $0.001 par value; 500,000,000 shares authorized; 59 9,465 (9,465) 15,577 (15,577) — 59 Additional paid in capital 141,340 — 16,499 — 16,906 — 174,745 Retained earnings 426,563 28,131 (6,666) (4,811) (1,293) — 441,924 Accumulated other comprehensive loss (53,291) (7,443) (368) (1,987) (36) — (63,125) TOTAL FRHC SHAREHOLDERS’ EQUITY $ 514,671 $ 30,153 $ — $ 8,779 $ — $ — $ 553,603 Non-controlling interest (6,996) 1 — — — — (6,995) TOTAL SHAREHOLDERS’ EQUITY $ 507,675 $ 30,154 $ — $ 8,779 $ — $ — $ 546,608 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 2,921,009 $ 185,267 $ (936) $ 72,253 $ (102) $ 50,259 $ 3,227,750 Three months ended December 31, 2021 As previously reported * FF Life acquisition Elimi-nations FF Insurance acquisition Elimi-nations Recast discontinued operations As restated Revenue: Fee and commission income $ 117,316 $ — $ — $ (3) $ — $ (25,905) $ 91,408 Net gain on trading securities 403 490 — 159 — 6,611 7,663 Interest income 27,828 6,534 — 2,324 — (3,029) 33,657 Insurance underwriting income — 18,030 — 3,364 — — 21,394 Net gain on foreign exchange operations 451 239 — 16 — 655 1,361 Net loss on derivative (314) — — — — — (314) TOTAL REVENUE, NET 145,684 25,293 — 5,860 — (21,668) 155,169 Expense: Fee and commission expense 22,716 3,946 — 196 — (2,076) 24,782 Interest expense 20,799 1,606 — 1,850 — (2,365) 21,890 Insurance claims incurred, net of reinsurance — 13,246 — 3,040 — — 16,286 Operating expense 50,496 1,681 — 1,657 — (22,253) 31,581 Provision for impairment losses 45 — — (365) — (13) (333) Other expense, net (64) 1,073 — — — (30) 979 TOTAL EXPENSE 93,992 21,552 — 6,378 — (26,737) 95,185 INCOME/(LOSS) BEFORE INCOME TAX 51,692 3,741 — (518) — 5,069 59,984 Income tax (expense)/benefit (806) 12 (50) (962) (1,806) INCOME/(LOSS) FROM CONTINUING OPERATIONS 50,886 3,753 — (568) — 4,107 58,178 Loss before income tax (expense)/benefit of discontinued operation — — — — — (5,067) (5,067) Income tax benefit of discontinued operations — — — — — 962 962 Loss from discontinued operation — — — — (4,105) (4,105) NET INCOME/LOSS $ 50,886 $ 3,753 $ — $ (568) $ — $ 2 $ 54,073 Less: Net loss attributable to non-controlling interest in subsidiary (343) — — — — — (343) NET INCOME/(LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 51,229 $ 3,753 $ — $ (568) $ — $ 2 $ 54,416 OTHER COMPREHENSIVE INCOME Change in unrealized gain on investments available-for-sale, net of tax effect — (1,063) — — — — (1,063) Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect — 953 — — — — 953 Foreign currency translation adjustments (7,336) (1,284) — (2,702) — 2,672 (8,650) OTHER COMPREHENSIVE LOSS (7,336) (1,394) — (2,702) — 2,672 (8,760) COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS $ 43,550 $ 2,359 $ — $ (3,270) $ — $ 2,674 $ 45,313 Less: Comprehensive loss attributable to non-controlling interest in subsidiary (343) — — — — — (343) COMPREHENSIVE INCOME/(LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 43,893 $ 2,359 $ — $ (3,270) $ — $ 2,674 $ 45,656 For the three months ended December 31, 2021, the Company’s EPS as reported was 0.86 for basic and diluted EPS. Due to the items noted above, the Company’s EPS has been recast to 0.98, (0.09), and 0.91 for basic and diluted EPS for continuing operations, discontinued operations, and total EPS, respectively. Nine months ended December 31, 2021 As previously reported * FF Life acquisition Elimi-nations FF Insurance acquisition Elimi-nations Recast discontinued operations As restated Revenue: Fee and commission income $ 327,966 $ — $ (91) $ 86 $ (161) $ (65,251) 262,549 Net gain on trading securities 185,554 1,090 — 1,587 — 9,716 197,947 Net realized loss on investments available for sale — — — — — — Interest income 69,259 16,634 — 6,541 — (9,920) 82,514 Insurance underwriting income — 42,091 — 9,400 — — 51,491 Net gain on foreign exchange operations 885 277 — 26 — 2,888 4,076 Net loss on derivative (1,028) — — — — — (1,028) TOTAL REVENUE, NET 582,636 60,092 (91) 17,640 (161) (62,567) 597,549 Expense: Fee and commission expense 67,547 7,074 (91) 558 (161) (6,301) 68,626 Interest expense 51,256 3,604 — 4,816 — (6,824) 52,852 Insurance claims incurred, net of reinsurance — 31,862 — 9,234 — — 41,096 Operating expense 117,384 4,293 — 4,935 — (53,840) 72,772 Provision for impairment losses 704 — — 297 — (90) 911 Other expense/(income), net 600 1,949 — (3) — (120) 2,426 TOTAL EXPENSE 237,491 48,782 (91) 19,837 (161) (67,175) 238,683 INCOME BEFORE INCOME TAX 345,145 11,310 — (2,197) — 4,608 358,866 Income tax expense (38,037) 11 — (57) — (943) (39,026) INCOME FROM CONTINUING OPERATIONS 307,108 11,321 — (2,254) — 3,665 319,840 Income/(loss) before income tax(expense)/benefit of discontinued operation — — — — — (4,609) (4,609) Income tax (expense)/benefit of discontinued operations — — — — — 953 953 Income from discontinued operation — — — — — (3,656) (3,656) NET INCOME $ 307,108 $ 11,321 $ — $ (2,254) $ — $ 9 $ 316,184 Less: Net loss attributable to non-controlling interest in subsidiary (415) — — — — — (415) NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 307,523 11,321 — (2,254) — $ 9 $ 316,599 OTHER COMPREHENSIVE INCOME Change in unrealized gain on investments available-for-sale, net of tax effect — (1,789) — — — — (1,789) Reclassification adjustment relating to available-for-sale investments disposed of in the period, net of tax effect — 1,606 — — — — 1,606 Foreign currency translation adjustments (3,106) (1,213) — (2,702) 2,574 (4,447) OTHER COMPREHENSIVE INCOME (3,106) (1,396) — (2,702) — 2,574 (4,630) COMPREHENSIVE INCOME BEFORE NON-CONTROLLING INTERESTS $ 304,002 $ 9,925 $ — $ (4,956) $ — $ 2,583 $ 311,554 Less: Comprehensive loss attributable to non-controlling interest in subsidiary (415) — — — — — (415) COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS 304,417 9,925 — (4,956) — 2,583 311,969 For the nine months ended December 31, 2021, the Company’s EPS as reported was 5.18 for basic and diluted EPS. Due to the items noted above, the Company’s EPS has been recast to 5.40, (0.08), and 5.34 for basic and diluted EPS for continuing operations, discontinued operations, and total EPS, respectively. *amounts with restatement in fee and commission income and interest income, for more information please see Note 4 Restatement.

RESTATEMENT

RESTATEMENT	9 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
RESTATEMENT	RESTATEMENT As previously disclosed in our quarterly report on Form 10-Q for the three and six months ended September 30, 2022, it was determined that there was an error in the Company's accounting related to the classification of loans issued and bank customer accounts in the Company's Condensed Consolidated Statement of Cash Flows, and during the course of the Company's preparation of quarterly report on Form 10-Q for the three months ended December 31, 2022, it was determined that there was an error in the Company's quarterly report on Form 10-Q for the three months ended December 31, 2021 related to the classification of interest income from margin lending to clients on the Company's Condensed Consolidated Statement of Operations. Specifically, the Company identified that activities related to certain loans had been classified within "Cash flows from operating activities" and should have been classified within "Cash flows from investing activities". In addition, the Company identified that activities related to bank customer accounts had been classified within "Cash flows from operating activities" and should have been classified within "Cash flows from financing activities". On the Condensed Consolidated Statement of Operations, the Company's interest income from margin lending to clients had been classified within fee and commission income and should have been classified within interest income. The Company has evaluated the effect of the foregoing incorrect classifications and concluded that restatement of previously filed consolidated financial statements as of and for the years ended March 31, 2022, 2021 and 2020 and for each of the quarterly periods ended June 30, 2022 and September 30, 2022 was necessary. The Company determined that the incorrect classifications did not have any impact on the Company’s net income or any per-share amounts. The following table summarizes the impact of the correction of the errors on the Condensed Consolidated Statement of Cash Flows for the period presented: Nine months ended December 31, 2021 As previously reported FF Life and FF Insurance acquisitions Adjustments for discontinued operations As recasted Correction of errors As restated Net cash flows (used in)/from operating activities $ (582,080) $ 25,782 (34,465) $ (590,763) $ (21,090) $ (611,853) Net cash flows used in investing activities (6,110) (52,276) — (58,386) (34,709) (93,095) Net cash flows (used in)/from financing activities 338,792 47,203 — 385,995 55,799 441,794 Effect of changes in foreign exchange rates on cash and cash equivalents 10,593 (2,221) (1,998) 6,374 — 6,374 NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH $ (238,805) $ 18,488 $ (36,463) $ (256,780) $ — $ (256,780) The following table summarizes the impact of the correction of errors broken down by continuing and discontinued operations: Nine months ended December 31, 2021 As restated Correction of errors As restated Net cash flows used in operating activities from continuing operations $ (256,764) $ (132,188) $ (388,952) Net cash flows (used in)/from operating activities from discontinued operations (333,999) 111,098 (222,901) Net cash flows used in investing activities from continuing operations (56,167) (34,138) (90,305) Net cash flows used in investing activities from discontinued operations (2,219) (571) (2,790) Net cash flows from financing activities from continuing operations 320,364 83,448 403,812 Net cash flows from/used in financing activities from discontinued operations 65,631 (27,649) 37,982 Effect of changes in foreign exchange rates on cash and cash equivalents from continuing operations (7,321) — (7,321) Effect of changes in foreign exchange rates on cash and cash equivalents from discontinued operations 13,695 — 13,695 NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH $ (256,780) $ — $ (256,780) In the Company's previously issued condensed consolidated financial statements, interest income from margin lending to clients had been erroneously classified within fee and commission income from brokerage services. Such income has been reclassified to interest income as a separate sub-line item within interest income entitled interest income from margin lending to clients. For additional information see Note 19 Net interest income/(expense) to the condensed consolidated financial statements. The following tables summarize the impact of corrections of the errors on the Condensed Consolidated Statement of Operations for the periods presented: For the three months ended December 31, 2021 Issued FF Life and FF Insurance acquisition Adjustments for discontinued operations As restated Correction of errors As restated Fee and commission income $ 122,237 $ (3) $ (25,905) $ 96,329 $ (4,921) $ 91,408 Net gain on trading securities 403 649 6,611 7,663 — 7,663 Interest income 22,907 8,858 (3,029) 28,736 4,921 33,657 Insurance underwriting income — 21,394 — 21,394 — 21,394 Net gain on foreign exchange operations 451 255 655 1,361 — 1,361 Net loss on derivative (314) — — (314) — (314) TOTAL REVENUE, NET 145,684 31,153 (21,668) 155,169 — 155,169 For the nine months ended December 31, 2021 Issued FF Life and FF Insurance acquisition Adjustments for discontinued operations As restated Correction of errors As restated Fee and commission income $ 336,178 $ (166) $ (65,251) $ 270,761 $ (8,212) $ 262,549 Net gain on trading securities $ 185,554 2,677 9,716 197,947 — 197,947 Interest income 61,047 23,175 (9,920) 74,302 8,212 82,514 Insurance underwriting income — 51,491 — 51,491 — 51,491 Net gain on foreign exchange operations 885 303 2,888 4,076 — 4,076 Net loss on derivative (1,028) — — (1,028) — (1,028) TOTAL REVENUE, NET 582,636 77,480 (62,567) 597,549 — 597,549

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS	9 Months Ended
	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS	CASH AND CASH EQUIVALENTS As of December 31, 2022, and March 31, 2022, cash and cash equivalents consisted of the following: December 31, 2022 March 31, 2022 (Recasted) Short term deposits in National Bank (Kazakhstan) $ 350,203 $ 42,517 Securities purchased under reverse repurchase agreements 129,955 19,947 Short term deposits in commercial banks 98,846 70,155 Short term deposits on brokerage accounts 43,507 71,061 Petty cash in bank vault and on hand 20,552 18,607 Short term deposits in stock exchanges 19,293 2,828 Overnight deposits 1,667 — Cash in transit 63 35 Short term deposits in the Central Depository (Kazakhstan) 9 314 Total cash and cash equivalents $ 664,095 $ 225,464 As of December 31, 2022, and March 31, 2022, cash and cash equivalents were not insured. As of December 31, 2022, and March 31, 2022, the cash and cash equivalents balance included short-term collateralized securities received under reverse repurchase agreements on the terms presented below: December 31, 2022 Interest rates and remaining contractual maturity of the agreements Average interest rate Up to 30 days 30-90 days Total Securities purchased under reverse repurchase agreements Corporate debt 16.09 % $ 70,363 $ — $ 70,363 Non-US sovereign debt 13.15 % 40,678 — 40,678 US sovereign debt 2.74 % 18,596 — 18,596 Corporate equity 18.57 % 318 — 318 Total securities sold under repurchase agreements $ 129,955 $ — $ 129,955 March 31, 2022 (Recasted) Interest rates and remaining contractual maturity of the agreements Average interest rate Up to 30 days 30-90 days Total Securities purchased under reverse repurchase agreements US sovereign debt 16.38 % $ 9,952 $ — $ 9,952 Non-US sovereign debt 12.51 % 9,786 — 9,786 Corporate equity 16.90 % 152 — 152 Corporate debt 11.88 % 57 — 57 Total securities sold under repurchase agreements $ 19,947 $ — $ 19,947

RESTRICTED CASH

RESTRICTED CASH	9 Months Ended
	Dec. 31, 2022
Restricted Cash [Abstract]
RESTRICTED CASH	RESTRICTED CASH Restricted cash for the periods ended December 31, 2022, and March 31, 2022, consisted of: December 31, 2022 March 31, 2022 (Recasted) Brokerage customers’ cash $ 355,294 $ 531,032 Guaranty deposits 100,463 5,540 Deferred distribution payments 156 8,534 Restricted bank accounts — 2,844 Allowance for restricted cash (5,934) — Total restricted cash $ 449,979 $ 547,950 As of December 31, 2022, and March 31, 2022, the Company’s restricted cash included the cash portion of the funds segregated in a special custody account for the exclusive benefit of its brokerage customers. As of March 31, 2022, restricted cash included a deferred distribution payment amount of $8,534, representing cash held for distribution to shareholders who have not yet claimed their distributions from the 2011 sale of the Company’s legacy oil and gas exploration and production operations which is the subject of the Estate of Toleush Tolmakov litigation. As a result of disputes between a shareholder’s putative heirs, no party has yet established legal and beneficial ownership of the distribution payment. The Company did not claim an ownership interest in the distribution payment. During the three months ended December 31, 2022, $8,378 of this amount was deposited with the court registry in accordance with a court order and was written off by the Company. Interest on such amount in the amount of $156 continues to be recorded as restricted cash. For additional information regarding this matter see Part II, Item 1 Legal Proceedings of this quarterly report on Form 10-Q.

TRADING AND AVAILABLE-FOR-SALE

TRADING AND AVAILABLE-FOR-SALE SECURITIES AT FAIR VALUE	9 Months Ended
	Dec. 31, 2022
Debt Securities, Trading, and Equity Securities, FV-NI [Abstract]
TRADING AND AVAILABLE-FOR-SALE SECURITIES AT FAIR VALUE	TRADING AND AVAILABLE-FOR-SALE SECURITIES AT FAIR VALUE As of December 31, 2022, and March 31, 2022, trading and available-for-sale securities consisted of: December 31, 2022 March 31, 2022 (Recasted) Corporate debt $ 1,097,488 $ 712,134 Non-U.S. sovereign debt 734,068 360,570 Corporate equity 62,351 72,354 U.S. sovereign debt 34,012 10,435 Exchange traded notes 1,921 2,884 Total trading securities $ 1,929,840 $ 1,158,377 December 31, 2022 March 31, 2022 (Recasted) Corporate debt $ 157,548 $ 145,837 Non-U.S. sovereign debt 12,905 12,997 U.S. sovereign debt 3,873 2,530 Total available-for-sale securities, at fair value $ 174,326 $ 161,364 The following tables present maturity analysis for available-for-sale securities as of December 31, 2022, and March 31, 2022: December 31, 2022 Remaining contractual maturity of the agreements Up to 1 year 1-5 years 5-10 years More than 10 years Total Corporate debt 46,229 64,260 47,047 12 157,548 Non-US sovereign debt — 5,280 861 6,764 12,905 US sovereign debt — 898 1,712 1,263 3,873 Total available-for-sale securities, at fair value $ 46,229 $ 70,438 $ 49,620 $ 8,039 $ 174,326 March 31, 2022 Remaining contractual maturity of the agreements Up to 1 year 1-5 years 5-10 years More than 10 years Total Corporate debt 69,364 50,155 26,284 34 145,837 Non-US sovereign debt 1,692 864 1,086 9,355 12,997 US sovereign debt — — — 2,530 2,530 Total available-for-sale securities, at fair value $ 71,056 $ 51,019 $ 27,370 $ 11,919 $ 161,364 As of December 31, 2022, the Company held debt securities of two issuers each of which individually exceeded 10% of the Company’s total trading securities - Kazakhstan Sustainability Fund JSC (Fitch: BBB credit rating) in the amount of $727,340 and the Ministry of Finance of the Republic of Kazakhstan (S&P Global: BBB- credit rating) in the amount of $723,750. As of March 31, 2022, the Company held debt securities of two issuers each of which individually exceeded 10% of the Company’s total trading securities - the Ministry of Finance of the Republic of Kazakhstan and the Kazakhstan Sustainability Fund JSC in the amounts of $357,343 and $506,472, respectively. The Company recognized no other-than-temporary impairment in accumulated other comprehensive loss. The fair value of securities is determined using observable market data based on recent trading activity. Where observable market data is unavailable due to a lack of trading activity, the Company utilizes internally developed models to estimate fair value and independent third parties to validate assumptions, when appropriate. Estimating fair value requires significant management judgment, including benchmarking to similar instruments with observable market data and applying appropriate discounts that reflect differences between the securities that the Company is valuing and the selected benchmark. Depending on the type of securities owned by the Company, other valuation methodologies may be required. Measurement of fair value is classified within a hierarchy based upon the transparency of inputs used in the valuation of an asset or liability. Classification within the hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The valuation hierarchy contains three levels: • Level 1 - Valuation inputs are unadjusted quoted market prices for identical assets or liabilities in active markets. • Level 2 - Valuation inputs are quoted market prices for identical assets or liabilities in markets that are not active, quoted market prices for similar assets and liabilities in active markets, and other observable inputs directly or indirectly related to the asset or liability being measured. • Level 3 - Valuation inputs are unobservable and significant to the fair value measurement. The following tables present securities assets in the Сondensed Сonsolidated Balance Sheets or disclosed in the Notes to the condensed consolidated financial statements at fair value on a recurring basis as of December 31, 2022, and March 31, 2022: Weighted Average Total Fair Value Measurements as of December 31, 2022 using Quoted Prices in Significant Significant Unobservable (Level 1) (Level 2) (Level 3) Corporate debt 13.99 % $ 1,097,488 $ 1,001,417 $ 95,800 $ 271 Non-U.S. sovereign debt 12.26 % 734,068 577,828 156,213 27 Corporate equity — % 62,351 60,127 1,895 329 U.S. sovereign debt 4.30 % 34,012 34,012 — — Exchange traded notes — % 1,921 1,223 698 — Total trading securities $ 1,929,840 $ 1,674,607 $ 254,606 $ 627 Corporate debt 14.88 % $ 157,548 $ 134,427 $ 23,121 $ — Non-US sovereign debt 8.99 % 12,905 5,894 7,011 — US sovereign debt 4.20 % 3,873 3,873 — — Total available-for-sale securities, at fair value $ 174,326 $ 144,194 $ 30,132 $ — Weighted Average Interest Rate Total Fair Value Measurements as of March 31, 2022 (Recasted) using Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Corporate debt 9.09 % $ 712,134 $ 711,539 $ — $ 595 Non-U.S. sovereign debt 13.15 % 360,570 352,274 — 8,296 Corporate equity — 72,354 71,827 276 251 U.S. sovereign debt 2.35 % 10,435 10,435 — — Exchange traded notes — 2,884 2,884 — — Total trading securities $ 1,158,377 $ 1,148,959 $ 276 $ 9,142 Corporate debt 11.09 % $ 145,837 $ 145,837 $ — $ — Non-U.S. sovereign debt 5.51 % 12,997 12,997 — — U.S. sovereign debt 2.17 % 2,530 2,530 — — Total available-for-sale securities, at fair value $ 161,364 $ 161,364 $ — $ — The tables below present the valuation techniques and significant level 3 inputs used in the valuation as of December 31, 2022, and March 31, 2022. The tables are not intended to be all inclusive, but instead capture the significant unobservable inputs relevant to determination of fair value. Type Valuation Technique FV as of December 31, 2022 Significant Unobservable Inputs % Non-US sovereign debt DCF $ 27 Discount rate 48.8% Estimated number of years 11 years Corporate debt DCF 271 Discount rate 74.0% Estimated number of years 3 months Corporate equity DCF 329 Discount rate 58.8% Estimated number of years 9 years Total $ 627 Type Valuation Technique FV as of March 31, 2022 Significant Unobservable Inputs % Non-US sovereign debt DCF $ 7,524 Discount rate 69.0% Estimated number of years 11 years Non-US sovereign debt DCF 772 Discount rate 13.9% Estimated number of years 1 year Corporate debt DCF 595 Discount rate 45.0% Estimated number of years 3 months Corporate equity DCF 251 Discount rate 20.0% Estimated number of years 9 years Total $ 9,142 The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended December 31, 2022, and the year ended March 31, 2022: Trading securities Balance as of March 31, 2022 (Recasted) $ 9,142 Purchase of investments that use Level 3 inputs 1,980 Reclassification to level 2 (1,842) Reclassification of securities from Freedom UA to restricted accounts (2,384) Sale (5,089) Revaluation of investments that use Level 3 inputs (622) Translation difference (558) Balance as of December 31, 2022 $ 627 Balance as of March 31, 2021 (Recasted) $ 19,032 Reclassification to level 3 682 Reclassification to level 1 (18,370) Purchase of investments that use Level 3 inputs 10,812 Revaluation of investments that use Level 3 inputs (3,014) Balance as of March 31, 2022 (Recasted) $ 9,142 The table below presents the amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities as of December 31, 2022, and March 31, 2022: December 31, 2022 Assets measured at amortized cost Recognized impairment loss in Income Statement Unrealized gain/(loss) accumulated in other comprehensive Assets Maturity Date Corporate debt $ 154,689 $ (402) $ 2,883 $ 157,548 2023 - 2042 Non-US sovereign debt 14,482 — (1,577) 12,905 2024 - indefinite U.S. sovereign debt 4,574 — (701) 3,873 2024 - 2044 Total available-for-sale securities, at fair value $ 173,745 $ (402) $ 605 $ 174,326 March 31, 2022 (Recasted) Assets measured at amortized cost Unrealized loss accumulated in other comprehensive Assets Maturity Date Corporate debt $ 146,112 $ (275) $ 145,837 2022 - 2035 Non-U.S. sovereign debt 13,784 (787) 12,997 2022 - indefinite U.S. sovereign debt 2,912 (382) 2,530 2044 Total available-for-sale securities, at fair value $ 162,808 $ (1,444) $ 161,364

BROKERAGE AND OTHER RECEIVABLES

BROKERAGE AND OTHER RECEIVABLES, NET	9 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
MARGIN LENDING, BROKERAGE AND OTHER RECEIVABLES, NET	MARGIN LENDING, BROKERAGE AND OTHER RECEIVABLES, NET Margin lending, brokerage and other receivables as of December 31, 2022, and March 31, 2022, consisted of: December 31, 2022 March 31, 2022 (Recasted) Margin lending receivables $ 393,659 $ 138,983 Receivables from brokerage clients 6,624 4,386 Bonds coupon receivable 1,977 — Bank commissions receivable 1,852 598 Long-term installments receivables 1,184 1,367 Receivable from sale of securities 858 884 Receivable for underwriting and market-making services 526 296 Dividends accrued — 45 Other receivables 4,734 3,207 Allowance for receivables (7,846) (2,107) Total margin lending, brokerage and other receivables, net $ 403,568 $ 147,659 Margin lending receivables are amounts owed to the Company from customers as a result of borrowings by such customers against the value of qualifying securities, primarily for the purpose of purchasing additional securities. Amounts may fluctuate from period to period as overall client balances change as a result of market levels, client positioning and leverage. Credit exposures arising from margin lending activities are generally mitigated by their short-term nature, the value of collateral held and our right to call for margin when collateral values decline. The fair value of collateral received by the Company under margin loans as of December 31, 2022, and March 31, 2022 was $1,086,725 and $4,432,621 , respectively. As of December 31, 2022, and March 31, 2022, amounts due from a single related party customer were $161,139 and $107,649, respectively or 40% and 73% respectively, of total margin lending, brokerage and other receivables, net. Approximately 97% and 95% of these balances were due from Freedom Securities Trading Inc. (formerly known as FFIN Brokerage Services, Inc.) (“FFIN Brokerage”), a company owned by the Company's controlling shareholder, chairman and chief executive officer, Timur Turlov. Based on historical data, the Company considers receivables due from related parties fully collectible. As of December 31, 2022, and March 31, 2022, using historical and statistical data, the Comp any recorded an allowance for brokerage receivables in the amounts of $7,846 and $2,107, respectively.

LOANS ISSUED

LOANS ISSUED	9 Months Ended
	Dec. 31, 2022
Loans and Leases Receivable Disclosure [Abstract]
LOANS ISSUED	LOANS ISSUED Loans issued as of December 31, 2022, consisted of the following: Amount Outstanding Due Dates Average Interest Rate Fair Value of Collateral Loan Currency Mortgage loans $ 493,993 January, 2023 - December, 2047 8.70% $496,452 KZT Uncollateralized Bank customer loans 91,149 January, 2023 - December, 2042 16.53% — KZT Collateralized Bank customer loans 12,852 January, 2023 - December, 2025 1.91% 12,796 KZT/RUB Car loans 34,660 January, 2023 - December, 2029 27.25% 37,211 KZT Subordinated loans 5,000 December, 2025 3.00% — USD Loans issued to policyholders 1,426 March, 2023 - December, 2023 14.97% 1,697 KZT Other 297 March, 2023 - August, 2027 2.71% — EUR/KZT Total loans issued $ 639,377 Freedom Bank KZ provides mortgage loans to borrowers on behalf of the JSC Kazakhstan Sustainability Fund ("Program Operator") related to the state mortgage program "7-20-25" and transfers the rights of claim on the loans to the Program Operator. Under this program, borrowers can receive a mortgage at an interest rate of 7%, for 20 years. In accordance with the program and trust management agreement, Freedom Bank KZ carries out trust management of transferred mortgage loans, and transfers all repayments of principal amounts of mortgages plus 3% of the 7% interest to the Program Operator. The remaining 4% of the 7% interest is retained by Freedom Bank KZ as profit margin. Under the program and trust management agreement, Freedom Bank KZ is required to repurchase the rights of claims on transferred mortgage loans, when the loan principal amount and interest payments are overdue 90 days or more. The repurchase of delinquent loans is performed at the loan nominal value. Since the Freedom Bank KZ sells those loans with recourse for uncollectible amounts, retains part of interest from those loans, and agrees to service those loans after the sale, Freedom Bank KZ has determined that it retains control over the mortgage loans transferred and continues recognizing the loans. As Freedom Bank KZ continues to recognize the loans, it also recognizes the associated liability in the amount of $319,694 as of December 31, 2022, which is presented separately as liability arising from continuing involvement in the Condensed Consolidated Balance Sheets. As of March 31, 2022 the corresponding liability amounted to $6,447. As of December 31, 2022 and March 31,2022, mortgage loans include the state mortgage program "7-20-25" with a principal amount of $436,132 and $21,310, respectively . Total loans issued as of December 31, 2022, includes uncollateralized bank customer loans purchased from a related party, microfinance organization Freedom Finance Credit (“FFIN Credit”), a start-up created and controlled by the Company's controlling shareholder, chairman and chief executive officer, Timur Turlov. FFIN Credit is a non-bank credit institution that issues loans in Kazakhstan under simplified lending procedures. FFIN Credit was created as a pilot project to test and improve the scoring models used for qualifying and issuing loans. The principal operation of FFIN Credit is to provide loans to customers online using biometric identification and its proprietary scoring process. After completion of the pilot launch, it is anticipated that the ownership of FFIN Credit will be sold by Mr. Turlov to the Company. The agreements entered into by the Company with FFIN Credit to purchase uncollateralized bank customer loans provide the Company the ability to sell back to FFIN Credit up to $58,359 of the total loans purchased. The Company has determined that it has received control over the loans purchased from FFIN Credit, and accordingly the Company has recognized such loans on its Condensed Consolidated Balance Sheets. Dur ing the three and nine months ended December 31, 2022, the Company purchased loans in the aggregate amount of $50,594 and $89,935 and sold back loans totaling $12,977 and $32,904, resp ectively, to FFIN Credit, a company outside of the Company's group which is owned by Timur Turlov. During the three and nine months ended December 31, 2021, the Company purchased loans in the aggregate amo unt of $9,546 and $29,020 and sold back loans totaling $3,968 and $6,828 to FFIN Credit, respectively. As of December 31, 2022, the Company held outstanding loans purchased from FFIN Credit totaling $100,433, net of an allowance of $7,511. Loans issued as of March 31, 2022, consisted of the following: Amount Outstanding Due Dates Average Interest Rate Fair Value of Collateral Loan Currency Mortgage loans $ 51,924 April 2022 - March 2047 11.86 % 52,134 KZT Uncollateralized bank customer loans 34,067 April 2022 - March 2047 17.56 % — KZT Subordinated loan 5,033 December 2022-April 2024 4.89 % — USD Subordinated loan 1,256 December 2022-April 2024 7.00 % — UAH Other 123 February 2022-Febraury 2027 2.50 % — USD Loans to policyholders 43 July 2022 - March 2023 12.02 % 284 KZT Total loans issued (recasted) $ 92,446

PROVISION FOR INCOME TAXES

PROVISION FOR INCOME TAXES	9 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
PROVISION FOR INCOME TAXES	PROVISION FOR INCOME TAXES The Company is subject to taxation in Kazakhstan, Russia, Kyrgyzstan, Cyprus, Ukraine, Uzbekistan, Germany and the United States of America. The tax rates used for deferred tax assets and liabilities as of December 31, 2022, and March 31, 2022, were 21% for the U.S., 20% for Kazakhstan, the Russian Federation and Azerbaijan,10% for Kyrgyzstan, 31% for Germany, 12.5% for Cyprus, 18% for Ukraine, 25% for United Kingdom, 18% for Armenia and 15% for Uzbekistan. During the nine months ended December 31, 2022, and 2021, the effective tax rate was equal to 16.1% and 10.9%, respectively.

SECURITIES REPURCHASE AGREEMENT

SECURITIES REPURCHASE AGREEMENT OBLIGATIONS	9 Months Ended
	Dec. 31, 2022
Securities Sold under Agreements to Repurchase [Abstract]
SECURITIES REPURCHASE AGREEMENT OBLIGATIONS	SECURITIES REPURCHASE AGREEMENT OBLIGATIONS As of December 31, 2022, and March 31, 2022, trading securities included collateralized securities subject to repurchase agreements as described in the following table: December 31, 2022 Interest rates and remaining contractual maturity of the agreements Average interest rate Up to 30 days 30-90 days Total Securities sold under repurchase agreements Non-US sovereign debt 16.26 % $ 572,731 $ 51,898 $ 624,629 Corporate debt 16.44 % 586,939 4,774 591,713 US sovereign debt 1.91 % 17,586 — 17,586 Total securities sold under repurchase agreements $ 1,177,256 $ 56,672 $ 1,233,928 March 31, 2022 (Recasted) Interest rate and remaining contractual maturity of the agreements Average interest rate Up to 30 days 30-90 days Total Securities sold under repurchase agreements Corporate debt 11.96 % $ 609,405 $ 142 $ 609,547 Non-US sovereign debt 10.85 % 222,893 — 222,893 US sovereign debt 0.77 % 7,396 — 7,396 Corporate equity 14.00 % 388 — 388 Total securities sold under repurchase agreements $ 840,082 $ 142 $ 840,224 The fair value of collateral pledged under repurchase agreements as of December 31, 2022, and March 31, 2022, was $1,248,410 and $834,583, respectively. Securities pledged as collateral by the Company under repurchase agreements are liquid trading securities with market quotes and significant trading volume.

CUSTOMER LIABILITIES

CUSTOMER LIABILITIES	9 Months Ended
	Dec. 31, 2022
Contract with Customer, Liability [Abstract]
CUSTOMER LIABILITIES	CUSTOMER LIABILITIES The Company recognizes customer liabilities associated with deposit funds of its brokerage and bank customers. As of December 31, 2022, and March 31, 2022 , customer liabilities consisted of: December 31, 2022 March 31, 2022 (Recasted) Banking customers 1,026,605 246,284 Brokerage customers $ 759,847 $ 519,344 Total customer liabilities $ 1,786,452 $ 765,628 As of December 31, 2022, banking customer liabilities consisted of demand deposits and term deposits of $697,736 and $328,869, respectively. As of March 31, 2022, banking customer liabilities consisted of demand deposits and term deposits of $155,494 and $90,790 , respectively.

MARGIN LENDING AND TRADE PAYABL

MARGIN LENDING AND TRADE PAYABLES	9 Months Ended
	Dec. 31, 2022
Accounts Payable [Abstract]
MARGIN LENDING AND TRADE PAYABLES	MARGIN LENDING AND TRADE PAYABLES As of December 31, 2022, and March 31, 2022 , margin lending and trade payables of the Company was comprised of the following: December 31, 2022 March 31, 2022 (Recasted) Margin lending payables $ 139,214 $ 39,250 Payables to suppliers of goods and services 1,375 4,462 Trade payable for securities purchased 476 462 Other 1,276 909 Total margin lending and trade payables $ 142,341 $ 45,083 On December 31, 2022, and March 31, 2022, margin lending payable due to a single re lated party were $4,507 or 3% of total margin lending payable an d $38,889 or 86% of margin lending payable, respectively.

SECURITIES SOLD, NOT YET PURCHA

SECURITIES SOLD, NOT YET PURCHASED - AT FAIR VALUE	9 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
SECURITIES SOLD, NOT YET PURCHASED - AT FAIR VALUE	SECURITIES SOLD, NOT YET PURCHASED – AT FAIR VALUE The following table provides a reconciliation of the beginning and ending balances for securities sold, not yet purchased - at fair value by the Company, as of December 31, 2022, and March 31, 2022: Total Balance as of March 31, 2021 (Recasted) $ 8,569 Short sales 7,055 Repurchase (346) Net gain on trading securities (1,413) Balance as of March 31, 2022 (Recasted) $ 13,865 Balance as of March 31, 2022 (Recasted) $ 13,865 Short sales 410 Repurchase (15,627) Net loss on trading securities 1,352 Balance as of December 31, 2022 $ — A short sale involves the sale of a security that is not owned with the expectation of purchasing the same security (or a security exchangeable) at a later date at a lower price. A short sale involves the risk of a theoretically unlimited increase in the market price of the security that would result in a theoretically unlimited loss.

DEBT SECURITIES ISSUED

DEBT SECURITIES ISSUED	9 Months Ended
	Dec. 31, 2022
Debt Securities [Abstract]
DEBT SECURITIES ISSUED	DEBT SECURITIES ISSUED As of December 31, 2022, and March 31, 2022, outstanding debt securities issued by the Company included the following: Debt securities issued by: December 31, 2022 March 31, 2022 (Recasted) Freedom SPC $ 36,799 $ 13,203 Freedom Holding Corp. — 20,499 Accrued interest 393 688 Total debt securities issued $ 37,192 $ 34,390 As of December 31, 2022, and March 31, 2022, the Company’s outstanding debt securities had fixed annual coupon rates ranging from 5.5% to 7% and maturity dates ranging from December 2022 to October 2026. As of December 31, 2022, the Company fully redeemed FRHC notes, which were issued from December 2019 to February 2020. The FRHC notes denominated in U.S. dollars, bear interest at an annual rate of 7% and were due in December 2022. The FRHC notes were issued under Astana International Financial Centre law and traded on the AIX. The Company’s debt securities as of December 31, 2022, include $36,799 of Freedom SPC bonds issued in October 2021. The Freedom SPC bonds are denominated in U.S. dollars, bear interest at an annual rate of 5.5% and are due in October 2026. The Freedom SPC bonds were issued under Astana International Financial Centre law and trade on the AIX. FRHC is a guarantor of the Freedom SPC bonds. The proceeds from the issuance of the Freedom SPC bonds were loaned to FRHC pursuant to a loan agreement dated November 22, 2021. The interest rate under the loan agreement is 5.5% per annum. Interest payments are duly semi-annually in April and October. Repayment of the loan is due October 2026. Debt securities issued are initially recognized at the fair value of the consideration received, less directly attributable transaction costs. The group has no covenants to comply with.

INSURANCE CONTRACTS ASSETS AND

INSURANCE CONTRACTS ASSETS AND LIABILITIES FROM INSURANCE ACTIVITIES	9 Months Ended
	Dec. 31, 2022
Insurance [Abstract]
INSURANCE CONTRACTS ASSETS AND LIABILITIES FROM INSURANCE ACTIVITIES	INSURANCE CONTRACTS ASSETS AND LIABILITIES FROM INSURANCE ACTIVITIES As of December 31, 2022, and March 31, 2022, insurance and reinsurance receivables of the Company was comprised of the following: December 31, 2022 March 31, 2022 Assets: (Recasted) Amounts due from policyholders $ 5,615 $ 3,500 Claims receivable from reinsurance 897 769 Amounts due from reinsured 52 23 Less provision for impairment losses (995) (343) Insurance and reinsurance receivables: 5,569 3,949 Unearned premium reserve, reinsurers’ share 3,763 143 Reserves for claims and claims’ adjustment expenses, reinsurers’ share 1,911 1,620 Total $ 11,243 $ 5,712 As of December 31, 2022, and March 31, 2022, the premium receivables from policyholders increased due to the expansion of operations. As of December 31, 2022, and March 31, 2022, insurance and reinsurance payable of the Company was comprised of the following: December 31, 2022 March 31, 2022 Liabilities: (Recasted) Amounts payable to reinsurers $ 2,405 $ 402 Amounts payable to insured 2,305 685 Amounts payable to agents and brokers 2,081 1,981 Insurance and reinsurance payables: 6,791 3,068 Unearned premium reserve 31,103 17,985 Reserves for claims and claims’ adjustment expenses 118,648 98,437 Total $ 156,542 $ 119,490 As of December 31, 2022, and March 31, 2022, the amount payable to agents and brokers increased due to the expansion of operations.

NET GAIN ON TRADING SECURITIES

NET GAIN ON TRADING SECURITIES	9 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
NET GAIN ON TRADING SECURITIES	NET GAIN ON TRADING SECURITIES During the three and nine months ended December 31, 2022, and December 31, 2021, net gain on trading securities was comprised of: Three Months Ended December 31, 2022 Three Months Ended December 31, 2021 (Restated) Net unrealized gain/(loss) recognized during the reporting period on trading securities still held at the reporting date $ 73,257 $ (33,567) Net (loss)/gain recognized during the period on trading securities sold during the period (47,801) 41,230 Net gain recognized during the period on trading securities $ 25,456 $ 7,663 Nine Months Ended December 31, 2022 Nine Months Ended December 31, 2021 (Restated) Net unrealized gain recognized during the reporting period on trading securities still held at the reporting date $ 65,684 $ 7,903 Net (loss)/gain recognized during the period on trading securities sold during the period (26,790) 190,044 Net gain recognized during the period on trading securities $ 38,894 $ 197,947 During the quarter ended December 31, 2022, the Company sold 5,350,000 SPBX shares. As a result of such sale, for the three months ended December 31, 2022, we recognized net loss on trading securities sold of $51,240, which included $52,072 of unrealized net loss recognized during previous periods that was reclassified to realized net loss during the quarter ended December 31, 2022. During the quarter ended December 31, 2021, we exchanged approximately 1,000,000 shares of stock in the SPBX we held in our proprietary trading account for units in the SPBX ETF. As a result, for the three months ended December 31, 2021, we recognized net gain on trading securities sold of $39,658, which included $36,079 of unrealized net gain recognized during previous periods that was reclassified to realized net gain during the quarter ended December 31, 2021.

FEE AND COMMISSION INCOME

FEE AND COMMISSION INCOME	9 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
FEE AND COMMISSION INCOME	FEE AND COMMISSION INCOME Fee and commission income is recognized when, or as, the Company satisfies its performance obligations by transferring the promised services to the customers. A service is transferred to a customer when, or as, the customer obtains control of that service. A performance obligation may be satisfied at a point in time or over time. Revenue from a performance obligation satisfied at a point in time is recognized at the point in time that the Company determines the customer obtains control over the promised service. Revenue from a performance obligation satisfied over time is recognized by measuring the Company’s progress in satisfying the performance obligation in a manner that depicts the transfer of the services to the customer. The amount of revenue recognized reflects the consideration the Company expects to receive in exchange for those promised services (i.e., the “transaction price”). In determining the transaction price, the Company considers multiple factors, including the effects of variable consideration, if any. The Company’s revenues from contracts with customers are recognized when the performance obligations are satisfied at an amount that reflects the consideration expected to be received in exchange for such services. The majority of the Company’s performance obligations are satisfied at a point in time and are typically collected from customers by debiting their brokerage account with the Company. Brokerage Services and Bank services Commissions from brokerage services — The Company earns commission revenue by executing, settling and clearing transactions with clients primarily in exchange-traded and over-the-counter corporate equity and debt securities, money market instruments and exchange-traded options and futures contracts. Commissions from bank services — The Company earns bank commissions by executing client order for money transfer, purchase and sale of foreign currency, and other bank services. A substantial portion of the Company's revenue is derived from commissions from private clients through accounts with transaction-based pricing. Trade execution and clearing services, when provided together, represent a single performance obligation, as the services are not separately identifiable in the context of the contract. Commission revenue associated with combined trade execution and clearing services, as well as trade execution services on a standalone basis, are recognized at a point in time on trade date when the performance obligation is satisfied. Commission revenue is generally paid on settlement date, which is generally two business days after trade date for equity securities and corporate bond transactions and one day for government securities, options and commodities transactions. The Company records a receivable on the trade date and receives a payment on the settlement date. Investment Banking The Company earns underwriting revenues by providing capital raising solutions for corporate clients through initial public offerings, follow-on offerings, equity-linked offerings, private investments in public entities, and private placements. Underwriting revenues are recognized at a point in time on trade date, as the client obtains the control and benefit of the capital markets offering at that point. These fees are generally received within 90 days after the transactions are completed. Transaction-related expenses, primarily consisting of legal, travel and other costs directly associated with the transaction, are deferred and recognized in the same period as the related investment banking transaction revenue. Underwriting revenues and related expenses are presented gross on the condensed consolidated income statements of operations. Receivables and Contract Balances Receivables arise when the Company has an unconditional right to receive payment under a contract with a customer and are derecognized when the cash is received. Margin lending, brokerage and other receivables are disclosed in Note 8 in the notes to condensed consolidated financial statements. Contract assets arise when the revenue associated with the contract is recognized before the Company’s unconditional right to receive payment under a contract with a customer (i.e., unbilled receivable) and are derecognized when either it becomes a receivable or the cash is received. As of December 31, 2022 and March 31, 2022, contract asset balances were not material. Contract liabilities arise when customers remit contractual cash payments in advance of the Company satisfying its performance obligations under the contract and are derecognized when the revenue associated with the contract is recognized either when a milestone is met triggering the contractual right to bill the customer or when the performance obligation is satisfied. As of December 31, 2022 and March 31, 2022, contract liability balances were not material. During the three and nine months ended December 31, 2022, and December 31, 2021, fee and commission income was comprised of: Three months ended December 31, 2022 Central Asia Europe U.S. Middle East/Caucasus Total Brokerage services $ 19,490 $ 47,893 $ 1,149 $ — $ 68,532 Bank services 5,507 — — — 5,507 Underwriting and market-making services 4,778 — — — 4,778 Other fee and commission income 1,473 593 — — 2,066 Total fee and commission income $ 31,248 $ 48,486 $ 1,149 $ — $ 80,883 Nine months ended December 31, 2022 Central Asia Europe U.S. Middle East/Caucasus Total Brokerage services $ 31,814 $ 192,330 $ 3,332 $ — $ 227,476 Bank services 15,100 — — — 15,100 Underwriting and market-making services 8,008 — — — 8,008 Other fee and commission income 1,793 1,109 — — 2,902 Total fee and commission income $ 56,715 $ 193,439 $ 3,332 $ — $ 253,486 Three months ended December 31, 2021 (Restated) Central Asia Europe U.S. Middle East/Caucasus Total Brokerage service (1) $ 2,474 $ 82,970 $ 1,256 $ — $ 86,700 Bank services 2,295 — — — 2,295 Underwriting and market-making services 1,828 — — — 1,828 Other fee and commission income 393 192 — — 585 Total fee and commission income $ 6,990 $ 83,162 $ 1,256 $ — $ 91,408 ________________ (1) Amounts are shown after reclassification of interest income from margin lending. Please see Note 4. Nine months ended December 31, 2021 (Restated) Central Asia Europe U.S. Middle East/Caucasus Total Brokerage services (1) $ 5,706 $ 240,152 $ 3,391 $ — $ 249,249 Bank services 4,027 — — — 4,027 Underwriting and market-making services 5,832 — — — 5,832 Other fee and commission income 2,527 914 — — 3,441 Total fee and commission income $ 18,092 $ 241,066 $ 3,391 $ — $ 262,549 ____________________ (1) Amounts are shown after reclassification of interest income from margin lending. Please see Note 4.

NET INTEREST INCOME_EXPENSE

NET INTEREST INCOME/EXPENSE	9 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
NET INTEREST INCOME/EXPENSE	NET INTEREST INCOME/EXPENSE Net interest income/expense for the three and nine months ended December 31, 2022, and December 31, 2021 includes: Three months ended December 31, 2022 Three months ended December 31, 2021 Interest income: (Restated) Interest income on securities repurchased under reverse repurchase agreements and amounts due from banks $ 4,062 $ 280 Interest income on trading securities 44,760 20,745 Interest income on available-for-sale securities 6,727 6,470 Interest income on margin lending (2) 12,379 4,921 Interest income on loans issued 12,327 1,241 Total interest income $ 80,255 $ 33,657 Interest expense: Interest expense on securities repurchase agreement obligations $ 39,958 $ 15,671 Interest expense on customer liabilities 11,149 5,732 Interest expense on debt securities issued 842 394 Other interest expense 88 93 Total interest expense $ 52,037 $ 21,890 Net interest income $ 28,218 $ 11,767 Nine months ended December 31, 2022 Nine months ended December 31, 2021 Interest income: (Restated) Interest income on securities repurchased under reverse repurchase agreements and amounts due from banks $ 6,198 $ 887 Interest income on trading securities 116,922 54,966 Interest income on available-for-sale securities 13,280 16,244 Interest income on margin lending (2) 27,259 8,212 Interest income on loans issued 24,158 2,205 Total interest income $ 187,817 $ 82,514 Interest expense: Interest expense on securities repurchase agreement obligations $ 105,466 $ 38,548 Interest expense on customer accounts and deposits 24,780 12,645 Interest expense on debt securities issued 2,457 1,323 Interest expense on loans received 268 291 Other interest expense — 45 Total interest expense $ 132,971 $ 52,852 Net interest income $ 54,846 $ 29,662 ____________________ (2) Amounts for the three and nine months ended December 31, 2021, are shown after reclassification of interest income from margin lending. Please see Note 4

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS During the three and nine months ended December 31, 2022 and 2021, the Company engaged in various related party transactions, a substantial amount of which were conducted with Freedom Securities Trading Inc. (formerly known as FFIN Brokerage Services, Inc.) (“FFIN Brokerage”), a Belize company which is owned personally by the Company’s chief executive officer, chairman and majority shareholder, Timur Turlov, and is not part of the FRHC group of companies. FFIN Brokerage has its own brokerage customers, which include individuals and market-maker institutions and conducts business with the Company through a client omnibus account at Freedom EU. Fee and commission income earned from related parties is comprised primarily of brokerage commissions and commissions for money transfers by brokerage clients, principally FFIN Brokerage. Fee and commission income earned from FFIN Brokerage principally consists of fees and commissions paid by FFIN Brokerage to Freedom EU to execute trades requested by brokerage customers of FFIN Brokerage, as well as commissions paid by FFIN Brokerage for order flow, which is net compensation received from firms to which our broker-dealer subsidiaries send equity and options orders, and fees for outstanding short sale positions. During the three months ended December 31, 2022 and 2021, the Company earned fee and commission income from related parties in the amounts of $44,590 and $80,024, respectively. Fee and commission income generated from FFIN Brokerage accounted for approximately 98% of the Company's total related party fee and commission income for the three months ended December 31, 2022, as compared to approximately 94% of the Company's total related party fee and commission income for the three months ended December 31, 2021. During the nine months ended December 31, 2022 and 2021, the Company earned fee and commission income from related parties in the amounts of $181,396 and $230,026, respectively. Fee and commission income generated from FFIN Brokerage accounted for approximately 93% and 96% of the Company's total related party fee and commission income for the nine months ended December 31, 2022 and 2021, respectively. Interest income earned from related parties is comprised entirely of interest income from FFIN Brokerage, principally interest income from margin lending. During the three months ended December 31, 2022 and 2021, the Company earned interest income from related parties in the amounts of $10,796 and $3,807, respectively. Interest income generated from FFIN Brokerage accounted for approximately 100% of the Company's total related party interest income for each of the three months ended December 31, 2022, and the three months ended December 31, 2021. During the nine months ended December 31, 2022 and 2021, the Company earned interest income from related parties in the amounts of 21,659 and $4,221, respectively. Interest income generated from FFIN Brokerage accounted for approximately 100% of the Company's total related party interest income for each of the nine months ended December 31, 2022 and 2021, respectively . During the three months ended December 31, 2022 and 2021, the Company paid fee and commission expense for brokerage services to Wisdompoint Capital LTD and FFIN Brokerage in the amount of $2,304 and $3,823, respectively. During the nine months ended December 31, 2022 and 2021, the Company paid fee and commission expense for brokerage services to related parties in the amounts of $2,657 and $14,350, respectively. During the three months ended December 31, 2022 and 2021, the Company recorded stock-based compensation expense for restricted stock grants to related parties in the amount of $345 and $385, respectively. During the nine months ended December 31, 2022, and 2021, the Company recorded stock-based compensation expense for restricted stock grants to related parties in the amount of $1,028 and $950, respectively. Margin lending, brokerage and other receivables from related parties result principally from borrowings made under margin loans by related parties, principally FFIN Brokerage. As of December 31, 2022, and March 31, 2022, the Company had margin lending receivables with related parties totaling $161,139 and $107,649, respectively. 97% and 95% of these balances were due from FFIN Brokerage. Margin lending receivables from FFIN Brokerage principally represent margin loans granted by Freedom EU to FFIN Brokerage. As of December 31, 2022, and March 31, 2022, the Company had bank commission receivables and receivables from brokerage clients from related parties totaling $947 and $190, respectively. As of December 31, 2022, and March 31, 2022, the Company had margin lending payables to related parties, totaling $4,507 and $38,889, respectively. 100% of these balances were due to Wisdompoint Capital LTD, as of December 31, 2022, and March 31, 2022, respectively. Wisdompoint Capital LTD (formerly Tradernet Limited) is a Cyprus company related to Freedom EU through common management. Wisdompoint Capital LTD provides brokerage services to the Company. As of December 31, 2022, and March 31, 2022, the Company had accounts payable to Timur Turlov totaling $271 and $313, respectively. As of December 31, 2022, and March 31, 2022, the Company had amounts due to Timur Turlov related to the purchase price for the acquisition by the Company from Timur Turlov of two insurance companies, Freedom Life and Freedom Insurance, totaling $12,958 and $21,477, respectively. During the three months ended December 31, 2022 the Company paid the payable for acquisition of Freedom Life for $13,630. The payment of the consideration for Freedom Insurance is planned to be paid in February 2023. As of December 31, 2022, and March 31, 2022, the Company had customer liabilities to related parties totaling $351,140 and $325,904, respectively. As of December 31, 2022, and March 31, 2022, 73% and 54%, respectively, of these balances were deposits from FFIN Brokerage held by Freedom EU related to brokerage services provided by Freedom EU to FFIN Brokerage. As of December 31, 2022, and March 31, 2022, the Company had restricted customer cash deposited in current and brokerage accounts with related parties in the amounts of $127,211 and $222,651. As of December 31, 2022, and March 31, 2022, 19% and 78%, respectively, of these balances were from FFIN Brokerage. During the the three and nine months ended December 31, 2022, the Company purchased loans in the aggregate amount of $50,594 and $89,935 and sold back loans totaling $12,977 and $32,904, respectively, to FFIN Credit, a company outside of the FRHC group which is owned by Timur Turlov. As of December 31, 2022, and March 31, 2022 the Company had cash and cash equivalents held in brokerage accounts of related parties totaling $15,971 and $22,787 respectively. 100% of these balances were due to Wisdompoint Capital LTD. In July 2021 the Company sold 23.88% of its outstanding equity interest in Freedom UA for $415 to Askar Tashtitov, the Company’s president, reducing the Company's direct ownership interest in Freedom UA to approximately 9%. During the three months ended December 31, 2022 and 2021 Freedom Finance Technologies sold SPBX shares with a value of $832 and $1,912, respectively, to FFIN Brokerage. Margin lending, brokerage and related banking services were provided to related parties pursuant to standard client account agreements and at standard market rates.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Dec. 31, 2022
Equity [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY On October 6, 2022, the Company awarded a restricted stock grant totaling 20,000 shares of its common stock to key employees of the Company. Of the 20,000 shares awarded pursuant to the restricted stock grant awards, 4,000 shares vested on the date of the award, 4,000 shares vest on May 18, 2023, 4,000 shares vest on May 18, 2024, 4,000 shares vest on May 18, 2025 and 4,000 shares vest on May 18, 2026. On October 11, 2022, the Company awarded a stock grant totaling 18,284 shares of its common stock to key employees of the Company's subsidiary, which vested on the date of the award, and on October 20, 2022, the Company awarded a stock grant totaling 8,000 shares of its common stock to a consultant of the Company, which vested on the date of the award. In May 2022, Freedom KZ completed the acquisition of two insurance companies, Freedom Life and Freedom Insurance. Prior to being acquired by the Company, these two companies were 100% controlled by Timur Turlov. The consideration for the purchase was $26,588. The Company is required to pay the purchase price to Timur Turlov by no later than December 31, 2022. As at December 31,2022 Freedom KZ has repaid the payable for acquisition of Freedom Life for $13,630. The payment of the consideration for Freedom Insurance is planned to be paid in February 2023. During the three and nine months ended December 31, 2022, Timur Turlov made a capital contribution to the Company in the amount of $0 and $677, respectively. On March 30, 2022, the Company awarded a restricted stock grant totaling 7,500 shares of its common stock to one executive officer of the Company. Of the 7,500 shares awarded pursuant to the restricted stock grant awards, 3,000 shares vest on May 18, 2023, 1,500 shares vest on May 18, 2024, 1,500 shares vest on May 18, 2025 and 1,500 shares vest on May 18, 2026. On May 18, 2021, the Company awarded restricted stock grants totaling 1,031,500 shares of its common stock to 56 employees and consultants of the Company, including two executive officers of the Company. Of the 1,031,500 shares awarded pursuant to the restricted stock grant awards, 200,942 shares are subject to one-year vesting, 211,658 shares are subject to two-year vesting and 206,300 shares per year are subject to three four The Company recorded stock-based compensation expense for restricted stock grants and stock options in the amount of $3,945 and $10,746 during the three and nine months ended December 31, 2022. The Company recorded stock-based compensation expense for restricted stock grants and stock options in the amount of $4,561 and $11,283 during the three and nine months ended December 31, 2021.

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION	9 Months Ended
	Dec. 31, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract]
STOCK BASED COMPENSATION	STOCK BASED COMPENSATION During the nine months ended December 31, 2022, a total of 20,000 restricted shares with five year vesting period were awarded to key employees and 26,284 shares with immediate vesting were awarded to key employees. On October 11, 2022, the Company awarded a stock grant totaling 18,284 shares of its common stock to key employees of the Company's subsidiary, which vested on the date of the award, and on October 20, 2022, the Company awarded a stock grant totaling 8,000 shares of its common stock to a consultant of the Company, which vested on the date of the award. The compensation expense related to restricted stock grants was $3,945 during the three months ended December 31, 2022, and $4,561 during the three months ended December 31, 2021. As of December 31, 2022 and March 31, 2022, there was $14,379 and $28,899 of total unrecognized compensation cost related to non-vested shares of common stock granted . The cost is expected to be recognized over a weighted average period of 3.33 years. The Company has determined the fair value of restricted shares awarded as of grant date, using the Monte Carlo valuation model based on the following key assumptions: Term (years) 3.62 Volatility 35.2 % Risk-free rate 4.18 % The table below summarizes the activity for the Company’s restricted stock outstanding during the nine months ended December 31, 2022: Shares Weighted Outstanding, at March 31, 2022 1,049,500 $ 40,303 Granted 46,284 2,175 Vested (255,226) (10,153) Forfeited/cancelled/expired (68,000) (2,602) Outstanding, at December 31, 2022 772,558 $ 29,723

LEASES

LEASES	9 Months Ended
	Dec. 31, 2022
Leases [Abstract]
LEASES	LEASES The Company determines whether a contract contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When readily determinable, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company must discount lease payments based on an estimate of its incremental borrowing rate. The following table presents as of December 31, 2022, the annual maturities of the lease liabilities: Twelve months ended March 31, 2023 $ 2,248 2024 6,154 2025 5,965 2026 5,705 2027 4,743 Thereafter 6,733 Total payments 31,548 Less: amounts representing interest 7,373 Lease liability, net $ 24,175 Weighted average remaining lease term (in months) 23 Weighted average discount rate 12 % Lease commitments for short term operating leases as of December 31, 2022, was approximately $258. The Company’s lease expense for office sp ace was $1,414 and $2,530 for

ACQUISITIONS OF SUBSIDIARIES

ACQUISITIONS OF SUBSIDIARIES	9 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
ACQUISITIONS OF SUBSIDIARIES	ACQUISITIONS OF SUBSIDIARIES Acquisition of London-Almaty On September 1, 2022, the Company completed the acquisition of Insurance Company IC "London-Almaty", following receipt of the approval from the Agency of the Republic of Kazakhstan for Regulation and Development of Financial Market, by purchasing 100% of its outstanding shares. The Company acquired IC "London-Almaty" to expand its presence in the insurance sector. As of September 1, 2022, the date of the acquisition of IC "London-Almaty", the fair value of IC "London-Almaty" was $15,858. The total purchase price was allocated as follows: ASSETS Cash and cash equivalents $ 8,077 Due from banks 2,176 Trading securities 6,178 Value of business acquired 1,677 Assets from insurance activities 3,401 Fixed assets 806 Intangible assets 127 Other assets 1,505 TOTAL ASSETS 23,947 Insurance reserves 6,380 Liabilities from insurance activity 1,429 Other liabilities 280 TOTAL LIABILITIES 8,089 Net assets acquired 15,858 Goodwill 485 Total purchase price $ 16,343 On December 15, 2022, IC "London-Almaty" was merged into Freedom Insurance and its separate legal existence was terminated. The assets and liabilities of IC "London-Almaty" were transferred to Freedom Insurance at their respective carrying amounts on the date of the merger was completed. Acquisition of Ticketon As of September 30, 2022, the date of the acquisition of Ticketon by purchasing 100% of its authorized capital. The Company acquired Ticketon to accelerate its growth in fintech sector. The negative fair value of Ticketon on the date of the acquisition was $172. The total purchase price was allocated as follows: ASSETS Cash and cash equivalents $ 3,029 Brokerage and other receivables 169 Fixed assets 20 Intangible assets 33 Right-of-use asset 63 Other assets 606 TOTAL ASSETS 3,920 Deferred income tax liabilities 34 Lease liability 63 Other liabilities 3,995 TOTAL LIABILITIES 4,092 Net assets acquired (172) Goodwill 3,172 Total purchase price $ 3,000

ASSETS AND LIABILITIES HELD FOR

ASSETS AND LIABILITIES HELD FOR SALE	9 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
ASSETS AND LIABILITIES HELD FOR SALE	ASSETS AND LIABILITIES HELD FOR SALE In the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022, the Company announced its plans to divest its interests in its Russian securities brokerage and complementary banking operations in Russia (the "Russia Segment"). On October 17, 2022, the Company entered into an agreement with Maxim Povalishin for the sale of 100% of the share capital of the companies comprising the Russia Segment. Maxim Povalishin, the purchaser, is currently the Deputy General Director and a member of the Board of Directors of Freedom RU. The transaction was approved by the Central Bank of the Russian Federation on February 10, 2023, and the sale is expected to be completed before the end of the February 2023. The consideration for the purchase of the Russian Subsidiaries consists of the following: • Mr. Povalishin will be assigned the Company’s obligation to Freedom RU under an outstanding deferred payment in the amount of approximately RUB 6.6 billion (at foreign exchange rate on the reporting date approximately $91 million) (the “Deferred Payment Obligation”) which resulted from the purchase by the Company of 90.43% of the share capital of Freedom RU’s Kazakhstan subsidiary Freedom Finance JSC (“Freedom KZ”) (with its subsidiaries) from Freedom RU as part of a corporate restructuring, as a result of which the Company has become the 100% direct owner of Freedom KZ. The agreement for the purchase of Freedom KZ was entered on September 13, 2022, that was approved by regulatory body and finalized during November 2022; and • Mr. Povalishin will pay cash in an amount equal to (x) $140 million less (y) the amount of the Deferred Payment Obligation as translated into U.S. dollars at the official exchange rate on the closing date. In addition, in July 2022, Freedom RU established a Russian subsidiary Freedom Finance Auto LLC. In January 2023, Freedom RU concluded an agreement to sell this new subsidiary to Mr. Povalishin for RUB 50 million (approximately $695 based on the applicable currency exchange rate on the reporting date). On February 7, 2023, the sale of Freedom Finance Auto LLC was completed. The Company has classified the Russia Segment as discontinued operations as of December 31, 2022 and for the three and nine months ended December 31, 2022, because the subsidiaries to be disposed of in this transaction met the held for sale criteria as of December 31, 2022. The cumulative translation adjustment attributable to the Russia Segment of $18,650 is included within Accumulated Other Comprehensive Loss within the Condensed Consolidated Balance Sheet as of December 31, 2022. In light of the Russia/Ukraine Conflict, and the consequent U.S., UK and EU economic sanctions and Russian countersanctions, the Company was seeking to sell its interests in its three Russian subsidiaries that resulted in a net non-cash $43,973 impairment charge, which was recorded for the nine months ended December 31, 2022, within the line item Net income from discontinued operation on the Condensed Consolidated Statements of Operations. The Company will continue to evaluate the Russia Segment for changes in the valuation until it is sold. In accordance with United States tax regulations, the Company applies the check-the-box election for disregarding the Russian Segment and treating it as an asset. The Company's position that the loss arising from the Russian Segment in the amount of $43,973 for the nine months ended December 31, 2022, cannot be deducted for income tax purposes in the United States and, therefore, it does not recognize a related deferred tax asset. In accordance with US GAAP, the Company has reported separately the discontinued operations in the condensed consolidated financial statements. As of December 31, 2022 and March 31, 2022, the major classes of assets and liabilities from discontinued operations included the following: December 31, 2022 March 31, 2022 Cash and cash equivalents $ 582,314 $ 428,480 Restricted cash 18,052 28,406 Trading securities 112,801 122,497 Margin lending, brokerage and other receivables, net 240,414 210,087 Loans issued 17,201 2,395 Other assets 34,757 33,554 Less: valuation allowance (43,973) — Total assets held for sale $ 961,566 $ 825,419 Customer liabilities $ 820,394 $ 701,584 Securities repurchase agreement obligations 30,971 32,469 Debt securities issued 63,207 64,637 Other liabilities 16,912 13,788 Total liabilities held for sale 931,484 812,478 The results of operations for discontinued operations for the three and nine months ended December 31, 2022, and 2021, consist of the following: For The Three Months Ended For The Nine Months Ended December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Fee and commission income $ 14,230 $ 23,147 $ 62,290 $ 59,596 Net gain/(loss) on trading securities 799 (6,611) 13,898 (9,716) Net loss on derivative (43) — (43) — Interest income 17,599 5,786 47,460 15,574 Net gain/(loss) on foreign exchange operations 19,965 (655) 40,379 (2,889) TOTAL REVENUE, NET 52,550 21,667 163,984 62,565 Operating expense 29,839 22,253 83,379 53,841 Interest expense 3,124 2,365 13,143 6,824 Fee and commission expense 2,750 2,075 7,000 6,300 Provision for impairment losses 1,594 13 2,176 89 Provision for impairment of discontinued operations 2,509 — 43,973 — Other (income)/expense, net (933) 28 (154) 120 TOTAL EXPENSE 38,883 26,734 149,517 67,174 INCOME/(LOSS) BEFORE INCOME TAX $ 13,667 $ (5,067) $ 14,467 $ (4,609) The net cash flows used in operating and investing activities for discontinued operations for the nine months ended December 31, 2022, and 2021, consist of the following: For the Nine Months Ended December 31, 2022 2021* (Recasted) Cash Flows From Operating Activities Net income/(loss) from discontinued operations $ 9,929 $ (3,656) Adjustments to reconcile net income used in operating activities: Depreciation and amortization 1,794 1,637 Noncash lease expense 4,947 3,785 Change in deferred taxes 4,121 (1,892) Stock compensation expense 4,226 5,647 Unrealized loss/(gain) on trading securities (47,926) 9,082 Net change in accrued interest 810 1,436 Provision for impairment of discontinued operations 43,973 — Allowances for receivables 2,053 89 Changes in operating assets and liabilities: Trading securities 61,479 (262,438) Margin lending, brokerage and other receivables (4,755) (93,717) Other assets 1,557 (1,948) Securities sold, not yet purchased – at fair value 257 (24) Customer liabilities (47,602) 121,173 Current income tax liability 1 (623) Margin lending and trade payables (16) 319 Lease liabilities (5,509) (3,947) Other liabilities 2,826 2,176 Net cash flows from/(used in) operating activities from discontinued operations 32,165 (222,901) Cash Flows Used In Investing Activities Purchase of fixed assets (3,998) (2,918) Proceeds from sale of fixed assets — 699 Net change in loans issued to customers (17,649) (571) Net cash flows used in investing activities from discontinued operations (21,647) (2,790) The following table presents reconciliation of anticipated provision for impairment from sale of net assets held for sale as of disposal date: December 31, 2022 Pre-elimination balance Eliminations Post-elimination balance Cash and cash equivalents 582,314 — 582,314 Restricted cash 18,052 — 18,052 Trading securities 112,801 — 112,801 Margin lending, brokerage and other receivables, net 331,682 (91,269) 240,413 Loans issued 17,201 — 17,201 Other assets 34,758 — 34,758 Total assets held for sale $ 1,096,808 $ (91,269) $ 1,005,539 Customer liabilities 820,394 — 820,394 Securities repurchase agreement obligations 30,971 — 30,971 Debt securities issued 63,207 — 63,207 Other liabilities 16,913 — 16,913 Total liabilities held for sale $ 931,485 $ — $ 931,485 Net assets held for sale $ 165,323 $ 74,054 Unrealized loss from translation adjustment 18,650 Adjusted net assets held for sale $ 183,973 Expected selling price 140,000 Provision for impairment of discontinued operations $ (43,973)

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	– COMMITMENTS AND CONTINGENCIES Freedom Bank KZ is a party to certain off-balance sheet financial instruments. These financial instruments include guarantees and unfunded commitments under existing lines of credit. These commitments expose the Company to varying degrees of credit and market risk which are essentially the same as those involved in extending loans to customers, and are subject to the same credit policies used in underwriting loans. Collateral may be obtained based on the Company's credit evaluation of the counterparty. The Company's maximum exposure to credit loss is represented by the contractual amount of these commitments. Unfunded commitments under lines of credit Unfunded commitments under lines of credit include commercial, commercial real estate, home equity and consumer lines of credit to existing customers. These commitments may mature without being fully funded. Unfunded commitments under guarantees Unfunded commitments under guarantees are conditional commitments issued by Freedom Bank KZ to provide bank guarantees to customers. These commitments may mature without being fully funded. Bank guarantees Bank guarantees are conditional commitments issued by Freedom Bank KZ to guarantee the performance of a customer to a third party. These guarantees are primarily issued to support trade transactions or guarantee arrangements. The credit risk involved in issuing guarantees is essentially the same as that involved in extending loan facilities to customers. A significant portion of the issued guarantees are collateralized by cash. Total lending related commitments outstanding as of December 31, 2022, and March 31, 2022, were as follows: As of December 31, 2022 As of March 31, 2022 (Recasted) Unfunded commitments under lines of credits and guarantees $ 18,838 $ 11,292 Bank guarantees 4,874 6,384 Total $ 23,712 $ 17,676

SEGMENT REPORTING

SEGMENT REPORTING	9 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTING During the fourth quarter of 2022 fiscal year, the Company's CODM restructured the way he views the Company's business from a single operating segment to five geographic regional segments including Central Asia, Europe, United States, Russia and Middle East/Caucasus. The Company has classified the Russia segment as discontinued operations for the periods presented because the assets and liabilities to be disposed of in connection with this transaction met the held for sale criteria as of December 31, 2022. The Company's CODM do not review inter-segment revenues as part of segment reporting. The following tables summarize the Company's Statement of Operations and Statements of Other Comprehensive Income by its geographic segments. Intercompany balances were eliminated for separate disclosure: Three months ended December 31, 2022 STATEMENTS OF OPERATIONS Central Asia Europe U.S. Middle East/Caucasus Total Fee and commission income (1) $ 31,248 $ 48,486 $ 1,149 $ — $ 80,883 Net gain/(loss) on trading securities 28,080 819 (3,443) — 25,456 Interest income 66,324 11,417 2,500 14 80,255 Insurance underwriting income 28,557 — — — 28,557 Net gain/(loss) on foreign exchange operations 20,402 313 152 (1) 20,866 Net loss on derivative (21,469) — — — (21,469) TOTAL REVENUE, NET 153,142 61,035 358 13 214,548 Fee and commission expense 10,110 7,933 255 16 18,314 Interest expense 43,880 4,590 3,567 — 52,037 Insurance claims incurred, net of reinsurance 17,418 1 — — 17,419 Operating expense (2) 28,494 12,824 8,655 635 50,608 Provision for impairment losses 12,767 11,363 10 — 24,140 Other expense/(income), net 647 (74) — (3) 570 TOTAL EXPENSE 113,316 36,637 12,487 648 163,088 INCOME/(LOSS) BEFORE INCOME TAX FROM CONTINUING OPERATIONS $ 39,826 $ 24,398 $ (12,129) $ (635) $ 51,460 Income tax expense (95) (4,557) (398) (19) (5,069) INCOME/(LOSS) FROM CONTINUING OPERATIONS $ 39,731 $ 19,841 $ (12,527) $ (654) $ 46,391 Nine months ended December 31, 2022 STATEMENTS OF OPERATIONS Central Asia Europe U.S. Middle East/Caucasus Total Fee and commission income (1) $ 56,715 $ 193,439 $ 3,332 $ — 253,486 Net gain/(loss) on trading securities 65,497 (21,815) (4,788) — 38,894 Interest income 154,300 24,014 9,489 14 187,817 Insurance underwriting income 78,998 — — — 78,998 Net gain/(loss) on foreign exchange operations 32,270 (1,517) (747) 8 30,014 Net loss on derivative (22,523) — — — (22,523) TOTAL REVENUE, NET 365,257 194,121 7,286 22 566,686 Fee and commission expense 32,638 26,834 551 45 60,068 Interest expense 110,410 10,250 12,311 — 132,971 Insurance claims incurred, net of reinsurance 51,585 1 — — 51,586 Operating expense 70,975 34,923 19,015 1,454 126,367 Provision for impairment losses/(recoveries) 18,930 11,362 2 — 30,294 Other expense/(income), net 116 31 (8) (60) 79 TOTAL EXPENSE 284,654 83,401 31,871 1,439 401,365 INCOME/(LOSS) BEFORE INCOME TAX FROM CONTINUING OPERATIONS $ 80,603 $ 110,720 $ (24,585) $ (1,417) 165,321 Income tax expense (691) (18,403) (7,475) 2 (26,567) INCOME/(LOSS) FROM CONTINUING OPERATIONS $ 79,912 $ 92,317 $ (32,060) $ (1,415) 138,754 Three months ended December 31, 2021 (Restated) STATEMENTS OF OPERATIONS Central Asia Europe U.S. Middle East/Caucasus Total Fee and commission income $ 6,990 $ 83,162 $ 1,256 $ — $ 91,408 Net gain on trading securities 7,081 481 101 — 7,663 Interest income 28,703 4,940 14 — 33,657 Insurance underwriting income 21,394 — — — 21,394 Net gain/(loss) on foreign exchange operations 2,002 (437) (209) 5 1,361 Net loss on derivative (314) — — — (314) TOTAL REVENUE, NET 65,856 88,146 1,162 5 155,169 Fee and commission expense 6,523 18,106 153 — 24,782 Interest expense 17,553 3,919 418 — 21,890 Insurance claims incurred, net of reinsurance 16,286 — — — 16,286 Operating expense 15,247 10,517 5,903 (86) 31,581 Provision for impairment (recoveries)/losses (365) — 32 — (333) Other expense/(income), net 990 (13) 2 979 TOTAL EXPENSE 56,234 32,529 6,506 (84) 95,185 INCOME BEFORE INCOME TAX FROM CONTINUING OPERATIONS $ 9,622 $ 55,617 $ (5,344) $ 89 59,984 Income tax benefit/(expense) 1,256 (7,176) 4,114 — (1,806) INCOME FROM CONTINUING OPERATIONS $ 10,878 $ 48,441 $ (1,230) $ 89 $ 58,178 Nine months ended December 31, 2021 (Restated) STATEMENTS OF OPERATIONS Central Asia Europe U.S. Middle East/Caucasus Total Fee and commission income $ 18,092 $ 241,066 $ 3,391 $ — $ 262,549 Net gain/(loss) on trading securities 18,779 179,473 (305) — 197,947 Interest income 74,425 8,015 74 — 82,514 Income from insurance activity 51,491 — — — 51,491 Net gain/(loss) on foreign exchange operations 4,775 (497) (207) 5 4,076 Net loss on derivative (1,028) — — — (1,028) TOTAL REVENUE, NET 166,534 428,057 2,953 5 597,549 Fee and commission expense 11,177 56,946 503 — 68,626 Interest expense 44,311 7,422 1,119 — 52,852 Insurance claims incurred, net of reinsurance 41,096 — — — 41,096 Operating expense 38,327 20,089 14,275 81 72,772 Provision for impairment losses 868 11 32 — 911 Other expense/(income), net 2,449 (21) — (2) 2,426 TOTAL EXPENSE 138,228 84,447 15,929 79 238,683 INCOME/(LOSS) BEFORE INCOME TAX FROM CONTINUING OPERATIONS $ 28,306 $ 343,610 $ (12,976) $ (74) $ 358,866 Income tax benefit/(expense) 1,278 (21,190) (19,114) — (39,026) NET INCOME/(LOSS) FROM CONTINUING OPERATIONS $ 29,584 $ 322,420 $ (32,090) $ (74) $ 319,840 (1) All trading of U.S. and European exchange traded and OTC securities by all of the Company's securities brokerage firms, excluding PrimeEx, are routed to and executed through Freedom EU and all fee and commission income for those transactions is recognized at Freedom EU. (2) Operating expense includes significant noncash items stock based compensation expenses. The following table summarizes the Company's stock based compensation by its geographic segments: Three Months Ended December 31, Nine Months Ended December 31, 2022 2021* 2022 2021* Central Asia $ 2,077 $ 1,384 $ 4,215 $ 3,414 U.S. 717 691 1,869 1,737 Europe 145 196 436 485 Total stock based compensation $ 2,939 $ 2,271 $ 6,520 $ 5,636 The following tables summarize the Company's total asset and total liabilities by its geographic segments. Intercompany balances were eliminated for separate disclosure: December 31, 2022 Central Asia Europe U.S. Russia (Discontinued operations) Middle East/Caucasus Total Total assets $ 3,770,032 $ 519,760 $ 114,609 $ 961,566 $ 2,167 $ 5,368,134 Total liabilities 3,071,804 607,536 74,618 931,484 361 4,685,803 Net assets $ 698,228 $ (87,776) $ 39,991 $ 30,082 $ 1,806 $ 682,331 March 31, 2022 (Recasted) Central Asia Europe U.S. Russia (Discontinued operations) Middle East/Caucasus Total Total assets $ 1,423,529 $ 805,768 $ 172,679 $ 825,419 $ 355 $ 3,227,750 Total liabilities 1,203,473 489,883 175,136 812,478 172 2,681,142 Net assets $ 220,056 $ 315,885 $ (2,457) $ 12,941 $ 183 $ 546,608 Central Asia Segment The Central Asia segment comprises the Kazakhstan headquarters and operations in Kazakhstan (including in the AIFC), Kyrgyzstan, Uzbekistan, Ukraine and Turkey. Recently acquired insurance companies, Freedom Insurance, Freedom Life, and London Almaty, are included within Central Asia segment. Europe Segment The Cyprus securities brokerage firm, Freedom EU, oversees the Europe segment operations (consisting of operations in Cyprus, the UK, Germany, Spain, Greece, and France). U.S. Segment The U.S. segment currently consists of FRHC and the Company's PrimeEx subsidiary. Middle East/Caucasus Segment As of December 31, 2022, the Middle East/Caucasus segment consisted of four o ffices, in Azerbaijan, Armenia and the United Arab Emirates, that provide brokerage and investment education services. The Company entered into the Caucasus market during fiscal year 2022 by establishing subsidiaries in Azerbaijan and Armenia, and in April 2022 it entered into the Middle East market by establishing a subsidiary in the United Arab Emirates. Russia Segment The Russia segment, that was classified as assets and liabilities held for sale, includes the securities brokerage subsidiary Freedom RU and its subsidiaries Freedom Bank RU and Freedom Auto .

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS The Company has performed an evaluation of subsequent events through the time of filing this quarterly report on Form 10-Q with the SEC. During this period the Company did not have any additional material recognizable subsequent events other than as set forth below. On February 8, 2023, the Company acquired Kazakhstan company Paybox Technologies LLP and its subsidiaries ("Paybox"). The purchase price for the acquisition of Paybox was $11,500.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Accounting principles and Basis of presentation	The Company's accounting policies and accompanying condensed consolidated financial statements conform to accounting principles generally accepted in the United States of America (U.S. GAAP).The condensed consolidated financial statements present the condensed consolidated accounts of FRHC and its consolidated subsidiaries. In the opinion of management, all normal, recurring adjustments necessary for fair presentation of the condensed consolidated financial statements have been included.
Principles of consolidation	The condensed consolidated financial statements present the condensed consolidated accounts of FRHC and its consolidated subsidiaries. In the opinion of management, all normal, recurring adjustments necessary for fair presentation of the condensed consolidated financial statements have been included.
Consolidation of variable interest entities	In accordance with accounting standards regarding consolidation of variable interest entities ("VIEs"), VIEs are generally entities that lack sufficient equity to finance their activities without additional subordinated financial support from other parties or whose equity holders at risk lack adequate decision making ability. VIEs must be evaluated to determine the primary beneficiary of the risks and rewards of the VIE. The primary beneficiary is required to consolidate the VIE for financial reporting purposes. As of and for the three and nine months ended December 31, 2022, the only VIE of the Company was Freedom UA.
Use of estimates	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that the estimates utilized in preparing the Company's financial statements are reasonable and prudent. Actual results could differ from those estimates
Revenue and expense recognition	Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers ("ASC Topic 606"), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity's contracts to provide goods or services to customers. The core principle requires an entity to recognize revenue to depict the transfer of goods or services promised to customers in an amount that reflects the consideration that it expects to be entitled to receive in exchange for those goods or services recognized as performance obligations are satisfied. A significant portion of the Company's revenue-generating transactions are not subject to ASC Topic 606, including revenue generated from financial instruments, such as loans and investment securities, as these activities are subject to other U.S. GAAP guidance discussed elsewhere within these disclosures. Descriptions of the Company's revenue-generating activities that are within the scope of ASC Topic 606, which are presented in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income as components of total revenue, net are as follows: • Commissions on brokerage services; • Commissions on banking services (money transfers, foreign exchange operations and other); and • Commissions on investment banking services (underwriting, market making, and bondholders' representation services). Gross Versus Net Revenue ASC 606 provides guidance on proper recognition of principal versus agent considerations which is used to determine gross versus net revenue recognition. Under ASC 606, the core objective of the guidance on gross versus net revenue recognition is to help determine whether the Company is a principal or an agent in a transaction. In general, the primary difference between these two is the performance obligation being satisfied. The principal has a performance obligation to provide the desired goods or services to the end customer, whereas the agent arranges for the principal to provide the desired goods or services. Additionally, a fundamental characteristic of a principal in a transaction is control. A principal substantively controls the goods and services before they are transferred to the customer as well as controls the price of the good or service being provided. An agent normally receives a commission or fee for these activities. In addition to control, the level at which the Com controls the price of the good or service being transferred determines principal versus agent status. The more discretion over setting price a company has in providing the good or service, the more likely they are considered a principal rather than an agent. In certain cases, other parties are involved with providing products and services to our customers. If the Company is principal in the transaction (providing goods or services itself), revenues are reported based on the gross consideration received from the customer and any related expenses are reported gross in noninterest expense. If the Company is an agent in the transaction (arranging for another party to provide goods or services), the Company reports its net fee or commission retained as revenue.
Interest income	Interest income on margin loans, loans issued, trading securities, available-for-sale securities and reverse repurchase agreement obligations is recognized based on the contractual provisions of the underlying arrangements. Loan premiums and discounts are deferred and generally amortized into interest income as yield adjustments over the contractual life and/or commitment period using the effective interest method. Unamortized premiums, discounts and other basis adjustments on trading securities are generally recognized in interest income over the contractual lives of the securities using the effective interest method.
Loans and loans acquired	The Company's loan portfolio is divided into: mortgages, uncollateralized bank customer loans, collateralized bank customer loans, car loans and subordinated loans. Mortgage loans consist of loans provided to individuals to purchase real estate, which is used as collateral for the loan. Uncollateralized bank customer loans consist of loans provided through credit cards to individuals and retail unsecured banking loans provided to individuals. Collateralized bank customer loans consist of retail collateralized loans provided to individuals. Subordinated loans consist of uncollateralized loans provided to the legal entities to support their businesses, that ranks below other, more senior loans or securities with respect to claims on assets or earnings. Margin loans are not classified as part of the Company's loan portfolio and are instead recorded on the Condensed Consolidated Balance Sheets under Margin lending, brokerage and other receivables, net.All purchased loans are initially recorded at fair value, which includes consideration of expected future losses, at the date of the loan acquisition. To determine the fair value of loans at the date of acquisition, the Company estimates the discounted contractual cash flows due using an observable market rate of interest, adjusted for factors such as probable default rates of the borrowers, and the loan terms that a market participant would consider in determining fair value. In determining fair value, contractual cash flows are adjusted to include prepayment estimates based upon historical payment trends, forecasted default rates and loss severities and other relevant factors. The difference between the fair value and the contractual cash flows is recorded as a loan premium or discount, which may relate to either credit or non-credit factors, at acquisition. The Company accounts for purchased loans under the accounting guidance for purchased financial assets with credit deterioration when, at the time of purchase, the loans have experienced a more-than-insignificant deterioration in credit quality since origination. The Company recognizes an allowance for credit losses on purchased loans that have not experienced a more-than-insignificant deterioration in credit quality since origination at the time of purchase through earnings in a manner that is consistent with originated loans. The policies relating to the allowance for credit losses on loans is described below in the "Estimate of Incurred Loan Losses" section of this Note. Estimate of Incurred Loan Losses The allowance represents management's current estimate of incurred loan losses inherent in the Company's loan portfolio as of each balance sheet date. The provision for credit losses reflects credit losses the Company believes have been incurred and will eventually be recognized over time through charge-offs. Management performed a quarterly analysis of the Company's loan portfolio to determine if impairment had occurred and to assess the adequacy of the allowance based on historical and current trends as well as other factors affecting credit losses. The Company applied separate calculations of the allowances for its credit cards, mortgages and retail loan portfolios. Based on the adopted methodology, the Company estimated the probability of default based on historical default rates, adjusted for certain macro indicators, such as GDP, average exchange rates, unemployment rate, real wage index, inflation rate and retail trade index. Loss given default is calculated based on the collateral coverage of the loans. The Company's allowance for loan losses consists of two components that are allocated to cover the estimated probable losses in each loan portfolio based on the results of the Company's detailed review and loan impairment assessment process a component for loans collectively evaluated for impairment.
Derivative financial instruments	In the normal course of business, the Company invests in various derivative financial contracts including futures. Derivatives are initially recognized at fair value at the date a derivative contract is entered into and are subsequently re-measured to their fair value at each reporting date. The fair values are estimated based on quoted market prices or pricing models that take into account the current market and contractual prices of the underlying instruments and other factors. Derivatives are carried as assets when their fair value is positive and as liabilities when it is negative.
Functional currency	Management has adopted ASC 830, Foreign Currency Translation Matters as it pertains to its foreign currency translation. The Company's functional currencies are the Kazakhstan tenge, the Russian ruble, the euro, the U.S. dollar, the Ukrainian hryvnia, the Uzbekistani som, the Kyrgyzstani som, the Azerbaijani manat, the British pound sterling, the Armenian dram, the United Arab Emirates dirham and the Turkish lira, and its reporting currency is the U.S. dollar. For financial reporting purposes, foreign currencies are translated into U.S. dollars as the reporting currency. Monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average quarterly rates are used to translate revenues and expenses. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of shareholders' equity as "Accumulated other comprehensive loss". The Company uses exchange rates from the National Bank of the Republic of Kazakhstan for foreign currency translation purposes.
Cash and cash equivalents	Cash and cash equivalents are generally comprised of certain highly liquid investments with original maturities of three months or less at the date of purchase. Cash and cash equivalents include those reverse repurchase agreements, where maturity is less than 90 days, and the credit risk of the counterparty is low, which are recorded at the amounts at which the securities were acquired plus accrued interest.
Securities reverse repurchase and repurchase agreements	A reverse repurchase agreement is a transaction in which the Company purchases financial instruments from a seller, typically in exchange for cash, and simultaneously enters into an agreement to resell the same or substantially the same financial instruments to the seller for an amount equal to the cash or other consideration exchanged plus interest at a future date. Securities purchased under reverse repurchase agreements are accounted for as collateralized financing transactions and are recorded at the contractual amount for which the securities will be resold, including accrued interest. Financial instruments purchased under reverse repurchase agreements are recorded in the financial statements as cash placed on deposit collateralized by securities and classified as cash and cash equivalents in the Condensed Consolidated Balance Sheets. A repurchase agreement is a transaction in which the Company sells financial instruments to another party, typically in exchange for cash, and simultaneously enters into an agreement to reacquire the same or substantially the same financial instruments from the buyer for an amount equal to the cash or other consideration exchanged plus interest at a future date. These agreements are accounted for as collateralized financing transactions. The Company retains the financial instruments sold under repurchase agreements and classifies them as trading securities in the Condensed Consolidated Balance Sheets. The cash consideration received under repurchase agreements is classified as securities repurchase agreement obligations in the Condensed Consolidated Balance Sheets. The Company enters into reverse repurchase agreements, repurchase agreements, securities borrowed and securities loaned transactions to, among other things, acquire securities to leverage and grow its proprietary trading portfolio, cover short positions and settle other securities obligations, to accommodate customers' needs and to finance its inventory positions. The Company enters into these transactions in accordance with normal market practice. Under standard terms for repurchase transactions, the recipient of collateral has the right to sell or repledge the collateral, subject to returning equivalent securities on settlement of the transaction.
Available-for-sale securities	Financial assets categorized as available-for-sale ("AFS") are non-derivatives that are either designated as available-for-sale or not classified as (a) loans and receivables, (b) held to maturity investments or (c) trading securities. Gains and losses arising from changes in fair value are recognized in other comprehensive income and accumulated in the Accumulated other comprehensive loss, with the exception of other-than-temporary impairment losses, interest calculated using the effective interest method, and foreign exchange gains and losses are recognized in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income. When the investment is disposed of or is determined to be impaired, the cumulative gain or loss previously accumulated in the accumulated other comprehensive (loss)/income is then reclassified to net realized gain/(loss) on investments available-for-sale in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income.
Trading securities	Financial assets are classified as trading securities if the financial asset has been acquired principally for the purpose of selling it in the near term. Trading securities are stated at fair value, with any gains or losses arising on remeasurement recognized in revenue. Changes in fair value are recognized in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income and included in net gain on trading securities. Interest earned and dividend income are recognized in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income and included in interest income, according to the terms of the contract and when the right to receive the payment has been established. Investments in nonconsolidated managed funds are accounted for at fair value based on the net asset value of the funds provided by the fund managers with gains or losses included in net gain on trading securities in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income.
Debt securities issued	Debt securities issued are initially recognized at the fair value of the consideration received, less directly attributable transaction costs. Subsequently, amounts due are stated at amortized cost and any difference between net proceeds and the redemption value is recognized over the period of the borrowings using the effective interest method. If the Company purchases its own debt it is removed from the Condensed Consolidated Balance Sheets and the difference between the carrying amount of the liability and the consideration paid is recognized in the Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income.
Margin lending	The Company engages in securities financing transactions with and for clients through margin lending. In margin lending, the Company's customers borrow funds from the Company against the value of their qualifying securities, primarily for the purpose of purchasing additional securities.
Brokerage and other receivables	Margin lending, brokerage and other receivables comprise margin lending receivables, brokerage commissions and other receivables related to the securities brokerage and banking activity of the Company. At initial recognition, margin lending, brokerage and other receivables are recognized at fair value. Subsequently, margin lending, brokerage and other receivables are carried at cost net of any allowance for impairment losses.
Derecognition of financial assets	A financial asset (or, where applicable a part of a financial asset or a part of a group of similar financial assets) is derecognized where all of the following conditions are met: • The transferred financial assets have been isolated from the Company - put presumptively beyond the reach of the Company and its creditors, even in bankruptcy or other receivership. • The transferee has rights to pledge or exchange financial assets. • The Company or its agents do not maintain effective control over the transferred financial assets or third-party beneficial interests related to those transferred assets. Where the Company has not met the asset derecognition conditions above, it continues to recognize the asset to the extent of its continuing involvement.
Impairment of long-lived assets	In accordance with the accounting guidance for the impairment or disposal of long-lived assets, the Company periodically evaluates the carrying value of long-lived assets to be held and used when events and circumstances warrant such a review. The carrying value of a long-lived asset is considered impaired when the fair value from such asset is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Losses on long-lived assets to be disposed of are determined in a similar manner, except that fair values are reduced for the cost of disposal. During the fiscal year ended March 31, 2022, the Company write-off the client base that was recognized with the Company's acquisition of Zerich in the amount of $3,125 due to economic uncertainty during the Company's fourth fiscal quarter stemming from the Russia/Ukraine Conflict. During the nine months ended December 31, 2022, there were no write-offs.
Impairment of goodwill	The Company performs an impairment review at least annually unless indicators of impairment exist in interim periods. The entity compares the fair value of a reporting unit with its carrying amount. The goodwill impairment charge recognized for the amount by which the reporting unit’s carrying amount exceeds its fair value. If fair value exceeds the carrying amount, no impairment is recorded.
Assets and liabilities held for sale	The Company classifies assets and liabilities (the "disposal group") as held for sale in the period when all of the relevant criteria to be classified as held for sale are met. Criteria include management commitment to sell the disposal group in its present condition and the sale being deemed probable of being completed within one year. Assets held for sale are reported at the lower of their carrying value or fair value less cost to sell. Any loss resulting from the measurement is recognized in the period the held for sale criteria are met. The Company assesses the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and reports any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the initial carrying value of the disposal group. Assets held for sale are not amortized or depreciated. During the three months ended December 31, 2022, the Company accrued provision for impairment of discontinued operations by an amount of $2,509. As a result, the provision for impairment of discontinued operations, within the line item Net income from discontinued operation on the Condensed Consolidated Statements of Operations, amounted to $43,973 as of December 31, 2022. A disposal group that represents a strategic shift to the Company or is acquired with the intention to sell is reflected as a discontinued operation on the Condensed Consolidated Statements of Operation and Statement of Other Comprehensive Income and prior periods are recast to reflect the earnings or losses as income from discontinued operations. The Condensed Consolidated Financial Statements and related Notes reflect the securities brokerage and complementary banking operations in Russia as discontinued operations as the Company has entered into an agreement to divest these operations. The sale of these operations was approved by the Central Bank of the Russian Federation on February 10, 2023, and the sale is expected to be completed before the end of February 2023. See Note 25 Assets and Liabilities held for sale , for more information on assets held for sale and discontinued operations.
Income taxes	The Company recognizes deferred tax liabilities and assets based on the difference between the financial statements and tax basis of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to reverse. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. Current income tax expenses are provided for in accordance with the laws of the relevant taxing authorities. As part of the process of preparing financial statements, the Company is required to estimate its income taxes in each of the jurisdictions in which it operates. The Company accounts for income taxes using the asset and liability approach. Under this method, deferred income taxes are recognized for tax consequences in future years based on differences between the tax bases of assets and liabilities and their reported amounts in the financial statements at each year-end and tax loss carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates applicable for the differences that are expected to affect taxable income. The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority. The Company will include interest and penalties arising from the underpayment of income taxes in the provision for income taxes (if anticipated). As of December 31, 2022, and March 31, 2022, the Company had no accrued interest or penalties related to uncertain tax positions. The Global Intangible Low-Taxed Income (“GILTI”) provisions of the Tax Cuts and Jobs Act require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. The Company has presented the deferred tax impacts of GILTI tax in its Condensed Consolidated Balance Sheets as of December 31, 2022, and March 31, 2022, and in its Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2022, and 2021.
Financial instruments	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most advantageous market for the asset or liability. Fair value is the current bid price for financial assets, current ask price for financial liabilities and the average of current bid and ask prices when the Company is both in short and long positions for the financial instrument. A financial instrument is regarded as quoted in an active market if quoted prices are readily and regularly available from an exchange or other institution and those prices represent actual and regularly occurring market transactions on an arm’s length basis.
Leases	The Company follows ASU No. 2016-02, “Leases (Topic 842)”, which requires leases with durations greater than twelve months to be recognized on the balance sheet. Operating lease assets and corresponding lease liabilities were recognized on the Company's Condensed Consolidated Balance Sheets. Refer to Note 23 Leases , to the condensed consolidated financial statements for additional disclosure and significant accounting policies affecting leases.
Fixed assets	Fixed assets are carried at cost, net of accumulated depreciation. Maintenance, repairs, and minor renewals are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range between three
Insurance and reinsurance receivable	Insurance and reinsurance receivable is recognized when related income is earned and measured on initial recognition at the fair value of the consideration receivable. Subsequent to initial recognition, any insurance and reinsurance receivable is measured at cost net of any allowance for impairment losses.
Insurance and reinsurance payable	Payables on insurance business comprise advances received, amounts payable to insured (claims and premium refund payable) and amounts payable to agents and brokers, and advances received from insurers and reinsurers. Payables on reinsurance business comprise net amounts payable to reinsurers. Amounts payable to reinsurers include ceded reinsurance premiums, assumed premium refunds and claims on assumed reinsurance. Insurance and reinsurance payable are accounted for at amortized cost.
Unearned premium reserve and claims	Unearned premium is determined by the method of proportion for each contract, as the product of the insurance premium under the contract for the ratio of the expiration of the insurance cover (in days) to the balance sheet date (in days) from the date of recognition of the insurance premium in accounting as income until the end of the insurance coverage. The reinsurer's share in the unearned premium reserve is calculated separately for each insurance (reinsurance) contract and is determined as the ratio of the insurance premium under the reinsurance contract to the insurance premium under the insurance contract multiplied by the unearned premium reserve. Results of insurance activity includes net written insurance premiums reduced by the net change in the unearned premium reserve, commissions recognized from assumed insurance and reinsurance contracts, claims paid net and net change in the loss reserves. Net written insurance premiums represent gross written premiums less premiums ceded to reinsurers. Upon inception of a contract (except for classes of life and annuity insurance), premiums are recorded as written and are earned on a pro rata basis over the term of the related contract coverage. The unearned premium reserve represents the portion of the premiums written relating to the unexpired terms of coverage and is included in the accompanying statement of Condensed Consolidated Balance Sheets. Unearned premium reserve relates to non-life insurance products and non-annuity insurance products. Claims are expensed to th e Condensed Consolidated Statements of Operations and Statements of Other Comprehensive Income as incurred. Loss reserves Non-life and general insurance Loss reserves are a summary of estimates of ultimate losses, and include both claims reported but not settled (RBNS) and claims incurred but not reported (IBNR). RBNS is created for existing reported claims not settled at the reporting date. Estimates are made on the basis of information received by the Company during its investigation of insured events. IBNR is estimated by the Company based on its previous history of reported/settled claims using actuarial methods of calculation, which include claim development triangles. Reinsurance assets in IBNR are estimated applying the same actuarial method used in IBNR estimation. Life insurance Not incurred claims reserves (NIC) on life insurance contracts equal the NIC amount for all life insurance contracts valid as at the reporting date. NIC reserve on a separate contract of life insurance is equal to the maximum value of the net level premium reserve and gross-premium reserve. Net level premium reserve is the present value of future benefits (excluding survival benefits) less present value of future net premiums. Gross-premium reserve is present value of benefits, expenses of the Company that are directly related to consideration, settlement, and determination of the benefit amount, operating expenses of the Company related to conducting of the business, less present value of future gross-premiums. Annuity insurance NIC reserve on annuity contracts is the sum of the present value of future benefits, the claims for annuity insurance and administrative expenses on annuity insurance contracts maintenance, less the present value of insurance contributions (in case of lump sum - insurance premium), which the Company is due to receive after the settlement date. The reserves are either based on current assumptions or calculated using the assumptions established at the time the contract was issued, in which case a margin for risk and adverse deviation is generally included.
Segment information	Historically, the Company's chief operating decision maker ("CODM"), who is its chief executive officer, viewed the Company as a single operating segment offering financial services to its customers in a single geographic region covering Eurasia . During the fourth quarter of the Company's fiscal year ended March 31, 2022, the CODM restructured the Company's operations into five geographical regions ("segments"). These regions include Central Asia, Europe, the U.S., Russia and Middle East/Caucasus. In order to determine appropriate segment disclosure as stated in ASC 280-10-55-26 the Company followed the steps outlined below: • identified operating segments using the management approach; • determined whether two or more operating segments may be aggregated into a single operating segment; • applied the quantitative thresholds and other criteria to determine reportable segments; • considered what information should be disclosed for each reportable segment; and
Recent accounting pronouncements	In June 2016, the FASB issued Accounting Standards Update No. 2016-13, "Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments", which introduced an expected credit loss methodology for the impairment of financial assets measured at amortized cost basis. That methodology replaces the probable, incurred loss model for those assets. In November 2019, the FASB issued ASU 2019-10 "Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842)". The Board developed a philosophy to extend and simplify how effective dates are staggered between larger public companies (bucket one) and all other entities (bucket two). Those other entities include private companies, smaller public companies, not-for-profit organizations, and employee benefit plans. Under this philosophy, a major update would first be effective for bucket-one entities, that is, public business entities that are SEC filers, excluding entities eligible to be smaller reporting companies (SRCs) under the SEC's definition. The Master Glossary of the Codification defines public business entities and SEC filers. All other entities, including SRCs, other public business entities, and nonpublic business entities (private companies, not-for-profit organizations, and employee benefit plans) would compose bucket two. For those entities, it is anticipated that the Board will consider requiring an effective date staggered at least two years after bucket one for major updates. The Company is currently evaluating the impact that ASU 2016-13 and 2017-12 will have on its consolidated financial statements and related disclosures. In August 2021, the FASB issued Accounting Standard Update No 2021-06 "Presentation of Financial Statements (Topic 205), Financial Services — Depository and Lending (Topic 942), and Financial Services — Investment Companies (Topic 946)" which amends various SEC paragraphs pursuant to the issuance of SEC Release No. 33-10786, Amendments to Financial Disclosures about Acquired and Disposed Businesses. SEC issued Final Rulemaking Release No. 33-10786, Amendments to Financial Disclosures about Acquired and Disposed Businesses, which modified the disclosure and presentation requirements concerning acquisitions and disposals of businesses. Primarily, the new rules amended (1) Rule 1-02(w) of Regulation S-X, Definition of Terms Used in Regulation S-X, Significant Subsidiary, (2) Rule 3-05 of Regulation S-X, Financial Statements of Businesses Acquired or to Be Acquired, (3) Rule 8-05 of Regulation S-X, Pro Forma Financial Information (which covers smaller reporting companies), and (4) Article 11 of Regulation S-X, Pro Forma Financial Information. In addition, new Rule 6-11 of Regulation S-X, Financial Statements of Funds Acquired or to Be Acquired, covering acquisitions specific to investment companies, was added. Corresponding changes were made to other Regulation S-X rules, various Securities Act and Securities Exchange Act rules, and Forms 8-K and 10-K. Compliance with the amended rules is required from the beginning of a registrant's fiscal year commencing after December 31, 2020 (i.e., the mandatory compliance date). Acquisitions and dispositions that are probable or consummated after the mandatory compliance date are required to be evaluated for significance pursuant to the amended rules. Early compliance is permitted, provided that all the amended rules are applied in their entirety from the early compliance date. ASU No. 2021-06 amends SEC material in the Codification to give effect to Release No. 33-10786. The new rules apply to fiscal years ending on or after December 15, 2021 (i.e., calendar-year 2021). Early voluntary compliance is allowed. Note that the rescission of Industry Guide 3 is effective on January 1, 2023. ASU No. 2021-06 amends SEC material in the Codification to give effect to Release No. 33-10835. The Company does not expect that the ASU 2021-06 will have a significant impact on its consolidated financial statements and related disclosures. In October 2021, the SEC issued the amendment of Business Combinations (Topic 805), No. 2021-08, which related to Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The main amendments were concentrated in paragraphs 805-20-25-16 through 25-17 and add paragraph 805-20-25-28C and its related heading, with a link to transition paragraph 805-20-65-3, where the topic provides limited exceptions to the recognition and measurement principles applicable to business combinations. Moreover, the topic amends paragraphs 805-20-30-10 through 30-12 and add paragraphs 805-20-30-27 through 30-30 and their related heading, with a link to transition paragraph 805-20-65-3. Paragraph 805-20-25-16 notes that the Business Combinations Topic provides limited exceptions to the recognition and measurement principles applicable to business combinations. In the topic has been added paragraph 805-20-65-3, in which the following represents the transition and effective date information related to Accounting Standards Update No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers: a. For public business entities, this paragraph shall be effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the impact that ASU 2021-06 will have on its consolidated financial statements and related disclosures. In March 2022, the FASB issued Accounting Standards Update No. 2022-01, "Derivatives and Hedging (Topic 815): Fair Value Hedging-Portfolio Layer Method", which introduces the amendments, which targeted on improvements to the optional hedge accounting model with the objective of improving hedge accounting to better portray the economic results of an entity's risk management activities in its financial statements. The amendments in this Update apply to the Company that elect to apply the portfolio layer method of hedge accounting in accordance with Table of Contents Topic 815. For a closed portfolio of prepayable financial assets or one or more beneficial interests secured by a portfolio of prepayable financial instruments, the last-of-layer method allows an entity to hedge a stated amount of the asset or assets in the closed portfolio that is anticipated to be outstanding for the designated hedge period. If the requirements for the last-of-layer method are met, prepayment risk is not incorporated into the measurement of the hedged item. Accordingly, ASU 2022-01 is effective for fiscal years beginning after December 15, 2022. ASU 2022-01 will not have an impact on the Company's consolidated financial statements and related disclosures. In March 2022, the FASB issued Accounting Standards Update No. 2022-02, "Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures", which introduces the amendments on solving two issues of creditors related to troubled debt restructurings and gross write-offs of vintage debt disclosures. The amendments in Update 2016-13 require that an entity measure and record the lifetime expected credit losses on an asset that is within the scope of the Update upon origination or acquisition, and, as a result, credit losses from loans modified as troubled debt restructurings (TDRs) have been incorporated into the allowance for credit losses. Investors and preparers observed that the additional designation of a loan modification as a TDR and the related accounting are unnecessarily complex and no longer provide decision-useful information. Moreover, investors and other financial statement users observed that disclosing gross write-offs by year of origination provides important information that allows them to better understand changes in the credit quality of an entity's loan portfolio and underwriting performance. Accordingly, ASU 2022-02 is effective for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact that ASU 2022-02 will have on its consolidated financial statements and related disclosures. In June 2022, FASB Issued Accounting Standard Updated No. 2022-03 “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The FASB has issued this standard to (1) clarify the guidance in Topic 820 – Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The amendments in this update affects all entities that have investments in equity securities measured at fair value that are subject to a contractual sale restriction. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact that ASU 2022-03 will have on its consolidated financial statements and related disclosures. In September 2022, the FASB issued Accounting Standards Update No. 2022-04 “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations” to enhance the transparency of supplier finance programs. This requires all entities, which apply those programs in connection with the purchase of goods and services (buyer party), to disclose qualitative and quantitative information about the use of the finance programs to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. Accordingly, ASU 2022-04 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company is currently evaluating the impact that ASU 2022-04 will have on its consolidated financial statements and related disclosures. In December 2022, FASB Issued Accounting Standard Updated No. 2022-05 “Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (LDTI)”. The amendments in Update 2018-12 require that an insurance entity apply a retrospective transition method as of the beginning of the earliest period presented or the beginning of the prior fiscal year if early application is elected. It amends in this Update the LDTI transition guidance to allow an insurance entity to make an accounting policy election on a transaction-by-transaction basis. The Board is issuing this Update to reduce implementation costs and complexity associated with the adoption of LDTI for contracts that have been derecognized in accordance with the amendments in this Update before the LDTI effective date. Without the amendments an insurance entity would be required to reclassify a portion of the previously recognized gains or losses to the LDTI transition adjustment because of the adoption of a new accounting standard. This Update affects insurance entities that have derecognized contracts before the LDTI effective date. For public business entities that meet the definition of a U.S. Securities and Exchange Commission (SEC) filer and are not smaller reporting companies, LDTI is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Early application is permitted. The Company is currently evaluating the impact that ASU 2022-05 will have on its consolidated financial statements and related disclosures.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
VIE, consolidated statements	The carrying amounts of the VIE’s consolidated assets and liabilities are as follows: December 31, 2022 March 31, 2022 Cash and cash equivalents 1 134 Restricted cash 1,942 2,843 Trading securities 3,477 2,942 Margin lending, brokerage and other receivables, net 967 435 Fixed assets, net 800 1,043 Intangible assets, net 140 205 Right-of-use asset 424 905 Other assets 84 127 Total assets 7,835 8,634 Customer liabilities 6,441 8,439 Securities repurchase agreement obligations 12 3,267 Trade payables 81 35 Lease liability 454 914 Other liabilities 296 434 Total liabilities 7,284 13,089
Schedule of changes in the carrying amount of goodwill	The changes in the carrying amount of goodwill as of March 31, 2022, and as of December 31, 2022, were as follows: Amount Balance as of March 31, 2022 (Recasted) $ 5,898 Acquisition of London Almaty 485 Acquisition of Ticketon 3,172 Foreign currency translation (95) Balance as of December 31, 2022 $ 9,460

RECAST (Tables)

RECAST (Tables)	9 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
Revision of prior period statements	The previously issued Condensed Consolidated Balance Sheet as of March 31, 2022, and Condensed Consolidated Statement of Operations and Statements of Other Comprehensive Income for the three and nine months ended December 31, 2021, have been revised as follows: As of March 31, 2022 As previously reported FF Life acquisition Elimi-nations FF Insurance acquisition Elimi-nations Recast discontinued operations As recasted ASSETS Cash and cash equivalents $ 625,547 $ 1,427 $ (901) $ 371 $ (82) $ (400,898) $ 225,464 Trading securities 1,203,479 8,875 — 68,520 — (122,497) 1,158,377 Restricted cash 553,680 — — — — (5,730) 547,950 Margin lending, brokerage and other receivables, net 357,567 173 (34) 60 (20) (210,087) 147,659 Loans issued 94,797 44 — — — (2,395) 92,446 Other assets 37,725 7,267 — 427 — (18,375) 27,044 Fixed assets, net 21,365 182 — 254 — (3,978) 17,823 Right-of-use asset 15,669 532 — 152 — (8,922) 7,431 Intangible assets, net 5,791 1,489 — 161 — (2,278) 5,163 Goodwill 5,388 359 — 151 — — 5,898 Available-for-sale securities, at fair value 1 161,363 — — — — 161,364 Insurance contract assets — 3,555 — 2,157 — — 5,712 Assets held for sale — — — — — 825,419 825,419 TOTAL ASSETS $ 2,921,009 $ 185,266 $ (935) $ 72,253 $ (102) $ 50,259 $ 3,227,750 LIABILITIES AND SHAREHOLDERS’ EQUITY Securities repurchase agreement obligations $ 775,178 $ 47,691 $ — $ 49,824 $ — $ (32,469) $ 840,224 Customer liabilities 1,417,937 — (901) — (82) (651,326) 765,628 Margin lending and trade payables 45,229 — — 21 (20) (147) 45,083 Liabilities from insurance activity — 106,329 — 13,161 — — 119,490 Current income tax liability 14,556 — — — — — 14,556 Securities sold, not yet purchased – at fair value 14,103 — — — — (238) 13,865 Debt securities issued 99,027 — — — — (64,637) 34,390 Lease liability 15,315 543 — 176 — (8,530) 7,504 Liability arising from continuing involvement 6,447 — — — — — 6,447 Other liabilities 25,542 550 (35) 292 — (4,872) 21,477 Liabilities held for sale — — — — — 812,478 812,478 TOTAL LIABILITIES $ 2,413,334 $ 155,113 $ (936) $ 63,474 $ (102) $ 50,259 $ 2,681,142 Commitments and Contingent Liabilities (Note 26) — — — — — — — SHAREHOLDERS’ EQUITY Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding — — — — — — — Common stock - $0.001 par value; 500,000,000 shares authorized; 59 9,465 (9,465) 15,577 (15,577) — 59 Additional paid in capital 141,340 — 16,499 — 16,906 — 174,745 Retained earnings 426,563 28,131 (6,666) (4,811) (1,293) — 441,924 Accumulated other comprehensive loss (53,291) (7,443) (368) (1,987) (36) — (63,125) TOTAL FRHC SHAREHOLDERS’ EQUITY $ 514,671 $ 30,153 $ — $ 8,779 $ — $ — $ 553,603 Non-controlling interest (6,996) 1 — — — — (6,995) TOTAL SHAREHOLDERS’ EQUITY $ 507,675 $ 30,154 $ — $ 8,779 $ — $ — $ 546,608 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 2,921,009 $ 185,267 $ (936) $ 72,253 $ (102) $ 50,259 $ 3,227,750 Three months ended December 31, 2021 As previously reported * FF Life acquisition Elimi-nations FF Insurance acquisition Elimi-nations Recast discontinued operations As restated Revenue: Fee and commission income $ 117,316 $ — $ — $ (3) $ — $ (25,905) $ 91,408 Net gain on trading securities 403 490 — 159 — 6,611 7,663 Interest income 27,828 6,534 — 2,324 — (3,029) 33,657 Insurance underwriting income — 18,030 — 3,364 — — 21,394 Net gain on foreign exchange operations 451 239 — 16 — 655 1,361 Net loss on derivative (314) — — — — — (314) TOTAL REVENUE, NET 145,684 25,293 — 5,860 — (21,668) 155,169 Expense: Fee and commission expense 22,716 3,946 — 196 — (2,076) 24,782 Interest expense 20,799 1,606 — 1,850 — (2,365) 21,890 Insurance claims incurred, net of reinsurance — 13,246 — 3,040 — — 16,286 Operating expense 50,496 1,681 — 1,657 — (22,253) 31,581 Provision for impairment losses 45 — — (365) — (13) (333) Other expense, net (64) 1,073 — — — (30) 979 TOTAL EXPENSE 93,992 21,552 — 6,378 — (26,737) 95,185 INCOME/(LOSS) BEFORE INCOME TAX 51,692 3,741 — (518) — 5,069 59,984 Income tax (expense)/benefit (806) 12 (50) (962) (1,806) INCOME/(LOSS) FROM CONTINUING OPERATIONS 50,886 3,753 — (568) — 4,107 58,178 Loss before income tax (expense)/benefit of discontinued operation — — — — — (5,067) (5,067) Income tax benefit of discontinued operations — — — — — 962 962 Loss from discontinued operation — — — — (4,105) (4,105) NET INCOME/LOSS $ 50,886 $ 3,753 $ — $ (568) $ — $ 2 $ 54,073 Less: Net loss attributable to non-controlling interest in subsidiary (343) — — — — — (343) NET INCOME/(LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 51,229 $ 3,753 $ — $ (568) $ — $ 2 $ 54,416 OTHER COMPREHENSIVE INCOME Change in unrealized gain on investments available-for-sale, net of tax effect — (1,063) — — — — (1,063) Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect — 953 — — — — 953 Foreign currency translation adjustments (7,336) (1,284) — (2,702) — 2,672 (8,650) OTHER COMPREHENSIVE LOSS (7,336) (1,394) — (2,702) — 2,672 (8,760) COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS $ 43,550 $ 2,359 $ — $ (3,270) $ — $ 2,674 $ 45,313 Less: Comprehensive loss attributable to non-controlling interest in subsidiary (343) — — — — — (343) COMPREHENSIVE INCOME/(LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 43,893 $ 2,359 $ — $ (3,270) $ — $ 2,674 $ 45,656 For the three months ended December 31, 2021, the Company’s EPS as reported was 0.86 for basic and diluted EPS. Due to the items noted above, the Company’s EPS has been recast to 0.98, (0.09), and 0.91 for basic and diluted EPS for continuing operations, discontinued operations, and total EPS, respectively. Nine months ended December 31, 2021 As previously reported * FF Life acquisition Elimi-nations FF Insurance acquisition Elimi-nations Recast discontinued operations As restated Revenue: Fee and commission income $ 327,966 $ — $ (91) $ 86 $ (161) $ (65,251) 262,549 Net gain on trading securities 185,554 1,090 — 1,587 — 9,716 197,947 Net realized loss on investments available for sale — — — — — — Interest income 69,259 16,634 — 6,541 — (9,920) 82,514 Insurance underwriting income — 42,091 — 9,400 — — 51,491 Net gain on foreign exchange operations 885 277 — 26 — 2,888 4,076 Net loss on derivative (1,028) — — — — — (1,028) TOTAL REVENUE, NET 582,636 60,092 (91) 17,640 (161) (62,567) 597,549 Expense: Fee and commission expense 67,547 7,074 (91) 558 (161) (6,301) 68,626 Interest expense 51,256 3,604 — 4,816 — (6,824) 52,852 Insurance claims incurred, net of reinsurance — 31,862 — 9,234 — — 41,096 Operating expense 117,384 4,293 — 4,935 — (53,840) 72,772 Provision for impairment losses 704 — — 297 — (90) 911 Other expense/(income), net 600 1,949 — (3) — (120) 2,426 TOTAL EXPENSE 237,491 48,782 (91) 19,837 (161) (67,175) 238,683 INCOME BEFORE INCOME TAX 345,145 11,310 — (2,197) — 4,608 358,866 Income tax expense (38,037) 11 — (57) — (943) (39,026) INCOME FROM CONTINUING OPERATIONS 307,108 11,321 — (2,254) — 3,665 319,840 Income/(loss) before income tax(expense)/benefit of discontinued operation — — — — — (4,609) (4,609) Income tax (expense)/benefit of discontinued operations — — — — — 953 953 Income from discontinued operation — — — — — (3,656) (3,656) NET INCOME $ 307,108 $ 11,321 $ — $ (2,254) $ — $ 9 $ 316,184 Less: Net loss attributable to non-controlling interest in subsidiary (415) — — — — — (415) NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 307,523 11,321 — (2,254) — $ 9 $ 316,599 OTHER COMPREHENSIVE INCOME Change in unrealized gain on investments available-for-sale, net of tax effect — (1,789) — — — — (1,789) Reclassification adjustment relating to available-for-sale investments disposed of in the period, net of tax effect — 1,606 — — — — 1,606 Foreign currency translation adjustments (3,106) (1,213) — (2,702) 2,574 (4,447) OTHER COMPREHENSIVE INCOME (3,106) (1,396) — (2,702) — 2,574 (4,630) COMPREHENSIVE INCOME BEFORE NON-CONTROLLING INTERESTS $ 304,002 $ 9,925 $ — $ (4,956) $ — $ 2,583 $ 311,554 Less: Comprehensive loss attributable to non-controlling interest in subsidiary (415) — — — — — (415) COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS 304,417 9,925 — (4,956) — 2,583 311,969 For the nine months ended December 31, 2021, the Company’s EPS as reported was 5.18 for basic and diluted EPS. Due to the items noted above, the Company’s EPS has been recast to 5.40, (0.08), and 5.34 for basic and diluted EPS for continuing operations, discontinued operations, and total EPS, respectively. *amounts with restatement in fee and commission income and interest income, for more information please see Note 4 Restatement.

RESTATEMENT (Tables)

RESTATEMENT (Tables)	9 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
Revision of prior period statements	The following table summarizes the impact of the correction of the errors on the Condensed Consolidated Statement of Cash Flows for the period presented: Nine months ended December 31, 2021 As previously reported FF Life and FF Insurance acquisitions Adjustments for discontinued operations As recasted Correction of errors As restated Net cash flows (used in)/from operating activities $ (582,080) $ 25,782 (34,465) $ (590,763) $ (21,090) $ (611,853) Net cash flows used in investing activities (6,110) (52,276) — (58,386) (34,709) (93,095) Net cash flows (used in)/from financing activities 338,792 47,203 — 385,995 55,799 441,794 Effect of changes in foreign exchange rates on cash and cash equivalents 10,593 (2,221) (1,998) 6,374 — 6,374 NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH $ (238,805) $ 18,488 $ (36,463) $ (256,780) $ — $ (256,780) The following table summarizes the impact of the correction of errors broken down by continuing and discontinued operations: Nine months ended December 31, 2021 As restated Correction of errors As restated Net cash flows used in operating activities from continuing operations $ (256,764) $ (132,188) $ (388,952) Net cash flows (used in)/from operating activities from discontinued operations (333,999) 111,098 (222,901) Net cash flows used in investing activities from continuing operations (56,167) (34,138) (90,305) Net cash flows used in investing activities from discontinued operations (2,219) (571) (2,790) Net cash flows from financing activities from continuing operations 320,364 83,448 403,812 Net cash flows from/used in financing activities from discontinued operations 65,631 (27,649) 37,982 Effect of changes in foreign exchange rates on cash and cash equivalents from continuing operations (7,321) — (7,321) Effect of changes in foreign exchange rates on cash and cash equivalents from discontinued operations 13,695 — 13,695 NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH $ (256,780) $ — $ (256,780) In the Company's previously issued condensed consolidated financial statements, interest income from margin lending to clients had been erroneously classified within fee and commission income from brokerage services. Such income has been reclassified to interest income as a separate sub-line item within interest income entitled interest income from margin lending to clients. For additional information see Note 19 Net interest income/(expense) to the condensed consolidated financial statements. The following tables summarize the impact of corrections of the errors on the Condensed Consolidated Statement of Operations for the periods presented: For the three months ended December 31, 2021 Issued FF Life and FF Insurance acquisition Adjustments for discontinued operations As restated Correction of errors As restated Fee and commission income $ 122,237 $ (3) $ (25,905) $ 96,329 $ (4,921) $ 91,408 Net gain on trading securities 403 649 6,611 7,663 — 7,663 Interest income 22,907 8,858 (3,029) 28,736 4,921 33,657 Insurance underwriting income — 21,394 — 21,394 — 21,394 Net gain on foreign exchange operations 451 255 655 1,361 — 1,361 Net loss on derivative (314) — — (314) — (314) TOTAL REVENUE, NET 145,684 31,153 (21,668) 155,169 — 155,169 For the nine months ended December 31, 2021 Issued FF Life and FF Insurance acquisition Adjustments for discontinued operations As restated Correction of errors As restated Fee and commission income $ 336,178 $ (166) $ (65,251) $ 270,761 $ (8,212) $ 262,549 Net gain on trading securities $ 185,554 2,677 9,716 197,947 — 197,947 Interest income 61,047 23,175 (9,920) 74,302 8,212 82,514 Insurance underwriting income — 51,491 — 51,491 — 51,491 Net gain on foreign exchange operations 885 303 2,888 4,076 — 4,076 Net loss on derivative (1,028) — — (1,028) — (1,028) TOTAL REVENUE, NET 582,636 77,480 (62,567) 597,549 — 597,549

CASH AND CASH EQUIVALENTS (Tabl

CASH AND CASH EQUIVALENTS (Tables)	9 Months Ended
	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Schedule of cash and cash equivalents	As of December 31, 2022, and March 31, 2022, cash and cash equivalents consisted of the following: December 31, 2022 March 31, 2022 (Recasted) Short term deposits in National Bank (Kazakhstan) $ 350,203 $ 42,517 Securities purchased under reverse repurchase agreements 129,955 19,947 Short term deposits in commercial banks 98,846 70,155 Short term deposits on brokerage accounts 43,507 71,061 Petty cash in bank vault and on hand 20,552 18,607 Short term deposits in stock exchanges 19,293 2,828 Overnight deposits 1,667 — Cash in transit 63 35 Short term deposits in the Central Depository (Kazakhstan) 9 314 Total cash and cash equivalents $ 664,095 $ 225,464
Schedule of repurchase agreements	As of December 31, 2022, and March 31, 2022, the cash and cash equivalents balance included short-term collateralized securities received under reverse repurchase agreements on the terms presented below: December 31, 2022 Interest rates and remaining contractual maturity of the agreements Average interest rate Up to 30 days 30-90 days Total Securities purchased under reverse repurchase agreements Corporate debt 16.09 % $ 70,363 $ — $ 70,363 Non-US sovereign debt 13.15 % 40,678 — 40,678 US sovereign debt 2.74 % 18,596 — 18,596 Corporate equity 18.57 % 318 — 318 Total securities sold under repurchase agreements $ 129,955 $ — $ 129,955 March 31, 2022 (Recasted) Interest rates and remaining contractual maturity of the agreements Average interest rate Up to 30 days 30-90 days Total Securities purchased under reverse repurchase agreements US sovereign debt 16.38 % $ 9,952 $ — $ 9,952 Non-US sovereign debt 12.51 % 9,786 — 9,786 Corporate equity 16.90 % 152 — 152 Corporate debt 11.88 % 57 — 57 Total securities sold under repurchase agreements $ 19,947 $ — $ 19,947

RESTRICTED CASH (Tables)

RESTRICTED CASH (Tables)	9 Months Ended
	Dec. 31, 2022
Restricted Cash [Abstract]
Schedule of restrictions on cash	Restricted cash for the periods ended December 31, 2022, and March 31, 2022, consisted of: December 31, 2022 March 31, 2022 (Recasted) Brokerage customers’ cash $ 355,294 $ 531,032 Guaranty deposits 100,463 5,540 Deferred distribution payments 156 8,534 Restricted bank accounts — 2,844 Allowance for restricted cash (5,934) — Total restricted cash $ 449,979 $ 547,950

TRADING AND AVAILABLE-FOR-SAL_2

TRADING AND AVAILABLE-FOR-SALE SECURITIES AT FAIR VALUE (Tables)	9 Months Ended
	Dec. 31, 2022
Debt Securities, Trading, and Equity Securities, FV-NI [Abstract]
Schedule of trading and available-for-sale securities	As of December 31, 2022, and March 31, 2022, trading and available-for-sale securities consisted of: December 31, 2022 March 31, 2022 (Recasted) Corporate debt $ 1,097,488 $ 712,134 Non-U.S. sovereign debt 734,068 360,570 Corporate equity 62,351 72,354 U.S. sovereign debt 34,012 10,435 Exchange traded notes 1,921 2,884 Total trading securities $ 1,929,840 $ 1,158,377 December 31, 2022 March 31, 2022 (Recasted) Corporate debt $ 157,548 $ 145,837 Non-U.S. sovereign debt 12,905 12,997 U.S. sovereign debt 3,873 2,530 Total available-for-sale securities, at fair value $ 174,326 $ 161,364
Schedule of maturity of available for sale securities	The following tables present maturity analysis for available-for-sale securities as of December 31, 2022, and March 31, 2022: December 31, 2022 Remaining contractual maturity of the agreements Up to 1 year 1-5 years 5-10 years More than 10 years Total Corporate debt 46,229 64,260 47,047 12 157,548 Non-US sovereign debt — 5,280 861 6,764 12,905 US sovereign debt — 898 1,712 1,263 3,873 Total available-for-sale securities, at fair value $ 46,229 $ 70,438 $ 49,620 $ 8,039 $ 174,326 March 31, 2022 Remaining contractual maturity of the agreements Up to 1 year 1-5 years 5-10 years More than 10 years Total Corporate debt 69,364 50,155 26,284 34 145,837 Non-US sovereign debt 1,692 864 1,086 9,355 12,997 US sovereign debt — — — 2,530 2,530 Total available-for-sale securities, at fair value $ 71,056 $ 51,019 $ 27,370 $ 11,919 $ 161,364
Schedule of present securities assets at fair value	The following tables present securities assets in the Сondensed Сonsolidated Balance Sheets or disclosed in the Notes to the condensed consolidated financial statements at fair value on a recurring basis as of December 31, 2022, and March 31, 2022: Weighted Average Total Fair Value Measurements as of December 31, 2022 using Quoted Prices in Significant Significant Unobservable (Level 1) (Level 2) (Level 3) Corporate debt 13.99 % $ 1,097,488 $ 1,001,417 $ 95,800 $ 271 Non-U.S. sovereign debt 12.26 % 734,068 577,828 156,213 27 Corporate equity — % 62,351 60,127 1,895 329 U.S. sovereign debt 4.30 % 34,012 34,012 — — Exchange traded notes — % 1,921 1,223 698 — Total trading securities $ 1,929,840 $ 1,674,607 $ 254,606 $ 627 Corporate debt 14.88 % $ 157,548 $ 134,427 $ 23,121 $ — Non-US sovereign debt 8.99 % 12,905 5,894 7,011 — US sovereign debt 4.20 % 3,873 3,873 — — Total available-for-sale securities, at fair value $ 174,326 $ 144,194 $ 30,132 $ — Weighted Average Interest Rate Total Fair Value Measurements as of March 31, 2022 (Recasted) using Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Corporate debt 9.09 % $ 712,134 $ 711,539 $ — $ 595 Non-U.S. sovereign debt 13.15 % 360,570 352,274 — 8,296 Corporate equity — 72,354 71,827 276 251 U.S. sovereign debt 2.35 % 10,435 10,435 — — Exchange traded notes — 2,884 2,884 — — Total trading securities $ 1,158,377 $ 1,148,959 $ 276 $ 9,142 Corporate debt 11.09 % $ 145,837 $ 145,837 $ — $ — Non-U.S. sovereign debt 5.51 % 12,997 12,997 — — U.S. sovereign debt 2.17 % 2,530 2,530 — — Total available-for-sale securities, at fair value $ 161,364 $ 161,364 $ — $ —
Schedule of valuation techniques and significant level 3 inputs	The tables below present the valuation techniques and significant level 3 inputs used in the valuation as of December 31, 2022, and March 31, 2022. The tables are not intended to be all inclusive, but instead capture the significant unobservable inputs relevant to determination of fair value. Type Valuation Technique FV as of December 31, 2022 Significant Unobservable Inputs % Non-US sovereign debt DCF $ 27 Discount rate 48.8% Estimated number of years 11 years Corporate debt DCF 271 Discount rate 74.0% Estimated number of years 3 months Corporate equity DCF 329 Discount rate 58.8% Estimated number of years 9 years Total $ 627 Type Valuation Technique FV as of March 31, 2022 Significant Unobservable Inputs % Non-US sovereign debt DCF $ 7,524 Discount rate 69.0% Estimated number of years 11 years Non-US sovereign debt DCF 772 Discount rate 13.9% Estimated number of years 1 year Corporate debt DCF 595 Discount rate 45.0% Estimated number of years 3 months Corporate equity DCF 251 Discount rate 20.0% Estimated number of years 9 years Total $ 9,142 The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended December 31, 2022, and the year ended March 31, 2022: Trading securities Balance as of March 31, 2022 (Recasted) $ 9,142 Purchase of investments that use Level 3 inputs 1,980 Reclassification to level 2 (1,842) Reclassification of securities from Freedom UA to restricted accounts (2,384) Sale (5,089) Revaluation of investments that use Level 3 inputs (622) Translation difference (558) Balance as of December 31, 2022 $ 627 Balance as of March 31, 2021 (Recasted) $ 19,032 Reclassification to level 3 682 Reclassification to level 1 (18,370) Purchase of investments that use Level 3 inputs 10,812 Revaluation of investments that use Level 3 inputs (3,014) Balance as of March 31, 2022 (Recasted) $ 9,142
Schedule of amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities	The table below presents the amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities as of December 31, 2022, and March 31, 2022: December 31, 2022 Assets measured at amortized cost Recognized impairment loss in Income Statement Unrealized gain/(loss) accumulated in other comprehensive Assets Maturity Date Corporate debt $ 154,689 $ (402) $ 2,883 $ 157,548 2023 - 2042 Non-US sovereign debt 14,482 — (1,577) 12,905 2024 - indefinite U.S. sovereign debt 4,574 — (701) 3,873 2024 - 2044 Total available-for-sale securities, at fair value $ 173,745 $ (402) $ 605 $ 174,326 March 31, 2022 (Recasted) Assets measured at amortized cost Unrealized loss accumulated in other comprehensive Assets Maturity Date Corporate debt $ 146,112 $ (275) $ 145,837 2022 - 2035 Non-U.S. sovereign debt 13,784 (787) 12,997 2022 - indefinite U.S. sovereign debt 2,912 (382) 2,530 2044 Total available-for-sale securities, at fair value $ 162,808 $ (1,444) $ 161,364

BROKERAGE AND OTHER RECEIVABL_2

BROKERAGE AND OTHER RECEIVABLES, NET (Tables)	9 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of brokerage and other receivables	Margin lending, brokerage and other receivables as of December 31, 2022, and March 31, 2022, consisted of: December 31, 2022 March 31, 2022 (Recasted) Margin lending receivables $ 393,659 $ 138,983 Receivables from brokerage clients 6,624 4,386 Bonds coupon receivable 1,977 — Bank commissions receivable 1,852 598 Long-term installments receivables 1,184 1,367 Receivable from sale of securities 858 884 Receivable for underwriting and market-making services 526 296 Dividends accrued — 45 Other receivables 4,734 3,207 Allowance for receivables (7,846) (2,107) Total margin lending, brokerage and other receivables, net $ 403,568 $ 147,659

LOAN ISSUED (Tables)

LOAN ISSUED (Tables)	9 Months Ended
	Dec. 31, 2022
Loans and Leases Receivable Disclosure [Abstract]
Schedule of loans issued	Loans issued as of December 31, 2022, consisted of the following: Amount Outstanding Due Dates Average Interest Rate Fair Value of Collateral Loan Currency Mortgage loans $ 493,993 January, 2023 - December, 2047 8.70% $496,452 KZT Uncollateralized Bank customer loans 91,149 January, 2023 - December, 2042 16.53% — KZT Collateralized Bank customer loans 12,852 January, 2023 - December, 2025 1.91% 12,796 KZT/RUB Car loans 34,660 January, 2023 - December, 2029 27.25% 37,211 KZT Subordinated loans 5,000 December, 2025 3.00% — USD Loans issued to policyholders 1,426 March, 2023 - December, 2023 14.97% 1,697 KZT Other 297 March, 2023 - August, 2027 2.71% — EUR/KZT Total loans issued $ 639,377 Loans issued as of March 31, 2022, consisted of the following: Amount Outstanding Due Dates Average Interest Rate Fair Value of Collateral Loan Currency Mortgage loans $ 51,924 April 2022 - March 2047 11.86 % 52,134 KZT Uncollateralized bank customer loans 34,067 April 2022 - March 2047 17.56 % — KZT Subordinated loan 5,033 December 2022-April 2024 4.89 % — USD Subordinated loan 1,256 December 2022-April 2024 7.00 % — UAH Other 123 February 2022-Febraury 2027 2.50 % — USD Loans to policyholders 43 July 2022 - March 2023 12.02 % 284 KZT Total loans issued (recasted) $ 92,446

SECURITIES REPURCHASE AGREEME_2

SECURITIES REPURCHASE AGREEMENT OBLIGATIONS (Tables)	9 Months Ended
	Dec. 31, 2022
Securities Sold under Agreements to Repurchase [Abstract]
Schedule of securities under repurchase agreement obligations	As of December 31, 2022, and March 31, 2022, trading securities included collateralized securities subject to repurchase agreements as described in the following table: December 31, 2022 Interest rates and remaining contractual maturity of the agreements Average interest rate Up to 30 days 30-90 days Total Securities sold under repurchase agreements Non-US sovereign debt 16.26 % $ 572,731 $ 51,898 $ 624,629 Corporate debt 16.44 % 586,939 4,774 591,713 US sovereign debt 1.91 % 17,586 — 17,586 Total securities sold under repurchase agreements $ 1,177,256 $ 56,672 $ 1,233,928 March 31, 2022 (Recasted) Interest rate and remaining contractual maturity of the agreements Average interest rate Up to 30 days 30-90 days Total Securities sold under repurchase agreements Corporate debt 11.96 % $ 609,405 $ 142 $ 609,547 Non-US sovereign debt 10.85 % 222,893 — 222,893 US sovereign debt 0.77 % 7,396 — 7,396 Corporate equity 14.00 % 388 — 388 Total securities sold under repurchase agreements $ 840,082 $ 142 $ 840,224

CUSTOMER LIABILITIES (Tables)

CUSTOMER LIABILITIES (Tables)	9 Months Ended
	Dec. 31, 2022
Contract with Customer, Liability [Abstract]
Schedule of customer liabilities	The Company recognizes customer liabilities associated with deposit funds of its brokerage and bank customers. As of December 31, 2022, and March 31, 2022 , customer liabilities consisted of: December 31, 2022 March 31, 2022 (Recasted) Banking customers 1,026,605 246,284 Brokerage customers $ 759,847 $ 519,344 Total customer liabilities $ 1,786,452 $ 765,628

MARGIN LENDING AND TRADE PAYA_2

MARGIN LENDING AND TRADE PAYABLES (Tables)	9 Months Ended
	Dec. 31, 2022
Accounts Payable [Abstract]
Schedule of trade payables	As of December 31, 2022, and March 31, 2022 , margin lending and trade payables of the Company was comprised of the following: December 31, 2022 March 31, 2022 (Recasted) Margin lending payables $ 139,214 $ 39,250 Payables to suppliers of goods and services 1,375 4,462 Trade payable for securities purchased 476 462 Other 1,276 909 Total margin lending and trade payables $ 142,341 $ 45,083

SECURITIES SOLD, NOT YET PURC_2

SECURITIES SOLD, NOT YET PURCHASED - AT FAIR VALUE (Tables)	9 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Securities sold, not yet purchased	The following table provides a reconciliation of the beginning and ending balances for securities sold, not yet purchased - at fair value by the Company, as of December 31, 2022, and March 31, 2022: Total Balance as of March 31, 2021 (Recasted) $ 8,569 Short sales 7,055 Repurchase (346) Net gain on trading securities (1,413) Balance as of March 31, 2022 (Recasted) $ 13,865 Balance as of March 31, 2022 (Recasted) $ 13,865 Short sales 410 Repurchase (15,627) Net loss on trading securities 1,352 Balance as of December 31, 2022 $ —

DEBT SECURITIES ISSUED (Tables)

DEBT SECURITIES ISSUED (Tables)	9 Months Ended
	Dec. 31, 2022
Debt Securities [Abstract]
Schedule of outstanding debt securities of the company	As of December 31, 2022, and March 31, 2022, outstanding debt securities issued by the Company included the following: Debt securities issued by: December 31, 2022 March 31, 2022 (Recasted) Freedom SPC $ 36,799 $ 13,203 Freedom Holding Corp. — 20,499 Accrued interest 393 688 Total debt securities issued $ 37,192 $ 34,390

INSURANCE CONTRACTS ASSETS AN_2

INSURANCE CONTRACTS ASSETS AND LIABILITIES FROM INSURANCE ACTIVITIES (Tables)	9 Months Ended
	Dec. 31, 2022
Insurance [Abstract]
Insurance and reinsurance receivables	As of December 31, 2022, and March 31, 2022, insurance and reinsurance receivables of the Company was comprised of the following: December 31, 2022 March 31, 2022 Assets: (Recasted) Amounts due from policyholders $ 5,615 $ 3,500 Claims receivable from reinsurance 897 769 Amounts due from reinsured 52 23 Less provision for impairment losses (995) (343) Insurance and reinsurance receivables: 5,569 3,949 Unearned premium reserve, reinsurers’ share 3,763 143 Reserves for claims and claims’ adjustment expenses, reinsurers’ share 1,911 1,620 Total $ 11,243 $ 5,712
Insurance and reinsurance payables	As of December 31, 2022, and March 31, 2022, insurance and reinsurance payable of the Company was comprised of the following: December 31, 2022 March 31, 2022 Liabilities: (Recasted) Amounts payable to reinsurers $ 2,405 $ 402 Amounts payable to insured 2,305 685 Amounts payable to agents and brokers 2,081 1,981 Insurance and reinsurance payables: 6,791 3,068 Unearned premium reserve 31,103 17,985 Reserves for claims and claims’ adjustment expenses 118,648 98,437 Total $ 156,542 $ 119,490

NET GAIN ON TRADING SECURITIES

NET GAIN ON TRADING SECURITIES (Tables)	9 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of net gain on trading securities	During the three and nine months ended December 31, 2022, and December 31, 2021, net gain on trading securities was comprised of: Three Months Ended December 31, 2022 Three Months Ended December 31, 2021 (Restated) Net unrealized gain/(loss) recognized during the reporting period on trading securities still held at the reporting date $ 73,257 $ (33,567) Net (loss)/gain recognized during the period on trading securities sold during the period (47,801) 41,230 Net gain recognized during the period on trading securities $ 25,456 $ 7,663 Nine Months Ended December 31, 2022 Nine Months Ended December 31, 2021 (Restated) Net unrealized gain recognized during the reporting period on trading securities still held at the reporting date $ 65,684 $ 7,903 Net (loss)/gain recognized during the period on trading securities sold during the period (26,790) 190,044 Net gain recognized during the period on trading securities $ 38,894 $ 197,947

FEE AND COMMISSION INCOME (Tabl

FEE AND COMMISSION INCOME (Tables)	9 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Disclosure of fee and commission income	During the three and nine months ended December 31, 2022, and December 31, 2021, fee and commission income was comprised of: Three months ended December 31, 2022 Central Asia Europe U.S. Middle East/Caucasus Total Brokerage services $ 19,490 $ 47,893 $ 1,149 $ — $ 68,532 Bank services 5,507 — — — 5,507 Underwriting and market-making services 4,778 — — — 4,778 Other fee and commission income 1,473 593 — — 2,066 Total fee and commission income $ 31,248 $ 48,486 $ 1,149 $ — $ 80,883 Nine months ended December 31, 2022 Central Asia Europe U.S. Middle East/Caucasus Total Brokerage services $ 31,814 $ 192,330 $ 3,332 $ — $ 227,476 Bank services 15,100 — — — 15,100 Underwriting and market-making services 8,008 — — — 8,008 Other fee and commission income 1,793 1,109 — — 2,902 Total fee and commission income $ 56,715 $ 193,439 $ 3,332 $ — $ 253,486 Three months ended December 31, 2021 (Restated) Central Asia Europe U.S. Middle East/Caucasus Total Brokerage service (1) $ 2,474 $ 82,970 $ 1,256 $ — $ 86,700 Bank services 2,295 — — — 2,295 Underwriting and market-making services 1,828 — — — 1,828 Other fee and commission income 393 192 — — 585 Total fee and commission income $ 6,990 $ 83,162 $ 1,256 $ — $ 91,408 ________________ (1) Amounts are shown after reclassification of interest income from margin lending. Please see Note 4. Nine months ended December 31, 2021 (Restated) Central Asia Europe U.S. Middle East/Caucasus Total Brokerage services (1) $ 5,706 $ 240,152 $ 3,391 $ — $ 249,249 Bank services 4,027 — — — 4,027 Underwriting and market-making services 5,832 — — — 5,832 Other fee and commission income 2,527 914 — — 3,441 Total fee and commission income $ 18,092 $ 241,066 $ 3,391 $ — $ 262,549 ____________________ (1) Amounts are shown after reclassification of interest income from margin lending. Please see Note 4.

NET INTEREST INCOME_EXPENSE (Ta

NET INTEREST INCOME/EXPENSE (Tables)	9 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Interest Income and Interest Expense Disclosure	NET INTEREST INCOME/EXPENSE Net interest income/expense for the three and nine months ended December 31, 2022, and December 31, 2021 includes: Three months ended December 31, 2022 Three months ended December 31, 2021 Interest income: (Restated) Interest income on securities repurchased under reverse repurchase agreements and amounts due from banks $ 4,062 $ 280 Interest income on trading securities 44,760 20,745 Interest income on available-for-sale securities 6,727 6,470 Interest income on margin lending (2) 12,379 4,921 Interest income on loans issued 12,327 1,241 Total interest income $ 80,255 $ 33,657 Interest expense: Interest expense on securities repurchase agreement obligations $ 39,958 $ 15,671 Interest expense on customer liabilities 11,149 5,732 Interest expense on debt securities issued 842 394 Other interest expense 88 93 Total interest expense $ 52,037 $ 21,890 Net interest income $ 28,218 $ 11,767 Nine months ended December 31, 2022 Nine months ended December 31, 2021 Interest income: (Restated) Interest income on securities repurchased under reverse repurchase agreements and amounts due from banks $ 6,198 $ 887 Interest income on trading securities 116,922 54,966 Interest income on available-for-sale securities 13,280 16,244 Interest income on margin lending (2) 27,259 8,212 Interest income on loans issued 24,158 2,205 Total interest income $ 187,817 $ 82,514 Interest expense: Interest expense on securities repurchase agreement obligations $ 105,466 $ 38,548 Interest expense on customer accounts and deposits 24,780 12,645 Interest expense on debt securities issued 2,457 1,323 Interest expense on loans received 268 291 Other interest expense — 45 Total interest expense $ 132,971 $ 52,852 Net interest income $ 54,846 $ 29,662 ____________________ (2) Amounts for the three and nine months ended December 31, 2021, are shown after reclassification of interest income from margin lending. Please see Note 4

STOCK BASED COMPENSATION (Table

STOCK BASED COMPENSATION (Tables)	9 Months Ended
	Dec. 31, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract]
Schedule of fair value of restricted shares awarded using the monte carlo valuation model	The Company has determined the fair value of restricted shares awarded as of grant date, using the Monte Carlo valuation model based on the following key assumptions: Term (years) 3.62 Volatility 35.2 % Risk-free rate 4.18 %
Schedule of the activity of the company's restricted stock outstanding	The table below summarizes the activity for the Company’s restricted stock outstanding during the nine months ended December 31, 2022: Shares Weighted Outstanding, at March 31, 2022 1,049,500 $ 40,303 Granted 46,284 2,175 Vested (255,226) (10,153) Forfeited/cancelled/expired (68,000) (2,602) Outstanding, at December 31, 2022 772,558 $ 29,723

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Disclosure of lease maturities	The following table presents as of December 31, 2022, the annual maturities of the lease liabilities: Twelve months ended March 31, 2023 $ 2,248 2024 6,154 2025 5,965 2026 5,705 2027 4,743 Thereafter 6,733 Total payments 31,548 Less: amounts representing interest 7,373 Lease liability, net $ 24,175 Weighted average remaining lease term (in months) 23 Weighted average discount rate 12 %
Supplemental lease information	The following table presents as of December 31, 2022, the annual maturities of the lease liabilities: Twelve months ended March 31, 2023 $ 2,248 2024 6,154 2025 5,965 2026 5,705 2027 4,743 Thereafter 6,733 Total payments 31,548 Less: amounts representing interest 7,373 Lease liability, net $ 24,175 Weighted average remaining lease term (in months) 23 Weighted average discount rate 12 %

ACQUISITIONS AND DISPOSAL OF SU

ACQUISITIONS AND DISPOSAL OF SUBSIDIARIES (Tables)	9 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	As of September 1, 2022, the date of the acquisition of IC "London-Almaty", the fair value of IC "London-Almaty" was $15,858. The total purchase price was allocated as follows: ASSETS Cash and cash equivalents $ 8,077 Due from banks 2,176 Trading securities 6,178 Value of business acquired 1,677 Assets from insurance activities 3,401 Fixed assets 806 Intangible assets 127 Other assets 1,505 TOTAL ASSETS 23,947 Insurance reserves 6,380 Liabilities from insurance activity 1,429 Other liabilities 280 TOTAL LIABILITIES 8,089 Net assets acquired 15,858 Goodwill 485 Total purchase price $ 16,343 ASSETS Cash and cash equivalents $ 3,029 Brokerage and other receivables 169 Fixed assets 20 Intangible assets 33 Right-of-use asset 63 Other assets 606 TOTAL ASSETS 3,920 Deferred income tax liabilities 34 Lease liability 63 Other liabilities 3,995 TOTAL LIABILITIES 4,092 Net assets acquired (172) Goodwill 3,172 Total purchase price $ 3,000

ASSETS AND LIABILITIES HELD F_2

ASSETS AND LIABILITIES HELD FOR SALE (Tables)	9 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Disposal groups, including discontinued operations	As of December 31, 2022 and March 31, 2022, the major classes of assets and liabilities from discontinued operations included the following: December 31, 2022 March 31, 2022 Cash and cash equivalents $ 582,314 $ 428,480 Restricted cash 18,052 28,406 Trading securities 112,801 122,497 Margin lending, brokerage and other receivables, net 240,414 210,087 Loans issued 17,201 2,395 Other assets 34,757 33,554 Less: valuation allowance (43,973) — Total assets held for sale $ 961,566 $ 825,419 Customer liabilities $ 820,394 $ 701,584 Securities repurchase agreement obligations 30,971 32,469 Debt securities issued 63,207 64,637 Other liabilities 16,912 13,788 Total liabilities held for sale 931,484 812,478 The results of operations for discontinued operations for the three and nine months ended December 31, 2022, and 2021, consist of the following: For The Three Months Ended For The Nine Months Ended December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Fee and commission income $ 14,230 $ 23,147 $ 62,290 $ 59,596 Net gain/(loss) on trading securities 799 (6,611) 13,898 (9,716) Net loss on derivative (43) — (43) — Interest income 17,599 5,786 47,460 15,574 Net gain/(loss) on foreign exchange operations 19,965 (655) 40,379 (2,889) TOTAL REVENUE, NET 52,550 21,667 163,984 62,565 Operating expense 29,839 22,253 83,379 53,841 Interest expense 3,124 2,365 13,143 6,824 Fee and commission expense 2,750 2,075 7,000 6,300 Provision for impairment losses 1,594 13 2,176 89 Provision for impairment of discontinued operations 2,509 — 43,973 — Other (income)/expense, net (933) 28 (154) 120 TOTAL EXPENSE 38,883 26,734 149,517 67,174 INCOME/(LOSS) BEFORE INCOME TAX $ 13,667 $ (5,067) $ 14,467 $ (4,609) The net cash flows used in operating and investing activities for discontinued operations for the nine months ended December 31, 2022, and 2021, consist of the following: For the Nine Months Ended December 31, 2022 2021* (Recasted) Cash Flows From Operating Activities Net income/(loss) from discontinued operations $ 9,929 $ (3,656) Adjustments to reconcile net income used in operating activities: Depreciation and amortization 1,794 1,637 Noncash lease expense 4,947 3,785 Change in deferred taxes 4,121 (1,892) Stock compensation expense 4,226 5,647 Unrealized loss/(gain) on trading securities (47,926) 9,082 Net change in accrued interest 810 1,436 Provision for impairment of discontinued operations 43,973 — Allowances for receivables 2,053 89 Changes in operating assets and liabilities: Trading securities 61,479 (262,438) Margin lending, brokerage and other receivables (4,755) (93,717) Other assets 1,557 (1,948) Securities sold, not yet purchased – at fair value 257 (24) Customer liabilities (47,602) 121,173 Current income tax liability 1 (623) Margin lending and trade payables (16) 319 Lease liabilities (5,509) (3,947) Other liabilities 2,826 2,176 Net cash flows from/(used in) operating activities from discontinued operations 32,165 (222,901) Cash Flows Used In Investing Activities Purchase of fixed assets (3,998) (2,918) Proceeds from sale of fixed assets — 699 Net change in loans issued to customers (17,649) (571) Net cash flows used in investing activities from discontinued operations (21,647) (2,790) The following table presents reconciliation of anticipated provision for impairment from sale of net assets held for sale as of disposal date: December 31, 2022 Pre-elimination balance Eliminations Post-elimination balance Cash and cash equivalents 582,314 — 582,314 Restricted cash 18,052 — 18,052 Trading securities 112,801 — 112,801 Margin lending, brokerage and other receivables, net 331,682 (91,269) 240,413 Loans issued 17,201 — 17,201 Other assets 34,758 — 34,758 Total assets held for sale $ 1,096,808 $ (91,269) $ 1,005,539 Customer liabilities 820,394 — 820,394 Securities repurchase agreement obligations 30,971 — 30,971 Debt securities issued 63,207 — 63,207 Other liabilities 16,913 — 16,913 Total liabilities held for sale $ 931,485 $ — $ 931,485 Net assets held for sale $ 165,323 $ 74,054 Unrealized loss from translation adjustment 18,650 Adjusted net assets held for sale $ 183,973 Expected selling price 140,000 Provision for impairment of discontinued operations $ (43,973)

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Other Commitments	Total lending related commitments outstanding as of December 31, 2022, and March 31, 2022, were as follows: As of December 31, 2022 As of March 31, 2022 (Recasted) Unfunded commitments under lines of credits and guarantees $ 18,838 $ 11,292 Bank guarantees 4,874 6,384 Total $ 23,712 $ 17,676

SEGMENT REPORTING (Tables)

SEGMENT REPORTING (Tables)	9 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Schedule of segment reporting information, by segment	The following tables summarize the Company's Statement of Operations and Statements of Other Comprehensive Income by its geographic segments. Intercompany balances were eliminated for separate disclosure: Three months ended December 31, 2022 STATEMENTS OF OPERATIONS Central Asia Europe U.S. Middle East/Caucasus Total Fee and commission income (1) $ 31,248 $ 48,486 $ 1,149 $ — $ 80,883 Net gain/(loss) on trading securities 28,080 819 (3,443) — 25,456 Interest income 66,324 11,417 2,500 14 80,255 Insurance underwriting income 28,557 — — — 28,557 Net gain/(loss) on foreign exchange operations 20,402 313 152 (1) 20,866 Net loss on derivative (21,469) — — — (21,469) TOTAL REVENUE, NET 153,142 61,035 358 13 214,548 Fee and commission expense 10,110 7,933 255 16 18,314 Interest expense 43,880 4,590 3,567 — 52,037 Insurance claims incurred, net of reinsurance 17,418 1 — — 17,419 Operating expense (2) 28,494 12,824 8,655 635 50,608 Provision for impairment losses 12,767 11,363 10 — 24,140 Other expense/(income), net 647 (74) — (3) 570 TOTAL EXPENSE 113,316 36,637 12,487 648 163,088 INCOME/(LOSS) BEFORE INCOME TAX FROM CONTINUING OPERATIONS $ 39,826 $ 24,398 $ (12,129) $ (635) $ 51,460 Income tax expense (95) (4,557) (398) (19) (5,069) INCOME/(LOSS) FROM CONTINUING OPERATIONS $ 39,731 $ 19,841 $ (12,527) $ (654) $ 46,391 Nine months ended December 31, 2022 STATEMENTS OF OPERATIONS Central Asia Europe U.S. Middle East/Caucasus Total Fee and commission income (1) $ 56,715 $ 193,439 $ 3,332 $ — 253,486 Net gain/(loss) on trading securities 65,497 (21,815) (4,788) — 38,894 Interest income 154,300 24,014 9,489 14 187,817 Insurance underwriting income 78,998 — — — 78,998 Net gain/(loss) on foreign exchange operations 32,270 (1,517) (747) 8 30,014 Net loss on derivative (22,523) — — — (22,523) TOTAL REVENUE, NET 365,257 194,121 7,286 22 566,686 Fee and commission expense 32,638 26,834 551 45 60,068 Interest expense 110,410 10,250 12,311 — 132,971 Insurance claims incurred, net of reinsurance 51,585 1 — — 51,586 Operating expense 70,975 34,923 19,015 1,454 126,367 Provision for impairment losses/(recoveries) 18,930 11,362 2 — 30,294 Other expense/(income), net 116 31 (8) (60) 79 TOTAL EXPENSE 284,654 83,401 31,871 1,439 401,365 INCOME/(LOSS) BEFORE INCOME TAX FROM CONTINUING OPERATIONS $ 80,603 $ 110,720 $ (24,585) $ (1,417) 165,321 Income tax expense (691) (18,403) (7,475) 2 (26,567) INCOME/(LOSS) FROM CONTINUING OPERATIONS $ 79,912 $ 92,317 $ (32,060) $ (1,415) 138,754 Three months ended December 31, 2021 (Restated) STATEMENTS OF OPERATIONS Central Asia Europe U.S. Middle East/Caucasus Total Fee and commission income $ 6,990 $ 83,162 $ 1,256 $ — $ 91,408 Net gain on trading securities 7,081 481 101 — 7,663 Interest income 28,703 4,940 14 — 33,657 Insurance underwriting income 21,394 — — — 21,394 Net gain/(loss) on foreign exchange operations 2,002 (437) (209) 5 1,361 Net loss on derivative (314) — — — (314) TOTAL REVENUE, NET 65,856 88,146 1,162 5 155,169 Fee and commission expense 6,523 18,106 153 — 24,782 Interest expense 17,553 3,919 418 — 21,890 Insurance claims incurred, net of reinsurance 16,286 — — — 16,286 Operating expense 15,247 10,517 5,903 (86) 31,581 Provision for impairment (recoveries)/losses (365) — 32 — (333) Other expense/(income), net 990 (13) 2 979 TOTAL EXPENSE 56,234 32,529 6,506 (84) 95,185 INCOME BEFORE INCOME TAX FROM CONTINUING OPERATIONS $ 9,622 $ 55,617 $ (5,344) $ 89 59,984 Income tax benefit/(expense) 1,256 (7,176) 4,114 — (1,806) INCOME FROM CONTINUING OPERATIONS $ 10,878 $ 48,441 $ (1,230) $ 89 $ 58,178 Nine months ended December 31, 2021 (Restated) STATEMENTS OF OPERATIONS Central Asia Europe U.S. Middle East/Caucasus Total Fee and commission income $ 18,092 $ 241,066 $ 3,391 $ — $ 262,549 Net gain/(loss) on trading securities 18,779 179,473 (305) — 197,947 Interest income 74,425 8,015 74 — 82,514 Income from insurance activity 51,491 — — — 51,491 Net gain/(loss) on foreign exchange operations 4,775 (497) (207) 5 4,076 Net loss on derivative (1,028) — — — (1,028) TOTAL REVENUE, NET 166,534 428,057 2,953 5 597,549 Fee and commission expense 11,177 56,946 503 — 68,626 Interest expense 44,311 7,422 1,119 — 52,852 Insurance claims incurred, net of reinsurance 41,096 — — — 41,096 Operating expense 38,327 20,089 14,275 81 72,772 Provision for impairment losses 868 11 32 — 911 Other expense/(income), net 2,449 (21) — (2) 2,426 TOTAL EXPENSE 138,228 84,447 15,929 79 238,683 INCOME/(LOSS) BEFORE INCOME TAX FROM CONTINUING OPERATIONS $ 28,306 $ 343,610 $ (12,976) $ (74) $ 358,866 Income tax benefit/(expense) 1,278 (21,190) (19,114) — (39,026) NET INCOME/(LOSS) FROM CONTINUING OPERATIONS $ 29,584 $ 322,420 $ (32,090) $ (74) $ 319,840 (1) All trading of U.S. and European exchange traded and OTC securities by all of the Company's securities brokerage firms, excluding PrimeEx, are routed to and executed through Freedom EU and all fee and commission income for those transactions is recognized at Freedom EU. (2) Operating expense includes significant noncash items stock based compensation expenses. The following table summarizes the Company's stock based compensation by its geographic segments: Three Months Ended December 31, Nine Months Ended December 31, 2022 2021* 2022 2021* Central Asia $ 2,077 $ 1,384 $ 4,215 $ 3,414 U.S. 717 691 1,869 1,737 Europe 145 196 436 485 Total stock based compensation $ 2,939 $ 2,271 $ 6,520 $ 5,636 The following tables summarize the Company's total asset and total liabilities by its geographic segments. Intercompany balances were eliminated for separate disclosure: December 31, 2022 Central Asia Europe U.S. Russia (Discontinued operations) Middle East/Caucasus Total Total assets $ 3,770,032 $ 519,760 $ 114,609 $ 961,566 $ 2,167 $ 5,368,134 Total liabilities 3,071,804 607,536 74,618 931,484 361 4,685,803 Net assets $ 698,228 $ (87,776) $ 39,991 $ 30,082 $ 1,806 $ 682,331 March 31, 2022 (Recasted) Central Asia Europe U.S. Russia (Discontinued operations) Middle East/Caucasus Total Total assets $ 1,423,529 $ 805,768 $ 172,679 $ 825,419 $ 355 $ 3,227,750 Total liabilities 1,203,473 489,883 175,136 812,478 172 2,681,142 Net assets $ 220,056 $ 315,885 $ (2,457) $ 12,941 $ 183 $ 546,608

DESCRIPTION OF BUSINESS (Detail

DESCRIPTION OF BUSINESS (Details) $ in Thousands, ₽ in Millions	1 Months Ended
	Jul. 31, 2021	Jan. 31, 2023 USD ($)	Jan. 31, 2023 RUB (₽)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)		Jun. 30, 2021
Related Party Transaction [Line Items]
Percent of net profits of Freedom UA after tax company is entitled to receive (in percent)				90%
Ownership interest sold during the period	23.88%
Total assets				$ 5,368,134	$ 3,227,750	[1]
Total liabilities				4,685,803	2,681,142	[1]
Subsequent event | Freedom Finance Auto LLC
Related Party Transaction [Line Items]
Expected consideration		$ 695	₽ 50
Variable interest entity, primary beneficiary
Related Party Transaction [Line Items]
Total assets				7,835	8,634
Total liabilities				$ 7,284	$ 13,089
LLC Freedom Finance Ukraine
Related Party Transaction [Line Items]
Ownership percentage, non-controlling interest	9%			9%			32.90%
Ownership percentage, controlling interest				91%
Ownership interest sold during the period	23.90%
UX
Related Party Transaction [Line Items]
Ownership percentage, non-controlling interest				24.30%
[1]* Please see Note 3

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	3 Months Ended				6 Months Ended	9 Months Ended		12 Months Ended
	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)		Dec. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)	Mar. 31, 2022 USD ($)
Property, Plant and Equipment [Line Items]
Impairment of intangible assets					$ 0			$ 3,125,000
Goodwill	$ 9,460,000	$ 5,898,000	[1]			$ 9,460,000		5,898,000	[1]
Goodwill impairment		2,300,000
Reversal of impairment						2,509,000
Provision for impairment of discontinued operations				$ 0		$ (43,973,000)	$ 0
Number of geographical regions | segment						5
Accrued interest or penalties related to uncertain tax positions	0	$ 0				$ 0		$ 0
Recast discontinued operations
Property, Plant and Equipment [Line Items]
Provision for impairment of discontinued operations	$ (2,509,000)			$ 0		$ 43,973,000	$ 0
Minimum
Property, Plant and Equipment [Line Items]
Useful lives of assets						3 years
Maximum
Property, Plant and Equipment [Line Items]
Useful lives of assets						65 years
[1]* Please see Note 3

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of VIE’s consolidated assets and liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Variable Interest Entity [Line Items]
Cash and cash equivalents	$ 664,095	$ 225,464	[1]
Restricted cash	449,979	547,950	[1]
Trading securities	1,929,840	1,158,377	[1]
Margin lending, brokerage and other receivables, net	403,568	147,659	[1]
Fixed assets, net	43,862	17,823	[1]
Intangible assets, net	9,010	5,163	[1]
Right-of-use asset	24,054	7,431	[1]
Other assets	47,754	27,044	[1]
TOTAL ASSETS	5,368,134	3,227,750	[1]
Customer liabilities	1,786,452	765,628	[1]
Securities repurchase agreement obligations	1,233,928	840,224	[1]
Margin lending and trade payables	142,341	45,083	[1]
Lease liability	24,175	7,504	[1]
Other liabilities	37,940	21,477	[1]
TOTAL LIABILITIES	4,685,803	2,681,142	[1]
Variable interest entity, primary beneficiary
Variable Interest Entity [Line Items]
Cash and cash equivalents	1	134
Restricted cash	1,942	2,843
Trading securities	3,477	2,942
Margin lending, brokerage and other receivables, net	967	435
Fixed assets, net	800	1,043
Intangible assets, net	140	205
Right-of-use asset	424	905
Other assets	84	127
TOTAL ASSETS	7,835	8,634
Customer liabilities	6,441	8,439
Securities repurchase agreement obligations	12	3,267
Margin lending and trade payables	81	35
Lease liability	454	914
Other liabilities	296	434
TOTAL LIABILITIES	$ 7,284	$ 13,089
[1]* Please see Note 3

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of changes in the carrying amount of goodwill (Details) $ in Thousands	9 Months Ended
	Dec. 31, 2022 USD ($)
Goodwill [Roll Forward]
Balance as of March 31, 2022 (Recasted)	$ 5,898	[1]
Foreign currency translation	(95)
Balance as of December 31, 2022	9,460
London Almaty
Goodwill [Roll Forward]
Acquisitions	485
Ticketon
Goodwill [Roll Forward]
Acquisitions	$ 3,172
[1]* Please see Note 3

RECAST - Narrative (Details)

RECAST - Narrative (Details) - USD ($) $ in Thousands	May 17, 2022	Dec. 31, 2022	Mar. 31, 2022
Change in Accounting Estimate [Line Items]
Customer liabilities		$ 1,786,452	$ 765,628	[1]
Recast discontinued operations
Change in Accounting Estimate [Line Items]
Customer liabilities		$ 820,394	701,584
As previously reported
Change in Accounting Estimate [Line Items]
Customer liabilities			1,417,937
Revision of prior period, adjustment | Recast discontinued operations
Change in Accounting Estimate [Line Items]
Customer liabilities			(651,326)
Freedom Insurance
Change in Accounting Estimate [Line Items]
Business acquisition, percentage of outstanding shares	100%
Total purchase price	$ 13,977
Freedom Life
Change in Accounting Estimate [Line Items]
Business acquisition, percentage of outstanding shares	100%
Total purchase price	$ 12,611
FF Life Acquisition | Revision of prior period, adjustment
Change in Accounting Estimate [Line Items]
Customer liabilities			0
FF Life Acquisition | Revision of prior period, adjustment | Elimi-nations
Change in Accounting Estimate [Line Items]
Customer liabilities			(901)
Insurance acquisitions | Revision of prior period, adjustment
Change in Accounting Estimate [Line Items]
Customer liabilities			0
Insurance acquisitions | Revision of prior period, adjustment | Elimi-nations
Change in Accounting Estimate [Line Items]
Customer liabilities			$ (82)
[1]* Please see Note 3

RECAST - Condensed Consolidated

RECAST - Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022		Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2021
ASSETS
Cash and cash equivalents	$ 664,095		$ 225,464	[1]
Trading securities	1,929,840		1,158,377	[1]
Restricted cash	449,979		547,950	[1]
Margin lending, brokerage and other receivables, net	403,568		147,659	[1]
Loans issued	639,377		92,446	[1]
Other assets	47,754		27,044	[1]
Fixed assets, net	43,862		17,823	[1]
Right-of-use asset	24,054		7,431	[1]
Intangible assets, net	9,010		5,163	[1]
Goodwill	9,460		5,898	[1]
Available-for-sale securities, at fair value	174,326		161,364	[1]
Insurance contract assets	11,243		5,712	[1]
Assets held for sale	961,566		825,419	[1]
TOTAL ASSETS	5,368,134		3,227,750	[1]
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations	1,233,928		840,224	[1]
Customer liabilities	1,786,452		765,628	[1]
Margin lending and trade payables	142,341		45,083	[1]
Liabilities from insurance activity	156,542		119,490	[1]
Current income tax liability	0		14,556	[1]
Securities sold, not yet purchased – at fair value	0		13,865	[1]			$ 8,569
Debt securities issued	37,192		34,390	[1]
Lease liability	24,175		7,504	[1]
Other liabilities	37,940		21,477	[1]
Liability arising from continuing involvement	319,694		6,447
Liabilities held for sale	931,484		812,478	[1]
TOTAL LIABILITIES	4,685,803		2,681,142	[1]
Commitments and Contingent Liabilities (Note 26)	0		0	[1]
SHAREHOLDERS’ EQUITY
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding	0		0	[1]
Common stock - $0.001 par value; 500,000,000 shares authorized;	59		59	[1]
Additional paid in capital	159,580		174,745	[1]
Retained earnings	592,115		441,924	[1]
Accumulated other comprehensive loss	(60,920)		(63,125)	[1]
TOTAL FRHC SHAREHOLDERS’ EQUITY	690,834		553,603	[1]
Non-controlling interest	(8,503)		(6,995)	[1]
TOTAL SHAREHOLDERS’ EQUITY	682,331	$ 621,331	546,608	[1]	$ 633,007	$ 583,132	$ 307,671
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	5,368,134		3,227,750	[1]
Recast discontinued operations
ASSETS
Cash and cash equivalents	582,314		428,480
Trading securities	112,801		122,497
Restricted cash	18,052		28,406
Margin lending, brokerage and other receivables, net	240,414		210,087
Loans issued	17,201		2,395
Other assets	34,757		33,554
TOTAL ASSETS	961,566		825,419
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations	30,971		32,469
Customer liabilities	820,394		701,584
Debt securities issued	63,207		64,637
Other liabilities	16,912		13,788
TOTAL LIABILITIES	$ 931,484		812,478
As previously reported
ASSETS
Cash and cash equivalents			625,547
Trading securities			1,203,479
Restricted cash			553,680
Margin lending, brokerage and other receivables, net			357,567
Loans issued			94,797
Other assets			37,725
Fixed assets, net			21,365
Right-of-use asset			15,669
Intangible assets, net			5,791
Goodwill			5,388
Available-for-sale securities, at fair value			1
Insurance contract assets			0
Assets held for sale			0
TOTAL ASSETS			2,921,009
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations			775,178
Customer liabilities			1,417,937
Margin lending and trade payables			45,229
Liabilities from insurance activity			0
Current income tax liability			14,556
Securities sold, not yet purchased – at fair value			14,103
Debt securities issued			99,027
Lease liability			15,315
Other liabilities			25,542
Liability arising from continuing involvement			6,447
Liabilities held for sale			0
TOTAL LIABILITIES			2,413,334
Commitments and Contingent Liabilities (Note 26)			0
SHAREHOLDERS’ EQUITY
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding			0
Common stock - $0.001 par value; 500,000,000 shares authorized;			59
Additional paid in capital			141,340
Retained earnings			426,563
Accumulated other comprehensive loss			(53,291)
TOTAL FRHC SHAREHOLDERS’ EQUITY			514,671
Non-controlling interest			(6,996)
TOTAL SHAREHOLDERS’ EQUITY			507,675
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY			2,921,009
Revision of prior period, adjustment | Recast discontinued operations
ASSETS
Cash and cash equivalents			(400,898)
Trading securities			(122,497)
Restricted cash			(5,730)
Margin lending, brokerage and other receivables, net			(210,087)
Loans issued			(2,395)
Other assets			(18,375)
Fixed assets, net			(3,978)
Right-of-use asset			(8,922)
Intangible assets, net			(2,278)
Goodwill			0
Available-for-sale securities, at fair value			0
Insurance contract assets			0
Assets held for sale			825,419
TOTAL ASSETS			50,259
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations			(32,469)
Customer liabilities			(651,326)
Margin lending and trade payables			(147)
Liabilities from insurance activity			0
Current income tax liability			0
Securities sold, not yet purchased – at fair value			(238)
Debt securities issued			(64,637)
Lease liability			(8,530)
Other liabilities			(4,872)
Liability arising from continuing involvement			0
Liabilities held for sale			812,478
TOTAL LIABILITIES			50,259
Commitments and Contingent Liabilities (Note 26)			0
SHAREHOLDERS’ EQUITY
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding			0
Common stock - $0.001 par value; 500,000,000 shares authorized;			0
Additional paid in capital			0
Retained earnings			0
Accumulated other comprehensive loss			0
TOTAL FRHC SHAREHOLDERS’ EQUITY			0
Non-controlling interest			0
TOTAL SHAREHOLDERS’ EQUITY			0
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY			50,259
Revision of prior period, adjustment | FF Life Acquisition
ASSETS
Cash and cash equivalents			1,427
Trading securities			8,875
Restricted cash			0
Margin lending, brokerage and other receivables, net			173
Loans issued			44
Other assets			7,267
Fixed assets, net			182
Right-of-use asset			532
Intangible assets, net			1,489
Goodwill			359
Available-for-sale securities, at fair value			161,363
Insurance contract assets			3,555
Assets held for sale			0
TOTAL ASSETS			185,266
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations			47,691
Customer liabilities			0
Margin lending and trade payables			0
Liabilities from insurance activity			106,329
Current income tax liability			0
Securities sold, not yet purchased – at fair value			0
Debt securities issued			0
Lease liability			543
Other liabilities			550
Liability arising from continuing involvement			0
Liabilities held for sale			0
TOTAL LIABILITIES			155,113
Commitments and Contingent Liabilities (Note 26)			0
SHAREHOLDERS’ EQUITY
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding			0
Common stock - $0.001 par value; 500,000,000 shares authorized;			9,465
Additional paid in capital			0
Retained earnings			28,131
Accumulated other comprehensive loss			(7,443)
TOTAL FRHC SHAREHOLDERS’ EQUITY			30,153
Non-controlling interest			1
TOTAL SHAREHOLDERS’ EQUITY			30,154
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY			185,267
Revision of prior period, adjustment | FF Life Acquisition | Elimi-nations
ASSETS
Cash and cash equivalents			(901)
Trading securities			0
Restricted cash			0
Margin lending, brokerage and other receivables, net			(34)
Loans issued			0
Other assets			0
Fixed assets, net			0
Right-of-use asset			0
Intangible assets, net			0
Goodwill			0
Available-for-sale securities, at fair value			0
Insurance contract assets			0
Assets held for sale			0
TOTAL ASSETS			(935)
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations			0
Customer liabilities			(901)
Margin lending and trade payables			0
Liabilities from insurance activity			0
Current income tax liability			0
Securities sold, not yet purchased – at fair value			0
Debt securities issued			0
Lease liability			0
Other liabilities			(35)
Liability arising from continuing involvement			0
Liabilities held for sale			0
TOTAL LIABILITIES			(936)
Commitments and Contingent Liabilities (Note 26)			0
SHAREHOLDERS’ EQUITY
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding			0
Common stock - $0.001 par value; 500,000,000 shares authorized;			(9,465)
Additional paid in capital			16,499
Retained earnings			(6,666)
Accumulated other comprehensive loss			(368)
TOTAL FRHC SHAREHOLDERS’ EQUITY			0
Non-controlling interest			0
TOTAL SHAREHOLDERS’ EQUITY			0
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY			(936)
Revision of prior period, adjustment | Insurance acquisitions
ASSETS
Cash and cash equivalents			371
Trading securities			68,520
Restricted cash			0
Margin lending, brokerage and other receivables, net			60
Loans issued			0
Other assets			427
Fixed assets, net			254
Right-of-use asset			152
Intangible assets, net			161
Goodwill			151
Available-for-sale securities, at fair value			0
Insurance contract assets			2,157
Assets held for sale			0
TOTAL ASSETS			72,253
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations			49,824
Customer liabilities			0
Margin lending and trade payables			21
Liabilities from insurance activity			13,161
Current income tax liability			0
Securities sold, not yet purchased – at fair value			0
Debt securities issued			0
Lease liability			176
Other liabilities			292
Liability arising from continuing involvement			0
Liabilities held for sale			0
TOTAL LIABILITIES			63,474
Commitments and Contingent Liabilities (Note 26)			0
SHAREHOLDERS’ EQUITY
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding			0
Common stock - $0.001 par value; 500,000,000 shares authorized;			15,577
Additional paid in capital			0
Retained earnings			(4,811)
Accumulated other comprehensive loss			(1,987)
TOTAL FRHC SHAREHOLDERS’ EQUITY			8,779
Non-controlling interest			0
TOTAL SHAREHOLDERS’ EQUITY			8,779
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY			72,253
Revision of prior period, adjustment | Insurance acquisitions | Elimi-nations
ASSETS
Cash and cash equivalents			(82)
Trading securities			0
Restricted cash			0
Margin lending, brokerage and other receivables, net			(20)
Loans issued			0
Other assets			0
Fixed assets, net			0
Right-of-use asset			0
Intangible assets, net			0
Goodwill			0
Available-for-sale securities, at fair value			0
Insurance contract assets			0
Assets held for sale			0
TOTAL ASSETS			(102)
LIABILITIES AND SHAREHOLDERS’ EQUITY
Securities repurchase agreement obligations			0
Customer liabilities			(82)
Margin lending and trade payables			(20)
Liabilities from insurance activity			0
Current income tax liability			0
Securities sold, not yet purchased – at fair value			0
Debt securities issued			0
Lease liability			0
Other liabilities			0
Liability arising from continuing involvement			0
Liabilities held for sale			0
TOTAL LIABILITIES			(102)
Commitments and Contingent Liabilities (Note 26)			0
SHAREHOLDERS’ EQUITY
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding			0
Common stock - $0.001 par value; 500,000,000 shares authorized;			(15,577)
Additional paid in capital			16,906
Retained earnings			(1,293)
Accumulated other comprehensive loss			(36)
TOTAL FRHC SHAREHOLDERS’ EQUITY			0
Non-controlling interest			0
TOTAL SHAREHOLDERS’ EQUITY			0
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY			$ (102)
[1]* Please see Note 3

RECAST- Condensed Consolidated

RECAST- Condensed Consolidated Balance Sheets - Additional Information (Details) - $ / shares	Dec. 31, 2022	Mar. 31, 2022
Accounting Changes and Error Corrections [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	20,000,000	20,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	500,000,000	500,000,000

RECAST- Condensed Consolidate_2

RECAST- Condensed Consolidated Statement of Operations and Other Comprehensive Income (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Revenue:
Fee and commission income	$ 80,883	$ 91,408	$ 253,486	$ 262,549
Net gain/(loss) on trading securities	25,456	7,663	38,894	197,947
Net realized loss on investments available for sale				0
Interest income	80,255	33,657	187,817	82,514
Insurance underwriting income	28,557	21,394	78,998	51,491
Net gain/(loss) on foreign exchange operations	20,866	1,361	30,014	4,076
Net loss on derivative	(21,469)	(314)	(22,523)	(1,028)
Total revenue, net	214,548	155,169	566,686	597,549
Expense:
Fee and commission expense	18,314	24,782	60,068	68,626
Interest expense	52,037	21,890	132,971	52,852
Insurance claims incurred, net of reinsurance	17,419	16,286	51,586	41,096
Operating expense	50,608	31,581	126,367	72,772
Provision for impairment losses/(recovery)	24,140	(333)	30,294	911
Other expense, net	570	979	79	2,426
TOTAL EXPENSE	163,088	95,185	401,365	238,683
INCOME BEFORE INCOME TAX	51,460	59,984	165,321	358,866
Income tax (expense)/benefit	(5,069)	(1,806)	(26,567)	(39,026)
INCOME FROM CONTINUING OPERATIONS	46,391	58,178	138,754	319,840
Income/(loss) before income tax (expense)/benefit of discontinued operations (including loss on disposal of $2,509 and $0 for the three months ended December 31, 2022 and 2021, respectively, and loss on disposal of $43,973 and $0 for nine months ended December 31, 2022 and 2021, respectively, see Note 25)	13,667	(5,067)	14,467	(4,609)
Income tax (expense)/benefit of discontinued operations	2,342	962	(4,538)	953
Income from discontinued operation	16,009	(4,105)	9,929	(3,656)
NET INCOME	62,400	54,073	148,683	316,184
Less: Net loss attributable to non-controlling interest in subsidiary	(464)	(343)	(1,508)	(415)
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS	62,864	54,416	150,191	316,599
OTHER COMPREHENSIVE INCOME
Change in unrealized gain on investments available-for-sale, net of tax effect	(54)	(1,063)	2,309	(1,789)
Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect	320	953	197	1,606
Translation difference	(5,611)	(8,650)	(301)	(4,447)
OTHER COMPREHENSIVE (LOSS)/ INCOME	(5,345)	(8,760)	2,205	(4,630)
COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS	57,055	45,313	150,888	311,554
Less: Comprehensive loss attributable to non-controlling interest in subsidiary	(464)	(343)	(1,508)	(415)
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ 57,519	$ 45,656	$ 152,396	$ 311,969
Earnings per common share-basic (in USD per share)	$ 1.38	$ 0.91	$ 2.86	$ 5.34
Earnings per common share- diluted (in USD per share)	1.36	0.91	2.81	5.34
Earnings from continuing operations per common share - basic (in USD per share)	0.79	0.98	2.37	5.40
Earnings from continuing operations per common share - diluted (in USD per share)	$ 0.78	0.98	$ 2.33	5.40
(Loss)/earnings from discontinued operations per common share - basic (in USD per share)		(0.09)		(0.08)
(Loss)/earnings from discontinued operations per common share - Diluted (in USD per share)		$ (0.09)		$ (0.08)
Recast discontinued operations
Revenue:
Fee and commission income	$ 14,230	$ 23,147	$ 62,290	$ 59,596
Net gain/(loss) on trading securities	799	(6,611)	13,898	(9,716)
Interest income	17,599	5,786	47,460	15,574
Net gain/(loss) on foreign exchange operations	19,965	(655)	40,379	(2,889)
Total revenue, net	52,550	21,667	163,984	62,565
Expense:
Fee and commission expense	2,750	2,075	7,000	6,300
Interest expense	3,124	2,365	13,143	6,824
Operating expense	29,839	22,253	83,379	53,841
Provision for impairment losses/(recovery)	1,594	13	2,176	89
Other expense, net	(933)	28	(154)	120
TOTAL EXPENSE	38,883	26,734	149,517	67,174
INCOME BEFORE INCOME TAX	$ 13,667	(5,067)	14,467	(4,609)
Income from discontinued operation			$ 9,929	(3,656)
As previously reported
Revenue:
Fee and commission income		117,316		327,966
Net gain/(loss) on trading securities		403		185,554
Net realized loss on investments available for sale				0
Interest income		27,828		69,259
Insurance underwriting income		0		0
Net gain/(loss) on foreign exchange operations		451		885
Net loss on derivative		(314)		(1,028)
Total revenue, net		145,684		582,636
Expense:
Fee and commission expense		22,716		67,547
Interest expense		20,799		51,256
Insurance claims incurred, net of reinsurance		0		0
Operating expense		50,496		117,384
Provision for impairment losses/(recovery)		45		704
Other expense, net		(64)		600
TOTAL EXPENSE		93,992		237,491
INCOME BEFORE INCOME TAX		51,692		345,145
Income tax (expense)/benefit		(806)		(38,037)
INCOME FROM CONTINUING OPERATIONS		50,886		307,108
Income/(loss) before income tax (expense)/benefit of discontinued operations (including loss on disposal of $2,509 and $0 for the three months ended December 31, 2022 and 2021, respectively, and loss on disposal of $43,973 and $0 for nine months ended December 31, 2022 and 2021, respectively, see Note 25)		0		0
Income tax (expense)/benefit of discontinued operations		0		0
Income from discontinued operation		0		0
NET INCOME		50,886		307,108
Less: Net loss attributable to non-controlling interest in subsidiary		(343)		(415)
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		51,229		307,523
OTHER COMPREHENSIVE INCOME
Change in unrealized gain on investments available-for-sale, net of tax effect		0		0
Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect		0		0
Translation difference		(7,336)		(3,106)
OTHER COMPREHENSIVE (LOSS)/ INCOME		(7,336)		(3,106)
COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS		43,550		304,002
Less: Comprehensive loss attributable to non-controlling interest in subsidiary		(343)		(415)
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		$ 43,893		$ 304,417
Earnings from continuing operations per common share - basic (in USD per share)		$ 0.86		$ 5.18
Earnings from continuing operations per common share - diluted (in USD per share)		$ 0.86		$ 5.18
Revision of prior period, adjustment
Revenue:
Net gain/(loss) on trading securities		$ 0		$ 0
Insurance underwriting income		0		0
Net gain/(loss) on foreign exchange operations		0		0
Net loss on derivative		0		0
Total revenue, net		0		0
Revision of prior period, adjustment | Recast discontinued operations
Revenue:
Fee and commission income		(25,905)		(65,251)
Net gain/(loss) on trading securities		6,611		9,716
Net realized loss on investments available for sale				0
Interest income		(3,029)		(9,920)
Insurance underwriting income		0		0
Net gain/(loss) on foreign exchange operations		655		2,888
Net loss on derivative		0		0
Total revenue, net		(21,668)		(62,567)
Expense:
Fee and commission expense		(2,076)		(6,301)
Interest expense		(2,365)		(6,824)
Insurance claims incurred, net of reinsurance		0		0
Operating expense		(22,253)		(53,840)
Provision for impairment losses/(recovery)		(13)		(90)
Other expense, net		(30)		(120)
TOTAL EXPENSE		(26,737)		(67,175)
INCOME BEFORE INCOME TAX		5,069		4,608
Income tax (expense)/benefit		(962)		(943)
INCOME FROM CONTINUING OPERATIONS		4,107		3,665
Income/(loss) before income tax (expense)/benefit of discontinued operations (including loss on disposal of $2,509 and $0 for the three months ended December 31, 2022 and 2021, respectively, and loss on disposal of $43,973 and $0 for nine months ended December 31, 2022 and 2021, respectively, see Note 25)		(5,067)		(4,609)
Income tax (expense)/benefit of discontinued operations		962		953
Income from discontinued operation		(4,105)		(3,656)
NET INCOME		2		9
Less: Net loss attributable to non-controlling interest in subsidiary		0		0
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		2		9
OTHER COMPREHENSIVE INCOME
Change in unrealized gain on investments available-for-sale, net of tax effect		0		0
Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect		0		0
Translation difference		2,672		2,574
OTHER COMPREHENSIVE (LOSS)/ INCOME		2,672		2,574
COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS		2,674		2,583
Less: Comprehensive loss attributable to non-controlling interest in subsidiary		0		0
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		2,674		2,583
Revision of prior period, adjustment | FF Life Acquisition
Revenue:
Fee and commission income		0		0
Net gain/(loss) on trading securities		490		1,090
Net realized loss on investments available for sale
Interest income		6,534		16,634
Insurance underwriting income		18,030		42,091
Net gain/(loss) on foreign exchange operations		239		277
Net loss on derivative		0		0
Total revenue, net		25,293		60,092
Expense:
Fee and commission expense		3,946		7,074
Interest expense		1,606		3,604
Insurance claims incurred, net of reinsurance		13,246		31,862
Operating expense		1,681		4,293
Provision for impairment losses/(recovery)		0		0
Other expense, net		1,073		1,949
TOTAL EXPENSE		21,552		48,782
INCOME BEFORE INCOME TAX		3,741		11,310
Income tax (expense)/benefit		12		11
INCOME FROM CONTINUING OPERATIONS		3,753		11,321
Income/(loss) before income tax (expense)/benefit of discontinued operations (including loss on disposal of $2,509 and $0 for the three months ended December 31, 2022 and 2021, respectively, and loss on disposal of $43,973 and $0 for nine months ended December 31, 2022 and 2021, respectively, see Note 25)		0		0
Income tax (expense)/benefit of discontinued operations		0		0
Income from discontinued operation		0		0
NET INCOME		3,753		11,321
Less: Net loss attributable to non-controlling interest in subsidiary		0		0
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		3,753		11,321
OTHER COMPREHENSIVE INCOME
Change in unrealized gain on investments available-for-sale, net of tax effect		(1,063)		(1,789)
Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect		953		1,606
Translation difference		(1,284)		(1,213)
OTHER COMPREHENSIVE (LOSS)/ INCOME		(1,394)		(1,396)
COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS		2,359		9,925
Less: Comprehensive loss attributable to non-controlling interest in subsidiary		0		0
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		2,359		9,925
Revision of prior period, adjustment | FF Life Acquisition | Elimi-nations
Revenue:
Fee and commission income		0		(91)
Net gain/(loss) on trading securities		0		0
Net realized loss on investments available for sale				0
Interest income		0		0
Insurance underwriting income		0		0
Net gain/(loss) on foreign exchange operations		0		0
Net loss on derivative		0		0
Total revenue, net		0		(91)
Expense:
Fee and commission expense		0		(91)
Interest expense		0		0
Insurance claims incurred, net of reinsurance		0		0
Operating expense		0		0
Provision for impairment losses/(recovery)		0		0
Other expense, net		0		0
TOTAL EXPENSE		0		(91)
INCOME BEFORE INCOME TAX		0		0
Income tax (expense)/benefit				0
INCOME FROM CONTINUING OPERATIONS		0		0
Income/(loss) before income tax (expense)/benefit of discontinued operations (including loss on disposal of $2,509 and $0 for the three months ended December 31, 2022 and 2021, respectively, and loss on disposal of $43,973 and $0 for nine months ended December 31, 2022 and 2021, respectively, see Note 25)		0		0
Income tax (expense)/benefit of discontinued operations		0		0
Income from discontinued operation		0		0
NET INCOME		0		0
Less: Net loss attributable to non-controlling interest in subsidiary		0		0
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		0		0
OTHER COMPREHENSIVE INCOME
Change in unrealized gain on investments available-for-sale, net of tax effect		0		0
Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect		0		0
Translation difference		0		0
OTHER COMPREHENSIVE (LOSS)/ INCOME		0		0
COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS		0		0
Less: Comprehensive loss attributable to non-controlling interest in subsidiary		0		0
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		0		0
Revision of prior period, adjustment | Insurance acquisitions
Revenue:
Fee and commission income		(3)		86
Net gain/(loss) on trading securities		159		1,587
Net realized loss on investments available for sale				0
Interest income		2,324		6,541
Insurance underwriting income		3,364		9,400
Net gain/(loss) on foreign exchange operations		16		26
Net loss on derivative		0		0
Total revenue, net		5,860		17,640
Expense:
Fee and commission expense		196		558
Interest expense		1,850		4,816
Insurance claims incurred, net of reinsurance		3,040		9,234
Operating expense		1,657		4,935
Provision for impairment losses/(recovery)		(365)		297
Other expense, net		0		(3)
TOTAL EXPENSE		6,378		19,837
INCOME BEFORE INCOME TAX		(518)		(2,197)
Income tax (expense)/benefit		(50)		(57)
INCOME FROM CONTINUING OPERATIONS		(568)		(2,254)
Income/(loss) before income tax (expense)/benefit of discontinued operations (including loss on disposal of $2,509 and $0 for the three months ended December 31, 2022 and 2021, respectively, and loss on disposal of $43,973 and $0 for nine months ended December 31, 2022 and 2021, respectively, see Note 25)		0		0
Income tax (expense)/benefit of discontinued operations		0		0
Income from discontinued operation		0		0
NET INCOME		(568)		(2,254)
Less: Net loss attributable to non-controlling interest in subsidiary		0		0
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		(568)		(2,254)
OTHER COMPREHENSIVE INCOME
Change in unrealized gain on investments available-for-sale, net of tax effect		0		0
Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect		0		0
Translation difference		(2,702)		(2,702)
OTHER COMPREHENSIVE (LOSS)/ INCOME		(2,702)		(2,702)
COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS		(3,270)		(4,956)
Less: Comprehensive loss attributable to non-controlling interest in subsidiary		0		0
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		(3,270)		(4,956)
Revision of prior period, adjustment | Insurance acquisitions | Elimi-nations
Revenue:
Fee and commission income		0		(161)
Net gain/(loss) on trading securities		0		0
Net realized loss on investments available for sale				0
Interest income		0		0
Insurance underwriting income		0		0
Net gain/(loss) on foreign exchange operations		0		0
Net loss on derivative		0		0
Total revenue, net		0		(161)
Expense:
Fee and commission expense		0		(161)
Interest expense		0		0
Insurance claims incurred, net of reinsurance		0		0
Operating expense		0		0
Provision for impairment losses/(recovery)		0		0
Other expense, net		0		0
TOTAL EXPENSE		0		(161)
INCOME BEFORE INCOME TAX		0		0
Income tax (expense)/benefit				0
INCOME FROM CONTINUING OPERATIONS		0		0
Income/(loss) before income tax (expense)/benefit of discontinued operations (including loss on disposal of $2,509 and $0 for the three months ended December 31, 2022 and 2021, respectively, and loss on disposal of $43,973 and $0 for nine months ended December 31, 2022 and 2021, respectively, see Note 25)		0		0
Income tax (expense)/benefit of discontinued operations		0		0
Income from discontinued operation				0
NET INCOME		0		0
Less: Net loss attributable to non-controlling interest in subsidiary		0		0
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		0		0
OTHER COMPREHENSIVE INCOME
Change in unrealized gain on investments available-for-sale, net of tax effect		0		0
Reclassification adjustment for net realized gain on available-for-sale investments disposed of in the period, net of tax effect		0		0
Translation difference		0
OTHER COMPREHENSIVE (LOSS)/ INCOME		0		0
COMPREHENSIVE INCOME/(LOSS) BEFORE NON-CONTROLLING INTERESTS		0		0
Less: Comprehensive loss attributable to non-controlling interest in subsidiary		0		0
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS		$ 0		$ 0

RESTATEMENT - Adjustments (Deta

RESTATEMENT - Adjustments (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations	$ (465,791)	$ (611,853)
Net cash flows used in investing activities	(641,321)	(93,095)
Net cash flows (used in)/from financing activities	1,506,188	441,794
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations		6,374
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	$ 484,140	(256,780)
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations		(582,080)
Net cash flows used in investing activities		(6,110)
Net cash flows (used in)/from financing activities		338,792
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations		10,593
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		(238,805)
As previously reported | FF Life and FF Insurance acquisitions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		(256,780)
Revision of prior period, adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations		(21,090)
Net cash flows used in investing activities		(34,709)
Net cash flows (used in)/from financing activities		55,799
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations		0
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		0
Revision of prior period, adjustment | Recast discontinued operations
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations		(34,465)
Net cash flows used in investing activities		0
Net cash flows (used in)/from financing activities		0
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations		(1,998)
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		(36,463)
Revision of prior period, adjustment | FF Life and FF Insurance acquisitions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations		(590,763)
Net cash flows used in investing activities		(58,386)
Net cash flows (used in)/from financing activities		385,995
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations		6,374
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		(256,780)
Revision of prior period, adjustment | FF Life and FF Insurance acquisitions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations		25,782
Net cash flows used in investing activities		(52,276)
Net cash flows (used in)/from financing activities		47,203
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations		(2,221)
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		$ 18,488

RESTATEMENT - Adjustments, Cont

RESTATEMENT - Adjustments, Continuing and Discontinued Operations (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations	$ (497,956)	$ (388,952)
Net cash flows from/(used in) operating activities from discontinued operations	32,165	(222,901)
Net cash flows used in investing activities from continuing operations	(619,674)	(90,305)
Net cash flows used in investing activities from discontinued operations	(21,647)	(2,790)
Net cash flows from financing activities from continuing operations	1,480,083	403,812
Net cash flows from financing activities from discontinued operations	26,105	37,982
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations	23,591	(7,321)
Effect of changes in foreign exchange rates on cash and cash equivalents from discontinued operations	61,473	13,695
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	$ 484,140	(256,780)
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		(238,805)
As previously reported | FF Life and FF Insurance acquisitions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations		(256,764)
Net cash flows from/(used in) operating activities from discontinued operations		(333,999)
Net cash flows used in investing activities from continuing operations		(56,167)
Net cash flows used in investing activities from discontinued operations		(2,219)
Net cash flows from financing activities from continuing operations		320,364
Net cash flows from financing activities from discontinued operations		65,631
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations		(7,321)
Effect of changes in foreign exchange rates on cash and cash equivalents from discontinued operations		13,695
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		(256,780)
Revision of prior period, adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash flows used in operating activities from continuing operations		(132,188)
Net cash flows from/(used in) operating activities from discontinued operations		111,098
Net cash flows used in investing activities from continuing operations		(34,138)
Net cash flows used in investing activities from discontinued operations		(571)
Net cash flows from financing activities from continuing operations		83,448
Net cash flows from financing activities from discontinued operations		(27,649)
Effect of changes in foreign exchange rates on cash and cash equivalents from continued operations		0
Effect of changes in foreign exchange rates on cash and cash equivalents from discontinued operations		0
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		0
Revision of prior period, adjustment | FF Life and FF Insurance acquisitions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		$ (256,780)

RESTATEMENT - Adjustments to Re

RESTATEMENT - Adjustments to Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Fee and commission income		$ 91,408		$ 262,549
Net gain/(loss) on trading securities	$ 25,456	7,663	$ 38,894	197,947
Interest income		33,657		82,514
Insurance underwriting income	28,557	21,394	78,998	51,491
Net gain/(loss) on foreign exchange operations	20,866	1,361	30,014	4,076
Net loss on derivative	(21,469)	(314)	(22,523)	(1,028)
Total revenue, net	214,548	155,169	566,686	597,549
Recast discontinued operations
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net gain/(loss) on trading securities	799	(6,611)	13,898	(9,716)
Net gain/(loss) on foreign exchange operations	19,965	(655)	40,379	(2,889)
Total revenue, net	$ 52,550	21,667	$ 163,984	62,565
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Fee and commission income		122,237		336,178
Net gain/(loss) on trading securities		403		185,554
Interest income		22,907		61,047
Insurance underwriting income		0		0
Net gain/(loss) on foreign exchange operations		451		885
Net loss on derivative		(314)		(1,028)
Total revenue, net		145,684		582,636
As previously reported | FF Life and FF Insurance acquisitions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Fee and commission income		96,329		270,761
Net gain/(loss) on trading securities		7,663		197,947
Interest income		28,736		74,302
Insurance underwriting income		21,394		51,491
Net gain/(loss) on foreign exchange operations		1,361		4,076
Net loss on derivative		(314)		(1,028)
Total revenue, net		155,169		597,549
Revision of prior period, adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Fee and commission income		(4,921)		(8,212)
Net gain/(loss) on trading securities		0		0
Interest income		4,921		8,212
Insurance underwriting income		0		0
Net gain/(loss) on foreign exchange operations		0		0
Net loss on derivative		0		0
Total revenue, net		0		0
Revision of prior period, adjustment | Recast discontinued operations
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Fee and commission income		(25,905)		(65,251)
Net gain/(loss) on trading securities		6,611		9,716
Interest income		(3,029)		(9,920)
Insurance underwriting income		0		0
Net gain/(loss) on foreign exchange operations		655		2,888
Net loss on derivative		0		0
Total revenue, net		(21,668)		(62,567)
Revision of prior period, adjustment | FF Life and FF Insurance acquisitions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Fee and commission income		(3)		(166)
Net gain/(loss) on trading securities		649		2,677
Interest income		8,858		23,175
Insurance underwriting income		21,394		51,491
Net gain/(loss) on foreign exchange operations		255		303
Net loss on derivative		0		0
Total revenue, net		$ 31,153		$ 77,480

CASH AND CASH EQUIVALENTS - Sch

CASH AND CASH EQUIVALENTS - Schedule of cash and cash equivalents (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 664,095	$ 225,464	$ 165,633
Short term deposits in National Bank (Kazakhstan)
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	350,203	42,517
Securities purchased under reverse repurchase agreements
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	129,955	19,947
Short term deposits in commercial banks
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	98,846	70,155
Short term deposits on brokerage accounts
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	43,507	71,061
Petty cash in bank vault and on hand
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	20,552	18,607
Short term deposits in stock exchanges
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	19,293	2,828
Overnight deposits
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	1,667	0
Cash in transit
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	63	35
Short term deposits in the Central Depository (Kazakhstan)
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 9	$ 314

CASH AND CASH EQUIVALENTS - S_2

CASH AND CASH EQUIVALENTS - Schedule of collateralized securities received under reverse repurchase agreements (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Up to 30 days	$ 1,177,256	$ 840,082
30-90 days	56,672	142
Total contractual maturity	1,233,928	840,224
Cash and cash equivalents
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Up to 30 days	129,955	19,947
30-90 days	0	0
Total contractual maturity	129,955	19,947
Corporate debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Up to 30 days	586,939	609,405
30-90 days	4,774	142
Total contractual maturity	$ 591,713	$ 609,547
Corporate debt | Cash and cash equivalents
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average interest rate	16.09%	11.88%
Up to 30 days	$ 70,363	$ 57
30-90 days	0	0
Total contractual maturity	$ 70,363	$ 57
Non-US sovereign debt | Cash and cash equivalents
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average interest rate	13.15%	12.51%
Up to 30 days	$ 40,678	$ 9,786
30-90 days	0	0
Total contractual maturity	40,678	9,786
US sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Up to 30 days	17,586	7,396
30-90 days	0	0
Total contractual maturity	$ 17,586	$ 7,396
US sovereign debt | Cash and cash equivalents
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average interest rate	2.74%	16.38%
Up to 30 days	$ 18,596	$ 9,952
30-90 days	0	0
Total contractual maturity	$ 18,596	9,952
Corporate equity
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Up to 30 days		388
30-90 days		0
Total contractual maturity		$ 388
Corporate equity | Cash and cash equivalents
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average interest rate	18.57%	16.90%
Up to 30 days	$ 318	$ 152
30-90 days	0	0
Total contractual maturity	$ 318	$ 152

CASH AND CASH EQUIVALENTS - Nar

CASH AND CASH EQUIVALENTS - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair value of collateral received by the company under reverse repurchase agreements	$ 137,377	$ 19,911

RESTRICTED CASH - Schedule of r

RESTRICTED CASH - Schedule of restricted cash (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Line Items]
Restricted cash	$ 449,979	$ 547,950
Allowance for restricted cash	(5,934)		$ 0
Brokerage customers’ cash
Cash and Cash Equivalents [Line Items]
Restricted cash	355,294	531,032
Deferred distribution payments
Cash and Cash Equivalents [Line Items]
Restricted cash	156	8,534
Guaranty deposits
Cash and Cash Equivalents [Line Items]
Restricted cash	100,463	5,540
Restricted bank accounts
Cash and Cash Equivalents [Line Items]
Restricted cash	$ 0	$ 2,844

RESTRICTED CASH - Narrative (De

RESTRICTED CASH - Narrative (Details) - USD ($) number in Thousands, $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Cash and Cash Equivalents [Line Items]
Restricted cash	$ 449,979	$ 547,950
Deferred distribution payments written-off	837,800%
Deferred distribution payments
Cash and Cash Equivalents [Line Items]
Restricted cash	$ 156	$ 8,534

TRADING AND AVAILABLE FOR SALE

TRADING AND AVAILABLE FOR SALE SECURITIES AT FAIR VALUE - Schedule of trading and available-for-sale securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	$ 1,929,840	$ 1,158,377
Fair value of equity securities	174,326	161,364
Corporate debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	1,097,488	712,134
Fair value of equity securities	157,548	145,837
Non-U.S. sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	734,068	360,570
Fair value of equity securities	12,905	12,997
Corporate equity
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	62,351	72,354
U.S. sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	34,012	10,435
Fair value of equity securities	3,873	2,530
Exchange traded notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	$ 1,921	$ 2,884

TRADING AND AVAILABLE FOR SAL_2

TRADING AND AVAILABLE FOR SALE SECURITIES AT FAIR VALUE - Schedule of maturity of trading and available-for-sale securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	$ 174,326	$ 161,364
Corporate debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	157,548	145,837
Non-US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	12,905	12,997
US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	3,873	2,530
Up to 1 year
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	46,229	71,056
Up to 1 year | Corporate debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	46,229	69,364
Up to 1 year | Non-US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	0	1,692
Up to 1 year | US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	0	0
1-5 years
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	70,438	51,019
1-5 years | Corporate debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	64,260	50,155
1-5 years | Non-US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	5,280	864
1-5 years | US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	898	0
5-10 years
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	49,620	27,370
5-10 years | Corporate debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	47,047	26,284
5-10 years | Non-US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	861	1,086
5-10 years | US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	1,712	0
More than 10 years
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	8,039	11,919
More than 10 years | Corporate debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	12	34
More than 10 years | Non-US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	6,764	9,355
More than 10 years | US sovereign debt
Debt Securities, Available-for-sale [Line Items]
Fair value of equity securities	$ 1,263	$ 2,530

TRADING AND AVAILABLE FOR SAL_3

TRADING AND AVAILABLE FOR SALE SECURITIES AT FAIR VALUE - Narrative (Details)	3 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2022 USD ($) issuer	Mar. 31, 2022 USD ($) issuer
Defined Benefit Plan Disclosure [Line Items]
Number of issuers | issuer		2	2
Other-than-temporary impairment in accumulated other comprehensive loss		$ 0	$ 0
Kazakhstan Sustainability Fund JSC
Defined Benefit Plan Disclosure [Line Items]
Percentage of trading securities	10%	10%
Debt securities		$ 727,340,000	506,472,000
Ministry of Finance of the Republic of Kazakhstan
Defined Benefit Plan Disclosure [Line Items]
Percentage of trading securities	10%	10%
Debt securities		$ 723,750,000	$ 357,343,000

TRADING AND AVAILABLE FOR SAL_4

TRADING AND AVAILABLE FOR SALE SECURITIES AT FAIR VALUE - Schedule of present securities assets at fair value (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	$ 1,929,840	$ 1,158,377
Fair value of equity securities	174,326	161,364
Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	1,929,840	1,158,377
Fair value of equity securities	174,326	161,364
Level 1 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	1,674,607	1,148,959
Fair value of equity securities	144,194	161,364
Level 2 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	254,606	276
Fair value of equity securities	30,132	0
Level 3 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	627	9,142
Fair value of equity securities	0	0
Corporate debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	1,097,488	712,134
Fair value of equity securities	$ 157,548	$ 145,837
Corporate debt | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities, weighted average interest rate	13.99%	9.09%
Trading securities	$ 1,097,488	$ 712,134
Total available-for-sale securities, weighted average interest rate	14.88%	11.09%
Fair value of equity securities	$ 157,548	$ 145,837
Corporate debt | Level 1 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	1,001,417	711,539
Fair value of equity securities	134,427	145,837
Corporate debt | Level 2 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	95,800	0
Fair value of equity securities	23,121	0
Corporate debt | Level 3 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	271	595
Fair value of equity securities	0	0
Non-U.S. sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	734,068	360,570
Fair value of equity securities	$ 12,905	$ 12,997
Non-U.S. sovereign debt | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities, weighted average interest rate	12.26%	13.15%
Trading securities	$ 734,068	$ 360,570
Total available-for-sale securities, weighted average interest rate	8.99%	5.51%
Fair value of equity securities	$ 12,905	$ 12,997
Non-U.S. sovereign debt | Level 1 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	577,828	352,274
Fair value of equity securities	5,894	12,997
Non-U.S. sovereign debt | Level 2 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	156,213	0
Fair value of equity securities	7,011	0
Non-U.S. sovereign debt | Level 3 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	27	8,296
Fair value of equity securities	0	0
Corporate equity
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	$ 62,351	$ 72,354
Corporate equity | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities, weighted average interest rate	0%	0%
Trading securities	$ 62,351	$ 72,354
Corporate equity | Level 1 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	60,127	71,827
Corporate equity | Level 2 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	1,895	276
Corporate equity | Level 3 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	329	251
US sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	34,012	10,435
Fair value of equity securities	$ 3,873	$ 2,530
US sovereign debt | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities, weighted average interest rate	4.30%	2.35%
Trading securities	$ 34,012	$ 10,435
Total available-for-sale securities, weighted average interest rate	4.20%	2.17%
Fair value of equity securities	$ 3,873	$ 2,530
US sovereign debt | Level 1 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	34,012	10,435
Fair value of equity securities	3,873	2,530
US sovereign debt | Level 2 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	0	0
Fair value of equity securities	0	0
US sovereign debt | Level 3 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	0	0
Fair value of equity securities	0	0
Exchange traded notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	$ 1,921	$ 2,884
Exchange traded notes | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities, weighted average interest rate	0%	0%
Trading securities	$ 1,921	$ 2,884
Exchange traded notes | Level 1 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	1,223	2,884
Exchange traded notes | Level 2 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	698	0
Exchange traded notes | Level 3 | Fair value, recurring
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Trading securities	$ 0	$ 0

TRADING AND AVAILABLE FOR SAL_5

TRADING AND AVAILABLE FOR SALE SECURITIES AT FAIR VALUE - Schedule of valuation techniques and significant level 3 inputs used in the valuation (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 30, 2022	Dec. 31, 2022	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value		$ 627	$ 9,142
Non-U.S. sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value		$ 27	$ 7,524
Fair value input		48.80%	69%
Estimated number of years	11 years	11 years
Corporate debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value		$ 271	$ 595
Fair value input		74%	45%
Estimated number of years	3 months	3 months
Corporate equity
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value		$ 329	$ 251
Fair value input		58.80%	20%
Estimated number of years	9 years	9 years
Non-US sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value			$ 772
Fair value input			13.90%
Estimated number of years	1 year

TRADING AND AVAILABLE FOR SAL_6

TRADING AND AVAILABLE FOR SALE SECURITIES AT FAIR VALUE - Schedule of reconciliation of the beginning and ending balance for investments that use Level 3 inputs (Details) - Trading securities - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Dec. 31, 2022	Mar. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Investments beginning	$ 9,142	$ 19,032
Purchase of investments that use Level 3 inputs	1,980	10,812
Reclassification to level 2	(1,842)
Reclassification of securities from Freedom UA to restricted accounts	(2,384)
Sale	(5,089)
Revaluation of investments that use Level 3 inputs	(622)	(3,014)
Translation difference	(558)
Reclassification to level 3		682
Reclassification to level 1		(18,370)
Investments ending	$ 627	$ 9,142

TRADING AND AVAILABLE FOR SAL_7

TRADING AND AVAILABLE FOR SALE SECURITIES AT FAIR VALUE - Schedule of amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Assets measured at amortized cost	$ 173,745	$ 162,808
Recognized impairment loss in Income Statement	(402)
Unrealized gain/(loss) accumulated in other comprehensive income/(loss)	605
Unrealized gain/(loss) accumulated in other comprehensive income/(loss)		(1,444)
Assets measured at fair value	174,326	161,364
Corporate debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Assets measured at amortized cost	154,689	146,112
Recognized impairment loss in Income Statement	(402)
Unrealized gain/(loss) accumulated in other comprehensive income/(loss)	2,883
Unrealized gain/(loss) accumulated in other comprehensive income/(loss)		(275)
Assets measured at fair value	157,548	145,837
Non-US sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Assets measured at amortized cost	14,482	13,784
Recognized impairment loss in Income Statement	0
Unrealized gain/(loss) accumulated in other comprehensive income/(loss)	(1,577)	(787)
Assets measured at fair value	12,905	12,997
U.S. sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Assets measured at amortized cost	4,574	2,912
Recognized impairment loss in Income Statement	0
Unrealized gain/(loss) accumulated in other comprehensive income/(loss)	(701)	(382)
Assets measured at fair value	$ 3,873	$ 2,530

BROKERAGE AND OTHER RECEIVABL_3

BROKERAGE AND OTHER RECEIVABLES, NET - Schedule of brokerage and other receivables (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	$ 403,568	$ 147,659
Allowance for receivables	(7,846)	(2,107)
Margin lending receivables
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	393,659	138,983
Receivable from sale of securities
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	858	884
Receivables from brokerage clients
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	6,624	4,386
Bonds coupon receivable
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	1,977	0
Bank commissions receivable
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	1,852	598
Long-term installments receivables
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	1,184	1,367
Receivable for underwriting and market-making services
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	526	296
Dividends accrued
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	0	45
Other receivables
Cash and Cash Equivalents [Line Items]
Brokerage and other receivables	$ 4,734	$ 3,207

BROKERAGE AND OTHER RECEIVABL_4

BROKERAGE AND OTHER RECEIVABLES, NET - Narrative (Details) - USD ($)	Dec. 31, 2022	Mar. 31, 2022
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Brokerage and other receivables due from related party	$ 161,139,000	$ 107,649,000
Due from related party customer (in percent)	40%	73%
Other receivables	$ (403,568,000)	$ (147,659,000)
Allowance for credit loss	7,846,000	2,107,000
Collateral received, fair value	$ 1,086,725	$ 4,432,621
FFIN Brokerage
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Margin lending receivables from related party as a percentage of related party margin lending receivables	97%	95%

LOANS ISSUED - Summary of loans

LOANS ISSUED - Summary of loans issued (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Financing Receivable, Past Due [Line Items]
Loans issued	$ 639,377	$ 92,446	[1]
Mortgage loans
Financing Receivable, Past Due [Line Items]
Loans issued	$ 493,993	$ 51,924
Average Interest Rate	8.70%	11.86%
Fair Value of Collateral	$ 496,452	$ 52,134
Uncollateralized Bank customer loans
Financing Receivable, Past Due [Line Items]
Loans issued	$ 91,149	$ 34,067
Average Interest Rate	16.53%	17.56%
Fair Value of Collateral	$ 0	$ 0
Collateralized Bank customer loans
Financing Receivable, Past Due [Line Items]
Loans issued	$ 12,852
Average Interest Rate	1.91%
Fair Value of Collateral	$ 12,796
Car loans
Financing Receivable, Past Due [Line Items]
Loans issued	$ 34,660
Average Interest Rate	27.25%
Fair Value of Collateral	$ 37,211
Subordinated loans
Financing Receivable, Past Due [Line Items]
Loans issued	$ 5,000	$ 1,256
Average Interest Rate	3%	7%
Fair Value of Collateral	$ 0	$ 0
Subordinated loan
Financing Receivable, Past Due [Line Items]
Loans issued		$ 5,033
Average Interest Rate		4.89%
Fair Value of Collateral		$ 0
Loans issued to policyholders
Financing Receivable, Past Due [Line Items]
Loans issued	$ 1,426	$ 43
Average Interest Rate	14.97%	12.02%
Fair Value of Collateral	$ 1,697	$ 284
Other
Financing Receivable, Past Due [Line Items]
Loans issued	$ 297	$ 123
Average Interest Rate	2.71%	2.50%
Fair Value of Collateral	$ 0	$ 0
[1]* Please see Note 3

LOANS ISSUED - Narrative (Detai

LOANS ISSUED - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Financing Receivable, Past Due [Line Items]
Debt, weighted average interest rate, period term			20 years
Other liabilities	$ 351,140		$ 351,140		$ 325,904
Loans issued	639,377		639,377		92,446	[1]
Payments to acquire loans			57,031	$ 22,192
Freedom Bank KZ
Financing Receivable, Past Due [Line Items]
Other liabilities	319,694		319,694		6,447
FFIN Credit
Financing Receivable, Past Due [Line Items]
Payments to acquire loans	50,594	$ 9,546	89,935	29,020
Proceeds from loans	12,977	$ 3,968	32,904	$ 6,828
Loans receivable	100,433		100,433
Loans receivable, allowance for credit loss	$ 7,511		$ 7,511
Bank customer loans loan | State mortgage program "7-20-25"
Financing Receivable, Past Due [Line Items]
Weighted average interest rate, over 20 year term	7%		7%
Weighted average interest rate, over 20 year term, transferred to program operator	3%		3%
Weighted average interest rate, over 20 year term, retained	4%		4%
Loans issued	$ 436,132		$ 436,132		21,310
Uncollateralized Bank customer loans
Financing Receivable, Past Due [Line Items]
Loans issued	91,149		91,149		$ 34,067
Maximum amount of loans purchased, allowed to be sold back	$ 58,359		$ 58,359
[1]* Please see Note 3

PROVISION FOR INCOME TAXES - Na

PROVISION FOR INCOME TAXES - Narrative (Details)	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Effective income tax rate	(16.10%)	(10.90%)
U.S.
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	21%		21%
Kazakhstan
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	20%		20%
Russia
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	20%		20%
Azerbaijan
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	20%		20%
Kyrgyzstan
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	10%		10%
Germany
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	31%		31%
Cyprus
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	12.50%		12.50%
Ukraine
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	18%		18%
United Kingdom
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	25%		25%
Armenia
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	18%		18%
Uzbekistan
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Income tax rates used for deferred tax assets and liabilities	15%		15%

SECURITIES REPURCHASE AGREEME_3

SECURITIES REPURCHASE AGREEMENT OBLIGATIONS - Schedule of trading securities including collateralized securities subject to repurchase agreements (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 30, 2022	Dec. 31, 2022	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Up to 30 days		$ 1,177,256	$ 840,082
30-90 days		56,672	142
Total contractual maturity		$ 1,233,928	840,224
Corporate debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average interest rate	11.96%	16.44%
Up to 30 days		$ 586,939	609,405
30-90 days		4,774	142
Total contractual maturity		$ 591,713	609,547
Non-US sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average interest rate	10.85%	16.26%
Up to 30 days		$ 572,731	222,893
30-90 days		51,898	0
Total contractual maturity		$ 624,629	222,893
U.S. sovereign debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average interest rate	0.77%	1.91%
Up to 30 days		$ 17,586	7,396
30-90 days		0	0
Total contractual maturity		$ 17,586	7,396
Corporate equity
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average interest rate	14%
Up to 30 days			388
30-90 days			0
Total contractual maturity			$ 388

SECURITIES REPURCHASE AGREEME_4

SECURITIES REPURCHASE AGREEMENT OBLIGATIONS - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Securities Sold under Agreements to Repurchase [Abstract]
Fair value of collateral pledged under repurchase agreements	$ 1,248,410	$ 834,583

CUSTOMER LIABILITIES - Schedule

CUSTOMER LIABILITIES - Schedule of customer liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Revenue, Major Customer [Line Items]
Customer liabilities	$ 1,786,452	$ 765,628	[1]
Brokerage customers
Revenue, Major Customer [Line Items]
Customer liabilities	759,847	519,344
Banking customers
Revenue, Major Customer [Line Items]
Customer liabilities	$ 1,026,605	$ 246,284
[1]* Please see Note 3

CUSTOMER LIABILITIES - Narrativ

CUSTOMER LIABILITIES - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Revenue, Major Customer [Line Items]
Banking customer liabilities, current accounts	$ 697,736	$ 155,494
Banking customer liabilities, deposits	328,869	90,790
Freedom Bank KZ
Revenue, Major Customer [Line Items]
Insured bank deposits, price per client	43
Insured bank deposits	$ 185,159	$ 42,697

MARGIN LENDING AND TRADE PAYA_3

MARGIN LENDING AND TRADE PAYABLES - Schedule of Trade Payables (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Regulatory Liabilities [Line Items]
Trade payables	$ 142,341	$ 45,083
Margin lending payables
Regulatory Liabilities [Line Items]
Trade payables	139,214	39,250
Payables to suppliers of goods and services
Regulatory Liabilities [Line Items]
Trade payables	1,375	4,462
Trade payable for securities purchased
Regulatory Liabilities [Line Items]
Trade payables	476	462
Other
Regulatory Liabilities [Line Items]
Trade payables	$ 1,276	$ 909

MARGIN LENDING AND TRADE PAYA_4

MARGIN LENDING AND TRADE PAYABLES - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Related Party Transaction [Line Items]
Trade payables	$ 697,736	$ 155,494
Related Party
Related Party Transaction [Line Items]
Trade payables	$ 4,507	$ 38,889
Trade payables due (in percent)	3%	86%

SECURITIES SOLD, NOT YET PURC_3

SECURITIES SOLD, NOT YET PURCHASED - AT FAIR VALUE - Schedule of Securities (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Dec. 31, 2022		Mar. 31, 2022
Securities Sold, Not Yet Purchased Activity [Roll Forward]
Securities sold, not yet purchased at fair value, beginning balance	$ 13,865	[1]	$ 8,569
Short sales	410		7,055
Repurchase	(15,627)		(346)
Net gain on trading securities	1,352		(1,413)
Securities sold, not yet purchased at fair value, ending balance	$ 0		$ 13,865	[1]
[1]* Please see Note 3

DEBT SECURITIES ISSUED - Summar

DEBT SECURITIES ISSUED - Summary (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Debt Instrument [Line Items]
Debt securities issued	$ 37,192	$ 34,390	[1]
Freedom SPC
Debt Instrument [Line Items]
Debt securities issued	36,799	13,203
Freedom Holding Corp. [Member]
Debt Instrument [Line Items]
Debt securities issued	0	20,499
Accrued interest
Debt Instrument [Line Items]
Debt securities issued	$ 393	$ 688
[1]* Please see Note 3

DEBT SECURITIES ISSUED - Narrat

DEBT SECURITIES ISSUED - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
FRHC notes
Debt Instrument [Line Items]
Interest rate	7%
SPC Notes
Debt Instrument [Line Items]
Debt instrument face amount	$ 36,799
FRHC Loan
Debt Instrument [Line Items]
Interest rate	5.50%
Minimum
Debt Instrument [Line Items]
Interest rate	5.50%	5.50%
Maximum
Debt Instrument [Line Items]
Interest rate	7%

INSURANCE CONTRACTS ASSETS AN_3

INSURANCE CONTRACTS ASSETS AND LIABILITIES FROM INSURANCE ACTIVITIES - Schedule of Insurance Receivables (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Effects of Reinsurance [Line Items]
Less provision for impairment losses	$ (995)	$ (343)
Insurance and reinsurance receivables:	5,569	3,949
Unearned premium reserve, reinsurers’ share	3,763	143
Reserves for claims and claims’ adjustment expenses, reinsurers’ share	1,911	1,620
Total	11,243	5,712	[1]
Amounts due from policyholders
Effects of Reinsurance [Line Items]
Insurance and reinsurance receivable, gross	5,615	3,500
Claims receivable from reinsurance
Effects of Reinsurance [Line Items]
Insurance and reinsurance receivable, gross	897	769
Amounts due from reinsured
Effects of Reinsurance [Line Items]
Insurance and reinsurance receivable, gross	$ 52	$ 23
[1]* Please see Note 3

INSURANCE CONTRACTS ASSETS AN_4

INSURANCE CONTRACTS ASSETS AND LIABILITIES FROM INSURANCE ACTIVITIES -Schedule of Insurance Payables (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Insurance and Reinsurance Payable [Line Items]
Insurance and reinsurance payables:	$ 6,791	$ 3,068
Unearned premium reserve	31,103	17,985
Reserves for claims and claims’ adjustment expenses	118,648	98,437
Liabilities from insurance activity	156,542	119,490	[1]
Amounts payable to insured
Insurance and Reinsurance Payable [Line Items]
Insurance and reinsurance payables:	2,305	685
Amounts payable to reinsurers
Insurance and Reinsurance Payable [Line Items]
Insurance and reinsurance payables:	2,405	402
Amounts payable to agents and brokers
Insurance and Reinsurance Payable [Line Items]
Insurance and reinsurance payables:	$ 2,081	$ 1,981
[1]* Please see Note 3

NET GAIN ON TRADING SECURITIE_2

NET GAIN ON TRADING SECURITIES - Summary of net gain on trading securities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Net unrealized gain recognized during the reporting period on trading securities still held at the reporting date	$ 73,257	$ (33,567)	$ 65,684	$ 7,903
Net (loss)/gain recognized during the period on trading securities sold during the period	(47,801)	41,230	(26,790)	190,044
Net gain recognized during the period on trading securities	$ 25,456	$ 7,663	$ 38,894	$ 197,947

NET GAIN ON TRADING SECURITIE_3

NET GAIN ON TRADING SECURITIES - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Number of equity securities exchanged (in shares)	5,350,000	1,000,000
Realized gain on the sale of equity securities	$ 51,240	$ 39,658
Unrealized gain on the sale of equity securities	$ 52,072	$ 36,079

FEE AND COMMISSION INCOME_EXPEN

FEE AND COMMISSION INCOME/EXPENSE-Schedule of commission income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Brokerage services	$ 68,532	$ 86,700	$ 227,476	$ 249,249
Bank services	5,507	2,295	15,100	4,027
Underwriting and market-making services	4,778	1,828	8,008	5,832
Other fee and commission income	2,066	585	2,902	3,441
Total fee and commission income	80,883	91,408	253,486	262,549
Central Asia
Disaggregation of Revenue [Line Items]
Brokerage services	19,490	2,474	31,814	5,706
Bank services	5,507	2,295	15,100	4,027
Underwriting and market-making services	4,778	1,828	8,008	5,832
Other fee and commission income	1,473	393	1,793	2,527
Total fee and commission income	31,248	6,990	56,715	18,092
Europe
Disaggregation of Revenue [Line Items]
Brokerage services	47,893	82,970	192,330	240,152
Bank services	0	0	0	0
Underwriting and market-making services	0	0	0	0
Other fee and commission income	593	192	1,109	914
Total fee and commission income	48,486	83,162	193,439	241,066
U.S.
Disaggregation of Revenue [Line Items]
Brokerage services	1,149	1,256	3,332	3,391
Bank services	0	0	0	0
Underwriting and market-making services	0	0	0	0
Other fee and commission income	0	0	0	0
Total fee and commission income	1,149	1,256	3,332	3,391
Middle East/Caucasus
Disaggregation of Revenue [Line Items]
Brokerage services	0	0	0	0
Bank services	0	0	0	0
Underwriting and market-making services	0	0	0	0
Other fee and commission income	0	0	0	0
Total fee and commission income	$ 0	$ 0	$ 0	$ 0

NET INTEREST INCOME_EXPENSE (De

NET INTEREST INCOME/EXPENSE (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Interest income:
Interest income on securities repurchased under reverse repurchase agreements and amounts due from banks	$ 4,062	$ 280	$ 6,198	$ 887
Interest income on trading securities	44,760	20,745	116,922	54,966
Interest income on available-for-sale securities	6,727	6,470	13,280	16,244
Interest income on margin lending (2)	12,379	4,921	27,259	8,212
Interest income on loans issued	12,327	1,241	24,158	2,205
Total interest income	80,255	33,657	187,817	82,514
Interest expense:
Interest expense on securities repurchase agreement obligations	39,958	15,671	105,466	38,548
Interest expense on customer liabilities	11,149	5,732	24,780	12,645
Interest expense on loans received			268	291
Interest expense on debt securities issued	842	394	2,457	1,323
Other interest expense	88	93	0	45
Total interest expense	52,037	21,890	132,971	52,852
Net interest income	$ 28,218	$ 11,767	$ 54,846	$ 29,662

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Jul. 31, 2021 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) issuer	Dec. 31, 2021 USD ($)	Mar. 31, 2022 USD ($)
Fair Value, Separate Account Investment [Line Items]
Commission income		$ 44,590	$ 80,024	$ 181,396	$ 230,026
Fee and commission income from related party as a percentage of related party commission income			94%
Commission expenses		2,304	$ 3,823	2,657	14,350
Restricted stock based compensation expense		345	385	1,028	950
Margin lending receivables		161,139		161,139		$ 107,649
Accounts payable due to a related party		271		$ 271		313
Number of businesses acquired | issuer				2
Payments to acquire subsidiaries				$ 13,630
Customer liabilities		351,140		351,140		325,904
Cash and cash equivalents		664,095	165,633	664,095	165,633	225,464
Ownership interest sold during the period	23.88%
FFIN Credit
Fair Value, Separate Account Investment [Line Items]
Proceeds from loans		12,977	3,968	32,904	$ 6,828
Brokerage accounts
Fair Value, Separate Account Investment [Line Items]
Restricted customer cash		$ 127,211		$ 127,211		$ 222,651
FFIN Brokerage
Fair Value, Separate Account Investment [Line Items]
Fee and commission income from related party as a percentage of related party commission income				98%
Margin lending receivables from related party as a percentage of related party margin lending receivables		97%		97%		95%
Other liabilities from related party as a percentage of related party other liabilities		73%		73%		54%
Restricted customer cash from related party as a percentage of related party Restricted customer cash		19%		19%		78%
FFIN Brokerage | Brokerage accounts
Fair Value, Separate Account Investment [Line Items]
Fee and commission income from related party as a percentage of related party commission income				93%	96%
FFIN Brokerage | FFIN Brokerage
Fair Value, Separate Account Investment [Line Items]
Interest income, related party		$ 10,796	3,807	$ 21,659	$ 4,221
Interest income, related party rate		100%		100%
FFIN Brokerage | Sale of SPBX ETF
Fair Value, Separate Account Investment [Line Items]
Loss on Sale of Investments		$ 832	$ 1,912
Affiliated Entity | Brokerage accounts
Fair Value, Separate Account Investment [Line Items]
Due from related parties		947		$ 947		$ 190
Freedom Life and Freedom Insurance
Fair Value, Separate Account Investment [Line Items]
Due to related parties		$ 12,958		$ 12,958		21,477
Wisdompoint Capital LTD | Brokerage accounts
Fair Value, Separate Account Investment [Line Items]
Related party cash holdings		100%		100%
Cash and cash equivalents		$ 15,971		$ 15,971		22,787
Wisdompoint Capital LTD | Margin Lending Payables
Fair Value, Separate Account Investment [Line Items]
Lending payables		$ 4,507		$ 4,507		$ 38,889
Related party cash holdings		100%		100%
Askar Tashitov | Freedom UA | Discontinued Operations, Disposed of by Sale
Fair Value, Separate Account Investment [Line Items]
Proceeds from Divestiture of Businesses	$ 415

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details)					1 Months Ended	3 Months Ended		9 Months Ended
	Oct. 11, 2022 shares	Oct. 06, 2022 shares	Mar. 30, 2022 individual shares	May 18, 2021 individual issuer shares	May 31, 2022 USD ($) company	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants (in shares)	18,284	20,000	7,500	1,031,500
Number of individuals			1	56
Number of companies acquired | company					2
Business acquisition consideration expected amount | $					$ 26,588,000
Payments to acquire subsidiaries | $								$ 13,630,000
Capital contributions | $						$ 0		677,000	$ 1,966,000
Stock-based compensation expense | $						$ 3,945,000	$ 4,561,000	$ 10,746,000	$ 11,283,000
Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of individuals | individual				2
Key Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants (in shares)	8,000
Share-based payment arrangement, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants (in shares)		4,000	3,000	200,942
Vesting period (in years)				1 year
Share-based payment arrangement, tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants (in shares)		4,000	1,500	211,658
Vesting period (in years)				2 years
Share-based payment arrangement, tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants (in shares)		4,000	1,500	206,300
Vesting period (in years)				4 years
Share-based payment arrangement, tranche three | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)				3 years
Share-based payment arrangement, tranche three | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)				5 years
Share based compensation award tranche four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants (in shares)		4,000	1,500
Share based compensation award tranche five
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock grants (in shares)		4,000
Freedom Life
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of voting interests acquired					100%
Freedom Insurance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of voting interests acquired					100%

STOCK BASED COMPENSATION - Narr

STOCK BASED COMPENSATION - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted (in shares)			46,284
Compensation expense	$ 3,945	$ 4,561
Unrecognized compensation cost	$ 14,379		$ 14,379	$ 28,899
Weighted average period			3 years 3 months 29 days
Key Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares)			26,284
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)			5 years
Restricted Stock | Key Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted (in shares)			20,000

STOCK BASED COMPENSATION - Sche

STOCK BASED COMPENSATION - Schedule of fair value of restricted shares awarded using the Monte Carlo valuation model (Details) - Monte Carlo	9 Months Ended
	Dec. 31, 2022
Class of Warrant or Right [Line Items]
Term (years)	3 years 7 months 13 days
Volatility	35.20%
Risk-free rate	4.18%

STOCK BASED COMPENSATION - Sc_2

STOCK BASED COMPENSATION - Schedule of the activity of the company's restricted stock outstanding (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Mar. 31, 2022
Shares
Restricted stock outstanding, beginning balance (in shares)	1,049,500
Granted (in shares)	46,284
Vested (in shares)	(255,226)
Forfeited/cancelled/expired (in shares)	(68,000)
Restricted stock outstanding, ending balance (in shares)	772,558
Weighted Average Fair Value
Weighted average fair value, beginning balance		$ 40,303
Weighted average exercise price granted	$ 2,175
Weighted average exercise price vested	(10,153)
Weighted average exercise price forfeited/cancelled/expired	(2,602)
Weighted average fair value, ending balance	$ 29,723

LEASES - Schedule of lease obli

LEASES - Schedule of lease obligations (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Operating Leases, Future Minimum Payments Receivable [Abstract]
2023	$ 2,248
2024	6,154
2024	5,965
2025	5,705
2026	4,743
Thereafter	6,733
Total payments	31,548
Less: amounts representing interest	7,373
Lease liability, net	$ 24,175
Weighted average remaining lease term (in months)	23 months
Weighted average discount rate	12%

LEASES - Narrative (Details)

LEASES - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Short term operating lease	$ 258
Rent expense for office space	$ 1,414	$ 286	$ 2,530	$ 777

ACQUISITIONS OF SUBSIDIARIES -

ACQUISITIONS OF SUBSIDIARIES - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 01, 2022
London Almaty
Asset Acquisition [Line Items]
Business acquisition, percentage of outstanding shares		100%
Business combination, recognized identifiable assets acquired and liabilities assumed, net		$ 15,858
Ticketon
Asset Acquisition [Line Items]
Business acquisition, percentage of outstanding shares	100%
Business combination, recognized identifiable assets acquired and liabilities assumed, net	$ (172)

ACQUISITIONS OF SUBSIDIARIES _2

ACQUISITIONS OF SUBSIDIARIES - Schedule of Net Assets Acquired (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 01, 2022	Dec. 31, 2022	Mar. 31, 2022	[1]
ASSETS
Goodwill			$ 9,460	$ 5,898
London Almaty
ASSETS
Cash and cash equivalents		$ 8,077
Due from banks		2,176
Trading securities		6,178
Value of business acquired		1,677
Assets from insurance activities		3,401
Fixed assets		806
Intangible assets		127
Other assets		1,505
TOTAL ASSETS		23,947
Insurance reserves		6,380
Liabilities from insurance activity		1,429
Other liabilities		280
TOTAL LIABILITIES		8,089
Net assets acquired		15,858
Goodwill		485
Total purchase price		$ 16,343
Ticketon
ASSETS
Cash and cash equivalents	$ 3,029
Brokerage and other receivables	169
Fixed assets	20
Intangible assets	33
Right-of-use asset	63
Other assets	606
TOTAL ASSETS	3,920
Other liabilities	3,995
Deferred income tax liabilities	34
Lease liability	63
TOTAL LIABILITIES	4,092
Net assets acquired	(172)
Goodwill	3,172
Total purchase price	$ 3,000
[1]* Please see Note 3

ASSETS AND LIABILITIES HELD F_3

ASSETS AND LIABILITIES HELD FOR SALE - Narrative (Details) $ in Thousands, ₽ in Millions			9 Months Ended
	Oct. 17, 2022 RUB (₽)	Oct. 17, 2022 USD ($)	Dec. 31, 2022 USD ($) subsidiary	Jan. 31, 2023 RUB (₽)	Jan. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Subsidiaries for sale | subsidiary			3
Freedom Finance JSC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Subsidiary ownership interest	90.43%	90.43%
Freedom KZ
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Subsidiary ownership interest	100%	100%
Recast discontinued operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Valuation allowance			$ 43,973			$ 0
Freedom RU
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operation, equity method investment retained after disposal, ownership interest prior to disposal	100%	100%
Discontinued operations, outstanding deferred payment	₽ 6,600	$ 91,000
Cash payment		$ 140,000
Freedom Finance Auto LLC | Subsequent event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Expected consideration				₽ 50	$ 695

ASSETS AND LIABILITIES HELD F_4

ASSETS AND LIABILITIES HELD FOR SALE - Balance sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	$ 664,095	$ 225,464	[1]
Restricted cash	449,979	547,950	[1]
Trading securities	1,929,840	1,158,377	[1]
Margin lending, brokerage and other receivables, net	403,568	147,659	[1]
Loans issued	639,377	92,446	[1]
Other assets	47,754	27,044	[1]
TOTAL ASSETS	5,368,134	3,227,750	[1]
Customer liabilities	1,786,452	765,628	[1]
Securities repurchase agreement obligations	1,233,928	840,224	[1]
Debt securities issued	37,192	34,390	[1]
Other liabilities	37,940	21,477	[1]
TOTAL LIABILITIES	4,685,803	2,681,142	[1]
Recast discontinued operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	582,314	428,480
Restricted cash	18,052	28,406
Trading securities	112,801	122,497
Margin lending, brokerage and other receivables, net	240,414	210,087
Loans issued	17,201	2,395
Other assets	34,757	33,554
Less: valuation allowance	(43,973)	0
TOTAL ASSETS	961,566	825,419
Customer liabilities	820,394	701,584
Securities repurchase agreement obligations	30,971	32,469
Debt securities issued	63,207	64,637
Other liabilities	16,912	13,788
TOTAL LIABILITIES	$ 931,484	$ 812,478
[1]* Please see Note 3

ASSETS AND LIABILITIES HELD F_5

ASSETS AND LIABILITIES HELD FOR SALE - Results of operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Fee and commission income	$ 80,883	$ 91,408	$ 253,486	$ 262,549
Net gain/(loss) on trading securities	25,456	7,663	38,894	197,947
Interest income	80,255	33,657	187,817	82,514
Net gain/(loss) on foreign exchange operations	20,866	1,361	30,014	4,076
Total revenue, net	214,548	155,169	566,686	597,549
Fee and commission expense	18,314	24,782	60,068	68,626
Interest expense	52,037	21,890	132,971	52,852
Operating expense	50,608	31,581	126,367	72,772
Provision for impairment losses/(recovery)	24,140	(333)	30,294	911
Provision for impairment of discontinued operations		0	(43,973)	0
Other expense	570	979	79	2,426
TOTAL EXPENSE	163,088	95,185	401,365	238,683
INCOME BEFORE INCOME TAX	51,460	59,984	165,321	358,866
Recast discontinued operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Fee and commission income	14,230	23,147	62,290	59,596
Net gain/(loss) on trading securities	799	(6,611)	13,898	(9,716)
Net loss on derivative	(43)	0	(43)	0
Interest income	17,599	5,786	47,460	15,574
Net gain/(loss) on foreign exchange operations	19,965	(655)	40,379	(2,889)
Total revenue, net	52,550	21,667	163,984	62,565
Fee and commission expense	2,750	2,075	7,000	6,300
Interest expense	3,124	2,365	13,143	6,824
Operating expense	29,839	22,253	83,379	53,841
Provision for impairment losses/(recovery)	1,594	13	2,176	89
Provision for impairment of discontinued operations	(2,509)	0	43,973	0
Other expense	(933)	28	(154)	120
TOTAL EXPENSE	38,883	26,734	149,517	67,174
INCOME BEFORE INCOME TAX	$ 13,667	$ (5,067)	$ 14,467	$ (4,609)

ASSETS AND LIABILITIES HELD F_6

ASSETS AND LIABILITIES HELD FOR SALE - Cash flow statement (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Cash Flows From Operating Activities
Net income/(loss) from discontinued operations	$ 16,009	$ (4,105)	$ 9,929	$ (3,656)
Depreciation and amortization			3,502	2,854
Noncash lease expense			3,453	2,587
Change in deferred taxes			(3,392)	(2,508)
Stock compensation expense			6,520	5,636
Net unrealized gain/(loss) recognized during the reporting period on trading securities still held at the reporting date	$ (73,257)	$ 33,567	(65,684)	(7,903)
Net change in accrued interest			(35,984)	(27,858)
Change in insurance reserves			42,236	35,381
Allowances for receivables			30,294	907
Trading securities			(630,879)	(364,995)
Margin lending, brokerage and other receivables			(270,725)	(141,678)
Other assets			(11,058)	(12,028)
Securities sold, not yet purchased – at fair value			(13,865)	5,979
Customer liabilities			240,362	(230,143)
Current income tax liability			(14,556)	6,404
Margin lending and trade payables			92,225	28,720
Lease liabilities			(3,470)	(2,839)
Other liabilities			10,432	735
Net cash flows from/(used in) operating activities from discontinued operations			32,165	(222,901)
Cash Flows Used In Investing Activities
Purchase of fixed assets			(27,345)	(4,078)
Proceeds from sale of fixed assets			0	172
Net change in loans issued to customers			(507,728)	(11,946)
Cash Provided by (Used in) Investing Activities, Discontinued Operations			(21,647)	(2,790)
Recast discontinued operations
Cash Flows From Operating Activities
Net income/(loss) from discontinued operations			9,929	(3,656)
Depreciation and amortization			1,794	1,637
Noncash lease expense			4,947	3,785
Change in deferred taxes			4,121	(1,892)
Stock compensation expense			4,226	5,647
Net unrealized gain/(loss) recognized during the reporting period on trading securities still held at the reporting date			(47,926)	9,082
Net change in accrued interest			810	1,436
Change in insurance reserves			43,973	0
Allowances for receivables			2,053	89
Trading securities			61,479	(262,438)
Margin lending, brokerage and other receivables			(4,755)	(93,717)
Other assets			1,557	(1,948)
Securities sold, not yet purchased – at fair value			257	(24)
Customer liabilities			(47,602)	121,173
Current income tax liability			1	(623)
Margin lending and trade payables			(16)	319
Lease liabilities			(5,509)	(3,947)
Other liabilities			2,826	2,176
Net cash flows from/(used in) operating activities from discontinued operations			32,165	(222,901)
Cash Flows Used In Investing Activities
Purchase of fixed assets			(3,998)	(2,918)
Proceeds from sale of fixed assets			0	699
Net change in loans issued to customers			(17,649)	(571)
Cash Provided by (Used in) Investing Activities, Discontinued Operations			$ (21,647)	$ (2,790)

ASSETS AND LIABILITIES HELD F_7

ASSETS AND LIABILITIES HELD FOR SALE - Provision for impairment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	$ 664,095		$ 664,095		$ 225,464	[1]
Restricted cash	449,979		449,979		547,950	[1]
Trading securities	1,929,840		1,929,840		1,158,377	[1]
Margin lending, brokerage and other receivables, net	403,568		403,568		147,659	[1]
Loans issued	639,377		639,377		92,446	[1]
Other assets	47,754		47,754		27,044	[1]
TOTAL ASSETS	5,368,134		5,368,134		3,227,750	[1]
Customer liabilities	1,786,452		1,786,452		765,628	[1]
Securities repurchase agreement obligations	1,233,928		1,233,928		840,224	[1]
Debt securities issued	37,192		37,192		34,390	[1]
Other liabilities	37,940		37,940		21,477	[1]
TOTAL LIABILITIES	4,685,803		4,685,803		2,681,142	[1]
Unrealized loss from translation adjustment			18,650
Adjusted net assets held for sale			183,973
Expected selling price	140,000		140,000
Provision for impairment of discontinued operations		$ 0	43,973	$ 0
Pre-elimination balance
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net assets held for sale	165,323		165,323
Post-elimination balance
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net assets held for sale	74,054		74,054
Recast discontinued operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	582,314		582,314		428,480
Restricted cash	18,052		18,052		28,406
Trading securities	112,801		112,801		122,497
Margin lending, brokerage and other receivables, net	240,414		240,414		210,087
Loans issued	17,201		17,201		2,395
Other assets	34,757		34,757		33,554
TOTAL ASSETS	961,566		961,566		825,419
Customer liabilities	820,394		820,394		701,584
Securities repurchase agreement obligations	30,971		30,971		32,469
Debt securities issued	63,207		63,207		64,637
Other liabilities	16,912		16,912		13,788
TOTAL LIABILITIES	931,484		931,484		$ 812,478
Provision for impairment of discontinued operations	2,509	$ 0	(43,973)	$ 0
Recast discontinued operations | Pre-elimination balance
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	582,314		582,314
Restricted cash	18,052		18,052
Trading securities	112,801		112,801
Margin lending, brokerage and other receivables, net	331,682		331,682
Loans issued	17,201		17,201
Other assets	34,758		34,758
TOTAL ASSETS	1,096,808		1,096,808
Customer liabilities	820,394		820,394
Securities repurchase agreement obligations	30,971		30,971
Debt securities issued	63,207		63,207
Other liabilities	16,913		16,913
TOTAL LIABILITIES	931,485		931,485
Recast discontinued operations | Eliminations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	0		0
Restricted cash	0		0
Trading securities	0		0
Margin lending, brokerage and other receivables, net	(91,269)		(91,269)
Loans issued	0		0
Other assets	0		0
TOTAL ASSETS	(91,269)		(91,269)
Customer liabilities	0		0
Securities repurchase agreement obligations	0		0
Debt securities issued	0		0
Other liabilities	0		0
TOTAL LIABILITIES	0		0
Recast discontinued operations | Post-elimination balance
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	582,314		582,314
Restricted cash	18,052		18,052
Trading securities	112,801		112,801
Margin lending, brokerage and other receivables, net	240,413		240,413
Loans issued	17,201		17,201
Other assets	34,758		34,758
TOTAL ASSETS	1,005,539		1,005,539
Customer liabilities	820,394		820,394
Securities repurchase agreement obligations	30,971		30,971
Debt securities issued	63,207		63,207
Other liabilities	16,913		16,913
TOTAL LIABILITIES	$ 931,485		$ 931,485
[1]* Please see Note 3

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Unfunded commitments under lines of credits and guarantees	$ 18,838	$ 11,292
Bank guarantees	4,874	6,384
Total	$ 23,712	$ 17,676

SEGMENT REPORTING - Narrative (

SEGMENT REPORTING - Narrative (Details)	3 Months Ended	9 Months Ended
	Mar. 31, 2022 segment	Dec. 31, 2022 segment office
Segment Reporting Information [Line Items]
Number of segments | segment	5	1
Middle East/Caucasus
Segment Reporting Information [Line Items]
Number of offices | office		4

SEGMENT REPORTING - Results by

SEGMENT REPORTING - Results by segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Fee and commission income	$ 80,883	$ 91,408	$ 253,486	$ 262,549
Net gain/(loss) on trading securities	25,456	7,663	38,894	197,947
Interest income	80,255	33,657	187,817	82,514
Insurance underwriting income	28,557	21,394	78,998	51,491
Net gain/(loss) on foreign exchange operations	20,866	1,361	30,014	4,076
Net loss on derivative	(21,469)	(314)	(22,523)	(1,028)
Total revenue, net	214,548	155,169	566,686	597,549
Fee and commission expense	18,314	24,782	60,068	68,626
Interest expense	52,037	21,890	132,971	52,852
Insurance claims incurred, net of reinsurance	17,419	16,286	51,586	41,096
Operating expense	50,608	31,581	126,367	72,772
Provision for impairment losses	24,140	(333)	30,294	911
Other expense	570	979	79	2,426
TOTAL EXPENSE	163,088	95,185	401,365	238,683
INCOME BEFORE INCOME TAX	51,460	59,984	165,321	358,866
Income tax expense	(5,069)	(1,806)	(26,567)	(39,026)
INCOME FROM CONTINUING OPERATIONS	46,391	58,178	138,754	319,840
Total stock based compensation	2,939	2,271	6,520	5,636
Central Asia
Segment Reporting Information [Line Items]
Fee and commission income	31,248	6,990	56,715	18,092
Net gain/(loss) on trading securities	28,080	7,081	65,497	18,779
Interest income	66,324	28,703	154,300	74,425
Insurance underwriting income	28,557	21,394	78,998	51,491
Net gain/(loss) on foreign exchange operations	20,402	2,002	32,270	4,775
Net loss on derivative	(21,469)	(314)	(22,523)	(1,028)
Total revenue, net	153,142	65,856	365,257	166,534
Fee and commission expense	10,110	6,523	32,638	11,177
Interest expense	43,880	17,553	110,410	44,311
Insurance claims incurred, net of reinsurance	17,418	16,286	51,585	41,096
Operating expense	28,494	15,247	70,975	38,327
Provision for impairment losses	12,767	(365)	18,930	868
Other expense	647	990	116	2,449
TOTAL EXPENSE	113,316	56,234	284,654	138,228
INCOME BEFORE INCOME TAX	39,826	9,622	80,603	28,306
Income tax expense	(95)	1,256	(691)	1,278
INCOME FROM CONTINUING OPERATIONS	39,731	10,878	79,912	29,584
Total stock based compensation	2,077	1,384	4,215	3,414
Europe
Segment Reporting Information [Line Items]
Fee and commission income	48,486	83,162	193,439	241,066
Net gain/(loss) on trading securities	819	481	(21,815)	179,473
Interest income	11,417	4,940	24,014	8,015
Insurance underwriting income	0	0	0	0
Net gain/(loss) on foreign exchange operations	313	(437)	(1,517)	(497)
Net loss on derivative	0	0	0	0
Total revenue, net	61,035	88,146	194,121	428,057
Fee and commission expense	7,933	18,106	26,834	56,946
Interest expense	4,590	3,919	10,250	7,422
Insurance claims incurred, net of reinsurance	1	0	1	0
Operating expense	12,824	10,517	34,923	20,089
Provision for impairment losses	11,363	0	11,362	11
Other expense	(74)	(13)	31	(21)
TOTAL EXPENSE	36,637	32,529	83,401	84,447
INCOME BEFORE INCOME TAX	24,398	55,617	110,720	343,610
Income tax expense	(4,557)	(7,176)	(18,403)	(21,190)
INCOME FROM CONTINUING OPERATIONS	19,841	48,441	92,317	322,420
Total stock based compensation	145	196	436	485
U.S.
Segment Reporting Information [Line Items]
Fee and commission income	1,149	1,256	3,332	3,391
Net gain/(loss) on trading securities	(3,443)	101	(4,788)	(305)
Interest income	2,500	14	9,489	74
Insurance underwriting income	0	0	0	0
Net gain/(loss) on foreign exchange operations	152	(209)	(747)	(207)
Net loss on derivative	0	0	0	0
Total revenue, net	358	1,162	7,286	2,953
Fee and commission expense	255	153	551	503
Interest expense	3,567	418	12,311	1,119
Insurance claims incurred, net of reinsurance	0	0	0	0
Operating expense	8,655	5,903	19,015	14,275
Provision for impairment losses	10	32	2	32
Other expense	0		(8)	0
TOTAL EXPENSE	12,487	6,506	31,871	15,929
INCOME BEFORE INCOME TAX	(12,129)	(5,344)	(24,585)	(12,976)
Income tax expense	(398)	4,114	(7,475)	(19,114)
INCOME FROM CONTINUING OPERATIONS	(12,527)	(1,230)	(32,060)	(32,090)
Total stock based compensation	717	691	1,869	1,737
Middle East/Caucasus
Segment Reporting Information [Line Items]
Fee and commission income	0	0	0	0
Net gain/(loss) on trading securities	0	0	0	0
Interest income	14	0	14	0
Insurance underwriting income	0	0	0	0
Net gain/(loss) on foreign exchange operations	(1)	5	8	5
Net loss on derivative	0	0	0	0
Total revenue, net	13	5	22	5
Fee and commission expense	16	0	45	0
Interest expense	0	0	0	0
Insurance claims incurred, net of reinsurance	0	0	0	0
Operating expense	635	(86)	1,454	81
Provision for impairment losses	0	0	0	0
Other expense	(3)	2	(60)	(2)
TOTAL EXPENSE	648	(84)	1,439	79
INCOME BEFORE INCOME TAX	(635)	89	(1,417)	(74)
Income tax expense	(19)	0	2	0
INCOME FROM CONTINUING OPERATIONS	$ (654)	$ 89	$ (1,415)	$ (74)

SEGMENT REPORTING - Net assets

SEGMENT REPORTING - Net assets by segment (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total assets	$ 5,368,134	$ 3,227,750	[1]
Total liabilities	4,685,803	2,681,142	[1]
Net assets	682,331	546,608
Central Asia
Segment Reporting Information [Line Items]
Total assets	3,770,032	1,423,529
Total liabilities	3,071,804	1,203,473
Net assets	698,228	220,056
Europe
Segment Reporting Information [Line Items]
Total assets	519,760	805,768
Total liabilities	607,536	489,883
Net assets	(87,776)	315,885
U.S.
Segment Reporting Information [Line Items]
Total assets	114,609	172,679
Total liabilities	74,618	175,136
Net assets	39,991	(2,457)
Russia
Segment Reporting Information [Line Items]
Total assets	961,566	825,419
Total liabilities	931,484	812,478
Net assets	30,082	12,941
Middle East/Caucasus
Segment Reporting Information [Line Items]
Total assets	2,167	355
Total liabilities	361	172
Net assets	$ 1,806	$ 183
[1]* Please see Note 3

SUBSEQUENT EVENTS - Narrative (

SUBSEQUENT EVENTS - Narrative (Details) $ in Thousands	Feb. 08, 2023 USD ($)
Paybox Technologies LLP | Subsequent event
Subsequent Event [Line Items]
Total purchase price	$ 11,500